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Abstract 
Polycystic ovary syndrome (PCOS) is the most common cause of female infertility worldwide, yet 
this prevalent endocrine disorder remains poorly understood. Although classically considered an 
ovarian disease, altered brain wiring may play a central role in the pathogenesis of PCOS. 
Neuroendocrine derangements in PCOS include elevated luteinizing hormone (LH) pulse 
secretion, which likely results from high gonadotropin-releasing hormone (GnRH) pulse frequency 
and mirrors defects within the GnRH neuronal network. Enhanced GABA actions in GnRH 
neurons have been proposed to be a culprit of altered GnRH/LH secretion and underlie some of 
the pathological features of the disorder. Pre-clinical and clinical evidence support the idea that 
prenatal androgen excess may program an abnormal GABA-to-GnRH neuron circuit to develop 
PCOS during adult life. In this regard, the present study aimed to answer fundamental questions 
about the ontogeny, rescue and biological function of altered GABAergic innervation to GnRH 
neurons. 
This PhD project used a prenatally androgenized (PNA) mouse model that recapitulates the 
cardinal features of PCOS and mimics the elevated LH pulse frequency of the disease. Initial 
studies aimed to address whether GnRH neuronal network changes observed in PNA mice were 
programmed through early androgen exposure or driven by adult androgen excess. Control and 
PNA GnRH-GFP transgenic mice were evaluated at postnatal day (PND) 25, prior to pubertal 
onset. Confocal imaging and analysis of GABA inputs onto GnRH neurons revealed that 
GABAergic contact was significantly increased in prepubertal PNA mice (P < 0.05). In addition, 
circulating testosterone levels at PND 25 were not different between PNA and control groups, 
suggesting that brain circuit abnormalities were not dependent upon early manifestation of 
androgen excess in a PCOS-like condition. 
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Serial blood sampling defined the developmental timing of androgen excess in PNA mice, 
showing that circulating testosterone levels rise significantly during early adulthood (PND 50 and 
PND 60) in PNA animals when compared to controls (P < 0.01). All hyperandrogenic PNA mice 
presented disruption of estrous cyclicity, displaying significant arrest in the metestrous stage and 
a complete absence of the proestrous stage (P < 0.0001), indicating anovulatory cycles. To 
determine whether neuroendocrine derangements of LH regulation would persist after the removal 
of hyperandrogenic ovaries, the same cohort of mice were ovariectomized (OVX) and serial blood 
sampling was performed to investigate LH pulse dynamics. Although LH pulse frequency was 
similar between the groups, OVX PNA mice exhibited greater LH pulse amplitude (P < 0.0001) 
and magnitude of LH release than controls (P < 0.001), implying that defects within the GnRH 
network remained in the absence of hyperandrogenic ovaries and suggesting that the primary 
pathology of PCOS is in the brain.  
Compelling clinical evidence indicates that long-term androgen receptor (AR) blockade 
with flutamide (Flut) is able to restore both the sensitivity of the GnRH pulse generator and 
menstrual cyclicity in PCOS women. This PhD project tested the hypothesis that these 
improvements may be the result from plastic changes in the brain that rescue normal GABAergic 
wiring to GnRH neurons. Control and PNA mice were treated with Flut (25 mg/kg/day) or an oil 
vehicle from PND 40 to PND 60. GABA inputs to GnRH neurons were assessed as previously 
performed for prepubertal animals and confirmed that oil-treated adult PNA mice display enhanced 
GABAergic contact on GnRH neurons (P < 0.01). Remarkably, Flut treatment was able to decrease 
and rescue normal GABA-to-GnRH neuron circuit features in PNA mice (F1, 21 treatment = 41.8; 
P < 0.0001). Results also showed that estrous cyclicity of PNA mice improved considerably during 
Flut treatment. Evaluation of ovarian morphology treatment showed that AR signaling blockade 
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improved preovulatory follicle recruitment and restored normal features of the granulosa and theca 
cell layers in these follicles.  
Previous neuroanatomical work indicates that increased GABAergic wiring to GnRH 
neurons in PNA mice originates largely from the arcuate nucleus (ARN) of the hypothalamus. In 
this PhD project, I investigated the functional role of GABA neurons originating in the ARN in 
regulating LH secretion using in vivo optogenetics. Selective targeting and expression of 
channelrhodopsin-2 E123T accelerated variant (ChETA) in the ARN GABA neurons was achieved 
using vesicular GABA transporter (VGAT)-Cre mice. ARN GABA neurons were activated by 
delivering blue light pulses (5ms) at 2 and 20 Hz during 10 minutes in diestrus female, male and 
PNA mice. Optogenetic activation at 20 Hz elicited robust LH release similarly in male and diestrus 
female (P < 0.05), whereas 2-Hz stimulation failed to evoke changes in LH levels. Interestingly, 
20-Hz light stimulation in PNA mice induced smaller changes in LH levels when compared to 
male and diestrus female groups (P < 0.05). These data suggest that altered LH release in PNA 
mice might reflect a decreased pituitary LH releasable pool due to a formerly high GnRH pulse 
frequency stimulation in the PCOS-like condition. 
Together, these findings support the idea that a prenatal androgen insult can program altered 
GABAergic brain circuits early in development, prior to pubertal onset, and might be the culprit 
for developing subsequent androgen excess during early adulthood. This PhD thesis also highlights 
that abnormal GABA-to-GnRH neuron circuit remains plastic in adult PNA mice; and that the 
specific GABAergic pathway from ARN GABA neuron is biologically relevant to modulate LH 
secretion. These data support the important role of ARN GABA neurons in the regulation of the 
GnRH neuron biology in healthy fertility and in the pathophysiology of PCOS.  
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1.1 Introduction 
Polycystic ovary syndrome (PCOS) is the main endocrine disorder leading to female infertility, 
affecting 5 to 20% of women in the reproductive age in New Zealand and around the world 
(Farquhar et al., 1994; Lizneva, Suturina, et al., 2016). Although PCOS is a major concern for 
health care and fertility management, critical knowledge of its etiology and pathophysiological 
mechanisms remain unclear. Three cardinal features characterize PCOS: polycystic ovaries, 
menstrual irregularities and excess androgen production known as hyperandrogenemia (HA) 
(Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2004). Other 
comorbidities such as a metabolic syndrome including diabetes mellitus type 2, and depression are 
also associated with PCOS (Milsom et al., 2013; Azziz et al., 2016). The heterogeneity of disease 
presentation has hindered better understanding of PCOS pathological mechanisms and the advance 
of new therapeutic interventions.  
Despite great efforts of clinical and basic research, the definitive origins of PCOS are still 
obscure making it target of treatments mainly based on the postpubertal manifestation of the 
disease. Genetic, epigenetic and environmental factors are proposed to trigger and be engaged in 
the broad-spectrum of the disorder. Among these factors, elevated maternal testosterone levels are 
highly associated with the development of PCOS in daughters (Sir-Petermann et al., 2009), 
implying that prenatal androgen excess may induce a biological program for the adult 
manifestation of the disease. Although PCOS has been classically considered an ovarian disorder 
(Hughesdon, 1982; Dumesic and Richards, 2013), increasing evidence has shown that disturbances 
in brain circuits controlling gonadotropin-releasing hormone (GnRH) neurons underlie the 
pathogenesis of PCOS.  
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Neuroendocrine impairments leading to abnormal luteinizing hormone (LH) secretion are 
common in women with PCOS. In particular, high LH pulse frequency secretion is a hallmark for 
the majority of PCOS patients (Pastor et al., 1998). This is likely to reflect altered gonadal steroid 
hormone-mediated negative feedback mechanisms within the GnRH neuronal network, which is 
composed by neuronal afferents that regulate the GnRH neuron activity (Chhabra et al., 2005; 
Blank, Mccartney and Marshall, 2006). The components of the GnRH neuronal network which 
guarantee proper GnRH neuron activity are diverse and not entirely defined (Herbison, 2014). 
Among steroid-sensitive afferent neurons in this brain network, gamma-amino butyric acid 
(GABA) neurons are recognized to be crucial players for the regulation of GnRH neuron activity. 
GABAergic transmission and innervation to GnRH neurons has been found to be increased in a 
prenatally androgenized (PNA) mouse model of PCOS which exhibits the cardinal features of the 
disease (Sullivan and Moenter, 2004; Moore et al., 2015). Recently, our research group discovered 
that GABA neurons residing in the arcuate nucleus (ARN) of the hypothalamus provide enhanced 
innervation to GnRH neurons in PNA mice associated with neuroendocrine and reproductive 
impairments (Moore et al., 2015). Therefore, this novel neuronal pathway might be biologically 
relevant for the control of GnRH/LH secretion. Yet it remains to be determined whether ARN 
GABA neurons have a functional role in normal and PCOS-like condition.  
This introduction will first review the literature regarding the general features and 
pathophysiological mechanisms of PCOS. It will also highlight evidence from clinical and PCOS 
animal models that attempt to understand the role of prenatal androgen exposure as a possible 
mechanism driving the development of the disease. In particular, this introduction will review both 
classical and more recent findings focusing on the impact of prenatal androgens in programing the 
GnRH neuronal network for the manifestation of PCOS during adult life. An overview of the 
hypothalamic-pituitary-gonadal (HPG) axis underpinning the functional aspects of GnRH neurons 
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and GnRH/LH pulsatile secretion is also discussed in this section. Finally, this introduction reviews 
key aspects of GABA actions in GnRH neurons and discuss the idea that abnormal GABAergic 




                                           
1.2 Polycystic Ovary Syndrome (PCOS) 
1.2.1 PCOS: diagnosis & pathophysiology 
The original description from Stein and Leventhal’s work described PCOS as an association among 
ovarian cysts, amenorrhea, hirsutism and obesity (Stein and Leventhal, 1935). However, it was not 
until 1990 that an official definition of PCOS was firstly established during a sponsored workshop 
by the United States of America (USA) National Institutes of Health (NIH) (Zawadzki and Dunaif, 
1992). From that meeting, PCOS was defined as the clinical and/or biochemical identification of 
hyperandrogenemia (HA) with chronic oligo-anovulation. A second and broader criteria emerged 
after a meeting in 2003 sponsored by the European Society for Human Reproduction and 
Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM) held in 
Rotterdam, Netherlands. As a consensus, the Rotterdam criteria stated that PCOS should be 
diagnosed upon the presence of two of the three symptoms: menstrual irregularities, HA and 
polycystic ovaries after ultrasonography report confirmation (Rotterdam ESHRE/ASRM-
Sponsored PCOS Consensus Workshop Group, 2004). 
In accordance with the Rotterdam criteria four possible PCOS phenotypes can be identified 
from the combination of the three main symptoms (Lizneva, Suturina, et al., 2016) (Table 1.1). 
This heterogeneity is suggestive of different etiological backgrounds yet the mechanisms 
underlying the PCOS pathogenesis remain unclear. Although this phenotypic approach was 
established in order to facilitate the identification of PCOS in clinical practice, different research 
groups have reinstated PCOS as a primarily hyperandrogenic disorder (Azziz et al., 2009). 
Therefore, the identification of polycystic ovaries with chronic oligo-ovulation (phenotype D in 
Table 1.1) would not be defined as PCOS according to the diagnostic criteria of the Androgen 
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Excess PCOS Society 2006 meeting (Azziz et al., 2006). In addition, PCOS is commonly 
associated with metabolic syndrome, cardiovascular diseases, cancer of the reproductive tract and 
psychosocial diseases such as depression (for a more detailed review, see Dumesic et al., 2015), 
making this disorder a major concern in health care management. This section covers the diagnosis 
and pathophysiological mechanisms of PCOS cardinal features. 
 
Table 1.1. Defining the possible phenotypic presentations of PCOS.  Current 
diagnostic criteria for PCOS may lead to confusion during clinical assessment due to the 
heterogeneous manifestation of this disease. Lizneva and colleagues proposed a four -
phenotype classification of PCOS, which can be used during clinical practi ce and when 
investigating the pathophysiological mechanisms of this disorder. HA = hyperandrogenemia. 
(Adapted from Lizneva et al.2016).  
1.2.1.1 Androgen excess in PCOS 
Among the three cardinal features of PCOS, androgen excess is a hallmark for the disease and it is 
considered to be the culprit for menstrual irregularities and associated metabolic traits (Azziz et 
al., 2009). Studies have shown that around 60% of women with PCOS display clinical evidence of 
HA, which includes hirsutism, acne and androgenic alopecia; and around 60-80% display the 
biochemical confirmation of increased androgen plasma levels (Conway, Honour and Jacobs, 
1989; Chang et al., 2005). Clinical assessment and grading of hirsutism usually applies the 
Ferriman-Gallwey scoring screening, which  evaluates the pattern of body hair growth in post-
pubertal women (Ferriman and Gallwey, 1961; Azziz et al., 2009). The measurement of total 
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testosterone levels and the exclusion of other possible causes of androgen excess such as androgen-
secreting adrenal tumors and congenital adrenal hyperplasia (CAH) are recommended during 
clinical screening (Balen et al., 2016). The careful assessment of dermatological signs of 
hyperandrogenism should be considered as it might be dependent on ethnicity or as secondary to 
increased body weight (Williamson et al., 2001; Ollila et al., 2017).  According to clinical reports, 
the calculation of bioavailable/free testosterone should be taken as the primary diagnostic tool 
during clinical assessment and be sufficient to diagnose hyperandrogenism (Balen et al., 2016).  
 Hirsutism in adolescent girls may be an early sign of androgen excess and for the 
manifestation of PCOS during reproductive age. It may indicate that androgen actions in the HPG 
axis might trigger and perpetuate the reproductive impairment of the syndrome later in life. The 
Ferriman-Gallwey score system might not be the best tool to identify hirsute girls during early 
menarche as it mainly considers subjects above 18 years old of age (Ferriman and Gallwey, 1961; 
Ibáñez et al., 2017). Alternatively, clinical studies may include the assessment of pubertal breast 
stage, which uses the Tanner scale (Marshall and Tanner, 1969), along with hormone 
measurements to assess and confirm developmental stage and hyperandrogenism (McCartney et 
al., 2009). The Endocrine Society guidelines indicates that chronic oligomenorrhea and the 
biochemical confirmation of hyperandrogenism can be applied to diagnose PCOS adolescent girls 
(Legro et al., 2013). Although there are some compelling evidence showing that HA is an 
appropriate marker for PCOS in adolescent girls (Ibáñez et al., 2014; Villarroel et al., 2015), 
elevated androgen levels associated with irregular menses may be transient and reflect an 
incomplete maturation of the HPG axis (Ibáñez et al., 2017). Therefore, a decisive criteria to 
determine whether HA in adolescence is critical for the development of PCOS remains unclear. 
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1.2.1.2 Ovarian dysfunction 
Ovarian follicular arrest, cystic-like fluid-filled structures and increased stromal content in the 
ovaries are common traits of polycystic ovaries (Webber et al., 2003; Conway et al., 2014). 
According to the Rotterdam criteria, polycystic ovaries are identified by ultrasound diagnostic 
imaging showing the presence of ≥ 12 follicles of 2-9 mm diameter (as average value from both 
ovaries) and increased ovarian volume (more than 10 cm3) (Jonard et al., 2003; Balen et al., 2016). 
A clinical report, which evaluated cortical biopsies of polycystic and normal ovaries, revealed that 
PCOS women exhibit an abnormal increase of the number of growing follicles (Webber et al., 
2003). The same report also demonstrated that the mean proportion of early preantral follicles 
(including primordial and primary) in anovulatory PCOS patients is six times higher than normal 
women.  
Dysregulation of the early follicular development is highly associated with androgen 
excess, suggesting that elevated androgen actions establish the full spectrum of ovarian dysfunction 
(Jonard and Dewailly, 2004). Ovaries are considered to be the main source of androgen excess in 
PCOS (Gilling-Smith et al., 1994). Androgen synthesis occurs in the ovarian theca cell layer 
following the activation of LH receptor (LHCGR) during normal follicular development (Tsang, 
Armstrong, and Whitfield 1980). An overview of the ovarian follicular development is important 
to understand how androgen excess may disrupt folliculogenesis. The initial steps are independent 
of the actions of gonadotropins and controlled by transcriptional and autocrine/paracrine factors 
(Richards and Pangas, 2010). Follicle-stimulating hormone (FSH) from the pituitary gland acts in 
the ovary in synergy with intra-ovarian signals, such as anti-müllerian hormone (AMH) and growth 
factors to promote small follicle growth. A cyclic recruitment is initiated and during later stages of 
folliculogenesis, grown antral follicles secrete activins and estrogens, which in turn, increase the 
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actions of FSH in the ovaries. The selection of dominant follicles is triggered in the final steps of 
folliculogenesis through synchronized actions of FSH and LH in the granulosa and theca cell layer, 
respectively, enhancing steroidogenesis. Therefore, from the initial cohort of recruited small 
follicles just one or a few dominant follicles, depending on the species, are selected to ovulate 
(Goodman and Goodman, 2009). The ovary itself is a target for androgen actions, which influence 
follicular growth, atresia attenuation and FSH-mediated actions on granulosa cells (Figure 1.1) 
(Prizant, Gleicher and Sen, 2014; Sen et al., 2014).  
 
Figure 1.1. Androgen-mediated actions in the ovary.  The theca cells are the main 
source of androgen production in the ovaries. Androgen actions throughout the ovarian 
follicular development has received more attention in recent years. Androgens are crucial 
for the transition from small follicles to antral follicles, although it is unclear whether they 
are able to regulate the follicle recruitment from primordial to primary type and whether 
they involved in ovulation. Androgen receptor (AR) is expressed in the theca cells (in blue), 
granulosa cells (in orange) and oocyte (in pink). AR signaling activation inhibits pro -
apoptotic factors impeding atresia to occur in excess and increases the expression of foll icle-
stimulating hormone (FSH) receptor in the granulosa cells. (Figure adapted from Prizant et 




                                           
Different studies have shown that androgen receptor (AR) is expressed in the oocytes, theca 
cells and granulosa cells of both humans and rodents (Chadha et al., 1994; Hirai et al., 1994; Lenie 
and Smitz, 2009). In the mouse, AR signaling in the granulosa cells has been recognized to be 
crucial for the normal expression of FSH receptor (FSH-R), prevent follicular atresia and promote 
follicular growth (Sen et al., 2014). Although essential to normal folliculogenesis, genetic studies 
knocking out AR from granulosa cells (GCARKO), revealed that AR signaling in these cells is not 
required for the presentation of ovarian dysfunction in a PCOS mouse model, which androgen 
excess is induced during adulthood (Caldwell et al., 2017). Likewise, AR signaling in the theca 
cells seems to have minimal impact on folliculogenesis or fertility in mice (Ma et al., 2017). 
Specific deletion of AR in oocytes using a Cre-recombinase technology driven by growth 
differentiation factor-9cre (oocyte-specific) generates fertile mice with normal folliculogenesis. 
Together, these findings suggest that androgen actions in granulosa cells are important for normal 
folliculogenesis; however, androgen-mediated PCOS ovarian dysfunction might be the result of 
upstream dysregulations in the HPG axis.  
1.2.1.3 Menstrual irregularities  
Menstrual irregularities indicate the occurrence of oligo- or anovulatory events and are a common 
feature of PCOS (Fauser et al., 2012). Oligomenorrhea is identified by a menstrual cycle that last 
more than 35 days or occurs less than eight times a year. Amenorrhea is diagnosed when menstrual 
cycles are longer than 199 days (Broekmans et al., 2006). In the clinics, plasma progesterone may 
also be used as marker for oligo-anovulation and blood levels should be below 3-4 ng/mL during 
the midluteal phase of the menstrual cycle (Legro et al., 2007; Dumesic et al., 2015). Clinical 
studies show that PCOS women may also present suboptimal FSH levels or elevated LH:FSH ratio, 
which are associated with anovulatory infertility (Manieri et al., 1992; Tarlatzis et al., 1995). Large 
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longitudinal cohort study showed that infertility was 15-fold higher in PCOS women whereas only 
16% of non-PCOS subjects noted infertility (Joham et al., 2015). In addition, results from a 31 
years follow-up study showed that 66% of PCOS women reported history of infertility in 
opposition to a significant lower number of 6% in the control group (Wild et al., 2000). Therefore, 
PCOS is a highly prevalent endocrine disorder leading to sub- and infertility making it a major 
concern for health management.     
1.2.1.4 PCOS & Metabolic syndrome 
PCOS diagnostic criteria does not include metabolic syndrome, although the disorder is commonly 
associated with obesity, insulin resistance (IR) and type 2 diabetes mellitus (Jayasena and Franks, 
2014; Ollila et al., 2017). Hyperinsulinemia and IR are known to exacerbate androgen excess and 
irregular cycles in obese and also non-obese PCOS women when compared to body weight 
matched subjects (Stepto et al., 2013). The molecular mechanisms of IR in PCOS are likely to be 
different from those observed in non-PCOS insulin resistant diabetic women (Book and Dunaif, 
1999). Possible causes of IR in PCOS include abnormalities in the insulin receptor activity and 
enhanced cytokine actions leading to impaired insulin signaling (Escobar-Morreale, Luque-
Ramírez and González, 2011). Reproductive tissues such as ovaries and pituitary are more resistant 
to hyperinsulinemia in the presence of elevated androgen levels in mice (Andrisse et al., 2017). 
Specifically, insulin stimulates the activity of ovarian P450scc enzyme increasing androgen 
production (Li et al., 2013) and increases the secretion of FSH and LH from culture rat pituitary 
(Adashi, Hsueh and Yen, 1981). Therefore, IR seems to be tissue-specific in PCOS and androgens 
might sustain insulin stimulatory actions in reproductive tissues (Figure 1.2).  
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Figure 1.2. Pathogenesis of PCOS and the relationship between hypothalamic -
pituitary-gonadal (HPG) dysfunction, androgen excess and metabolic features of 
the disease.  Genetic/epigenetic predisposition to increased androgen production by the 
polycystic ovaries is implicated in disrupting neuroendocrine mechanisms controlling LH 
secretion. Menstrual irregularities and distressing effects of hyperandrogenem ia such as 
hirsutism are commonly present in association with metabolic traits of PCOS. Elevated 
androgen levels can upregulate insulin-mediated pathway increasing luteinizing hormone 
(LH) secretion and induce insulin resistance in other peripheral tissues . Insulin resistance 
and hyperinsulinemia aggravate this scenario as insulin stimulate androgen synthesis. 
(Figure adapted from Jayasena and Franks, 2014).  
 
Body weight is not a determinant factor for the development of IR in PCOS as lean PCOS 
girls can present hyperinsulinemia before pubertal onset (Sir-Petermann et al., 2009), indicating 
that impaired insulin sensitivity might be part of PCOS pathogenesis. However, reports suggest 
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that IR and additional effect of western diet may maintain the increase testosterone production by 
the ovaries and anovulation (Jayasena and Franks, 2014). In some reported cases, pharmacological 
intervention that leads to increased insulin sensitivity such as metformin treatment is able to 
improve menstrual cyclicity, HA and fertility (Yilmaz et al., 2005; Gambineri et al., 2006). The 
importance of weight loss to improve menstrual cycles in PCOS patients seems to be 
overemphasized (Sirmans and Pate, 2013) showing a small effect of ~5% in improvement of 
menstrual cyclicity after weight loss as reported by the Androgen Excess and PCOS Society 
(Moran et al., 2009).  
It is important to highlight that the association of increased body weight, elevated androgen 
levels and decreased reproductive function does not always imply causation. Rosenfield and 
Bordini discussed several studies demonstrating that obesity and androgen levels may affect 
independently the female reproductive function by a biphasic effect on the gonadotropin secretion 
(Rosenfield and Bordini, 2010). This means that the too high or too low either relative adipose 
mass or androgen levels negatively impact LH secretion independently. Hence, in PCOS patients 
who exhibit elevated LH levels, the metabolic dysfunction can aggravate the disease symptoms but 
might not be causing the syndrome. Considering that around 30-50% of PCOS women do not show 
the metabolic syndrome (DeUgarte, Bartolucci and Azziz, 2005), it might suggest that distinct 
molecular targets might underlie the pathogenesis of either obese or non-obese PCOS phenotypes. 
Therefore, the next section will cover some of the genetic and developmental determinants which 
might be involved in the pathogenesis of PCOS. 
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1.2.2 Pathogenesis & developmental aspects of PCOS 
1.2.2.1 Genetic determinants & the genesis of PCOS 
Heritable alleles and their association with environmental factors may drive the phenotypic 
presentation of PCOS. Early reports pointed to PCOS as an autosomal dominant inheritance 
disorder with around 40-50% of prevalence between first-degree familial relatives (Hague et al., 
1988). However, this autosomal dominant inheritance was questioned after a twin study performed 
in an Australian monozygotic and dizygotic twin cohorts concluding that there was a clear 
difference in the genetic basis between hyperandrogenic and non-hyperandrogenic PCOS women 
(Jahanfar et al., 1995). Thus, it is unlikely that PCOS is a result from a single autosomal genetic 
determinant. A larger twin study performed in a Dutch cohort using quantitative estimation of the 
genetic influence found a strong genetic contribution with a heritability rate of 79% for the 
prevalence of PCOS according to the Rotterdam criteria (Vink et al., 2006). 
Genome-wide association studies (GWAS) attempt to provide genetic associations that 
may have mechanistic values to understand the development of PCOS. Two initial large GWAS 
analyzed risk loci for the developing PCOS in Han Chinese population and, together, they 
elucidated eleven candidate genes (Chen et al., 2011; Shi et al., 2012). Relevant PCOS association 
signals were found in the thyroid adenoma associated (THADA) gene intronic region, a gene 
associated with thyroid cancers, energy balance and risk for type 2 diabetes (Kloth et al., 2011; de 
Melo et al., 2015; Moraru et al., 2017); DENND1A loci, a gene that encodes connecdenn 1 and 
involved in trafficking of endosomes and involved in androgen production (Tee et al., 2016); and 
variants in the gene of FSH receptor (FSH-R), which is critical for folliculogenesis and fertility 
(Simoni et al., 2008).  
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A recently published comprehensive GWAS elucidated more aspects of the genetic genesis 
of PCOS and its neuroendocrine correlates (Day et al., 2015). This study evaluated more than 5,000 
Caucasian European women and used dense imputation of genotypes, which identify association 
signals and draw mechanistic interpretations from the genetic data. They discovered six genetic 
loci associated with PCOS: YAP1 (a transcriptional factor involved in cancer), THADA, RAD50 
(encodes a DNA double-strand break repair protein), KRR1 (a ribosome assembly factor), FSHB 
(β-subunit of FSH) and epidermal growth factor receptor (EGFR) family members such as ERBB4 
and ERBB3. This study also presented that polymorphisms which may lead to altered FSH 
secretion and signaling may participate in the neuroendocrine genesis of PCOS, once this was 
positively correlated with elevated LH:FSH ratio in their cohort. Notably, EGFR family members 
are involved not just in LH-mediated steroidogenesis (Park et al., 2004) and ovulation but also they 
have strong influence on brain circuitry development (Namba et al., 2017). Using Mendelian 
randomization analysis to infer causal roles, they identified that body weight, insulin resistance 
and low levels of sex hormone-binding globulin (SHBG) are risk factors for the development of 
PCOS. A strong and positive association between the risk of having PCOS and showing delayed 
menopause was found, suggesting an attenuation of ovarian ageing in these subjects (Day et al., 
2015). This is linked with earlier hypotheses proposing that a genetic predisposition to delayed 
reproductive senescence in PCOS would support the evolutionary paradox of being a highly 
prevalent disease that impairs female reproductive competence (Abbott, Dumesic and Franks, 
2002; Mulders et al., 2004; Casarini and Brigante, 2014). In addition to the genetic basis of the 




                                           
1.2.2.2 Developmental programing: role of intrauterine androgenization in the pathogenesis of 
PCOS 
Although there is a consensus that PCOS is not caused by one single determinant, there is a strong 
association between exposure to prenatal androgen excess and the presentation of the cardinal 
features of the disease after pubertal onset. In utero androgen excess in humans caused by 
congenital adrenal hyperplasia (CAH) and maternal Cushing`s disease, both which expose female 
fetuses to high androgen levels, leads the clinical manifestation of PCOS in adulthood (Hague et 
al., 1990; Barnes et al., 1994). Likewise, daughters of PCOS women, who have higher circulating 
testosterone levels during pregnancy than normal subjects, show signs of ovarian and metabolic 
dysfunction during pubertal development and an increased risk of developing PCOS in adulthood 
(Crisosto et al., 2007; Sir-Petermann et al., 2009). Placental tissue of mothers with PCOS exhibit 
higher activity of 3β-hydroxysteroid dehydrogenase type 1 (3β-HSD-1), which increases 
androstenedione levels, and lowers the activity of P450 aromatase, which is critical in converting 
androgens to estrogens (Maliqueo et al., 2013). Consequently, altered placental steroidogenesis in 
PCOS could sustain elevated intrauterine androgen levels during pregnancy and affect the 
development of female offspring. Together, these data point toward a prenatal androgen 
programing as potential mechanism to drive PCOS features later.  
The idea of a PCOS in utero origin propose two mains hypotheses on how the 
developmental programing generates the reproductive impairment of PCOS. One explanation 
makes the ovarian dysfunction as the starting point of the disease. Thus, androgen imprinting in 
the ovaries triggers an abnormal secretion of testosterone following the onset of puberty (Gilling-
Smith et al., 1994; Rosenfield and Bordini, 2010; Zhang et al., 2014). In turn, high testosterone 
plasma levels might modify the hypothalamic-pituitary-gonadal (HPG) axis functioning to the full 
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presentation of PCOS symptoms. A second explanation places the brain as the primary site in the 
PCOS pathogenesis. During perinatal life, hypothalamic circuits, which are involved in the control 
of reproductive and metabolic function, are highly responsive to sex steroid hormone modulation 
(Phoenix et al., 1959; McCarthy, Nugent and Lenz, 2017). Accordingly, prenatal androgen actions 
may alter the organization of components within the GnRH neuronal network and ultimately drive 
abnormal GnRH/LH pulsatility and ovulatory dysfunction (Blank, Mccartney and Marshall, 2006; 
Moore and Campbell, 2016). It is important to note that one explanation does not exclude the 
occurrence of the other and that both could happen concomitantly in PCOS. To investigate these 
different hypotheses, PCOS animal models, which can be generated with prenatal androgen 
exposure, have been broadly used in basic research.  
1.2.2.3 Prenatally androgenized (PNA) PCOS animal models 
Clinical studies are mostly aimed at controlling PCOS symptoms and are limited in terms of access 
to human tissues and hypothesis-driven investigation of pathological mechanisms. Therefore, the 
use of PCOS animal models has provided important evidence about the pathophysiology of the 
disease. Most of these models employ prenatal or early postnatal androgen exposure, which are 
able to recapitulate the cardinal traits of PCOS. Although the number of androgen exposure 
protocols has increased in recent years, the present literature review focuses on the most commonly 
used prenatally androgenized (PNA) models as they have provided substantial evidence about the 
PCOS-like development in non-human primates, sheep and rodents. 
1.2.2.3.1 Non-human primates 
Considering the shared characteristics among primates, the rhesus monkey (Macaca mulatta) is an 
ideal model to study PCOS. Similar to humans, monkeys are a precocious and monovulatory 
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species, and show complete intrauterine ovarian development. Prenatal androgen exposure was 
firstly proposed to be studied in non-human primates following evidence that elevated intrauterine 
androgen levels in CAH induce ovulatory dysfunction, HA and LH hypersecretion in female 
offspring (D H Abbott et al., 1998). Pregnant rhesus monkeys exposed to testosterone, during 
gestational days (GD) 40 to GD 60 (pregnancy ~ 165 days) generated female offspring that 
recapitulate the main PCOS features such as anovulation, HA, enhanced LH secretion and 
polycystic ovaries (Dumesic et al., 1997; D H Abbott et al., 1998; Eisner et al., 2002). Importantly, 
female rhesus monkeys can be naturally hyperandrogenic and develop PCOS-like features. A 
recent study revealed that the prevalence of PCOS-like monkeys within a laboratory population 
was close to findings in humans (~15%), and hyperandrogenic rhesus monkeys exhibit high serum 
concentration of LH and anti-müllerian hormone (AMH) positively associated with infertility 
(Abbott et al., 2017).  Therefore, neuroendocrine, ovarian and associated metabolic features of 
PCOS can be recapitulated in the non-primate model. However, the time consuming generation of 
these animals, high costs and poor availability of transgenic lines have limited their broad use in 
basic research. 
1.2.2.3.2 Sheep 
Sheep are monovulatory animals similar to humans and provide a valuable model to study PCOS. 
Early (GD 30-90) or mid (GD 69-90) gestation prenatal testosterone exposure is able to recapitulate 
anovulation, cystic-like ovarian morphology and HA (Birch et al., 2003).  The PNA sheep model 
exhibits elevated LH pulse frequency secretion and increased response to intermittent treatment of 
exogenous GnRH (Manikkam et al., 2008), recapitulating the neuroendocrine impairment of 
PCOS. PNA sheep also display disruption of the LH surge, and impaired estradiol- and 
progesterone-negative feedback on GnRH/LH release (Padmanabhan and Veiga-Lopez, 2013a). 
Chapter One 
19 
                                           
Although the model provides a good opportunity to study the cardinal features of PCOS, a high 
degree of virilization of the external genitalia is observed in PNA female sheep (Roland et al., 
2010), which raises the question whether this is modeling a masculinization of the brain or PCOS. 
The relatively high maintenance costs, longer gestational length (~150 days), seasonal  aspects of 
breeding  and lack the of specific transgenic animals presents hurdles for broader use of this model 
(for more details about this model, see review Veiga-lopez et al., 2009). 
1.2.2.3.3 Rodents 
Prenatal exposure during late pregnancy with testosterone or dihydrotestosterone (DHT), a non-
aromatizable androgen, evokes PCOS-like features in rats and mice. In rats, a small dose of 1 
mg/day during gestational days (GD) 21-23 is able to increase LH secretion frequency, attenuate 
progesterone receptor expression in the POA and eliminate the LH surge in adulthood (Foecking 
et al., 2005). By increasing the prenatal testosterone or DHT dose to 3 mg/day during the same 
period, PNA rats present higher testosterone levels, increased LH frequency and amplitude, 
irregular estrous cyclicity and ovarian dysfunction (Wu et al., 2010). A prenatal dose of 5 mg/day 
of testosterone during the same gestational period evokes the PCOS cardinal features and metabolic 
associated traits such as increased body weight, hyperinsulinemia and dyslipidemia in adulthood 
(Demissie et al., 2008). Therefore, these findings suggest that a differential intrauterine androgen 
milieu might be key to the heterogeneity manifestation of PCOS. PNA female rats also display 
anxiety-like behaviors that are associated with disrupted AR signaling in the amygdala (Hu et al., 
2015); indicating PNA rats as suitable models to investigate PCOS associated neurological 
diseases such as anxiety and depression.  
Likewise, mice and transgenic mouse technology has offered important genetic tools to 
understand and define PCOS pathogenesis. Prenatal exposure with DHT in mice at a dose of 250 
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μg/day during late pregnancy (GD 16-18) generates adult female mice displaying elevated 
testosterone plasma levels, ovarian dysfunction and impaired steroid-mediated negative feedback 
mechanisms such as in the human condition (Sullivan and Moenter, 2004; Moore, Prescott and 
Campbell, 2013). Neuroendocrine features of PCOS are also present in PNA mice such as high LH 
pulse frequency secretion (Moore, Prescott and Campbell, 2013). This neuroendocrine 
derangement is associated with an increase of dendritic spine density in GnRH neurons during 
adulthood (Moore, Prescott and Campbell, 2013) suggestive of enhanced afferent synaptic inputs 
onto these neurons. Aberrations within the hypothalamic circuits controlling GnRH/LH secretion 
are also observed in PNA mice (Moore, Prescott and Campbell, 2013; Moore et al., 2015), which 
will be further discussed in section 1.4.4. PNA mice are lean without significant and present mild 
metabolic phenotype including increased fasting glucose levels, early form of islet dysfunction in 
the pancreas and adipocyte hypertrophy (Roland et al., 2010; Caldwell et al., 2014). Modeling lean 
PCOS provides a unique opportunity to dissect out specific factors that might contribute to the 
reproductive impairment in PCOS without the secondary influence of increased body weight or 
hyperinsulinemia.   
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1.3 The control of reproduction & the female brain 
The control of female reproduction in mammals is ultimately dependent upon neural circuits in the 
brain. Located in the hypothalamus, gonadotropin-releasing hormone (GnRH) neurons provide the 
final output from the brain with pulsatile release of GnRH into the hypophyseal portal system 
signaling to the pituitary gland.  In the pituitary, GnRH promotes the secretion of follicle-
stimulating hormone (FSH) and luteinizing hormone (LH) into the systemic blood stream, which 
levels are tightly regulated during the female reproductive cycle. These two gonadotropins act 
downstream in the ovaries to coordinate ovarian follicle development, ovulation and the production 
of ovarian steroid hormones, such as estrogens and progesterone. Completing a closed-loop 
system, steroid hormones act back in the hypothalamus to regulate the GnRH neuron activity 
through a steroid-sensitive neuronal network. Therefore, the gonadal feedback information to the 
brain is crucial for the normal reproductive function (Goodman and Goodman, 2009; Herbison, 
2014).  
Internal and external clues can modulate the activity of GnRH neurons and impact the entire 
hypothalamic-pituitary-gonadal (HPG) axis. To guarantee fertility and balance it out with energy 
expenditure, neuroendocrine systems sense various cues and transmit the information to GnRH 
neurons. In a pathological state, however, an inappropriate regulation of GnRH neurons generates 
an abnormal secretion of gonadotropins, which negatively affects fertility. This is the case of 
PCOS, in which ~ 75% of patients with the disorder exhibit elevated LH pulsatile secretion, an 
enhanced response to exogenous gonadotropin stimulation and an increased LH:FSH ratio in the 
blood (Rebar et al., 1976; Taylor et al., 1997; Patel et al., 2004). Thus, PCOS is considered a 
neuroendocrine disorder associated with ovarian dysfunction and menstrual irregularities. The 
present section provides an overview of the intrinsic features of the GnRH neuron network and 
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discusses evidence supporting the notion that changes within this system may establish the 
development of PCOS.  
1.3.1 The GnRH system & the HPG axis   
1.3.1.1 Developmental, morphological & intriguing features of GnRH neurons 
When compared to other brain cells, GnRH neurons display peculiar characteristics from the time 
they are born to their final locus within the basal forebrain. The ontogenesis of GnRH neurons and 
the olfactory system are remarkably associated. In mice, GnRH neurons are born in the medial part 
of the olfactory placode of the developing nose known as vomeronasal organ (VNO) (Schwanzel-
Fukuda and Pfaff, 1989). Neural crest cells from the VNO give rise to GnRH neurons, which later 
migrate along the nervus terminalis, the vomeronasal nerve and then to the olfactory nerve through 
the cribriform plate and into the developing forebrain (Wray, Grant and Gainer, 1989; Forni et al., 
2011). In humans, GnRH-expressing cells are firstly detected in the basal lamina of the VNO, 
similar to rodents, and migration into the forebrain begins around the 48th day of gestation (Casoni 
et al., 2016). 
Various signals influence GnRH neuron migration such as cell adhesion molecules, 
neurotransmitters and growth factors (Wierman, Kiseljak-vassiliades and Tobet, 2011). 
Hypophysiotropic GnRH neurons, representing 50-70% of the total population, reach their final 
location in a scattered distribution throughout the anterior portion of the hypothalamus of rodents 
(Jennes, Stumpf and Sheedy, 1985; Silverman, Jhamandas and Renaud, 1987). Cell bodies of 
hypophysiotropic GnRH neurons are mainly located in the medial septum (MS), rostral preoptic 
area (rPOA),  organum vasculosum of the lamina terminalis (OVLT), and anterior hypothalamic 
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area (AHA) (Skynner et al., 1999), with GnRH neuron fibres extending toward the median 
eminence (ME) and hypophyseal portal system (Figure 1.3).  
 
Figure 1.3. GnRH neuron distribution in the mouse brain.  (A) View of the location 
of the hypothalamus (blue dashed lines) in the human and the mouse brain, both in a sagittal 
view. (B) This image shows magnified sagittal view of a schematic mouse brain showing the 
location of GnRH neurons (green dots) and brain coronal sections from GnRH -green 
fluorescent protein (GFP) mice. The GnRH neurons are found in a scattered distribution 
throughout the hypothalamus in the (a,b)medial septum (MS), (c)rostral preoptic area 
(rPOA), (c)organum vasculosum of the lamina terminalis (OVLT) and (d)anterior 
hypothalamic area (AHA). GnRH neuron fibres reach the hyp ophyseal portal vessels through 
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(e) median eminence (ME) to secrete GnRH pulses into the hypophyseal portal system to the 
pituitary gland (pit). Scale bar =100μm; fx: fornix, ac: anterior commissure, cc: corpus 
callosum. (Figure adapted and used with the permission of Dr Rebecca E. Campbell).  
 
The GnRH neuron population constitutes a heterogeneous group of cells with intriguing 
morphological and electrophysiological characteristics. The majority of adult GnRH neurons show 
a unipolar or bipolar morphology, which incorporates the cell body, and one or two dendrites 
(Jennes, Stumpf and Sheedy, 1985). Using transgenic mouse technology to drive the expression of 
green fluorescence protein (GFP) in GnRH neurons, the morphological features of GnRH-GFP 
neurons can be visualized, allowing further investigation of their cellular structure and 
electrophysiological features (Spergel et al., 1999). Using biocytin, a low molecular-weight dye, 
to fill GnRH-GFP neurons in acute mouse brain slices, it was revealed that these neurons display 
a long dendrite that extents over 1000 µm from the soma and is decorated with spines and filipodia 
(Campbell, Han and Herbison, 2005). At different levels of the hypothalamus, such as MS, OVLT 
and rPOA, GnRH neurons are found to project in different directions and fairly often display a 
“hair-pin” loop toward the ME (Herde and Herbison, 2015).    
The soma of GnRH neurons is decorated with somatic spines, which are neuronal structures 
that mainly harbour excitatory inputs (Harris and Weinberg, 2012). With electron microscopy 
resolution, at the level of the cell body, GnRH neurons can be classified as “smooth” or “spiny” 
cells according to the density of neuronal spines and cytoplasmic protrusions (Jennes, Stumpf and 
Sheedy, 1985). This spiny type of GnRH neurons was later associated with enhanced activity as 
most of these cells express c-Fos, a neuronal marker of increased neuronal activity, at the time of 
the preovulatory LH surge in mice (Chan et al., 2011). The remodelling of somatic spines might 
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be dependent on ovarian steroid signaling since ovariectomy is able to significantly reduce the 
spine density whereas estradiol treatment mimicking positive feedback increases the number of 
spines in activated (c-Fos-positive cells) GnRH neurons (Chan et al., 2011). Pathological 
conditions are associated with altered spine density in GnRH neuron. In normal female mice, c-
Fos-expressing GnRH neurons (surged) exhibit an increased density of somatic spines when 
compared with non-surged GnRH neurons following LH surge protocol (Moore, Prescott and 
Campbell, 2013). Conversely, in PNA mice, these cellular remodelling is absent as both surged 
and non-surged GnRH neurons display high number of somatic spines in GnRH neurons similarly 
(Moore, Prescott and Campbell, 2013). This finding suggests that a greater proportion of GnRH 
neurons might be in hyperactive state in PNA mice compared to normal females. 
The GnRH neuron dendrite is also decorated with dendritic spines as observed with electron 
microscopy (Jennes, Stumpf and Sheedy, 1985) or by using biocytin filling of GnRH neurons 
(Campbell, Han and Herbison, 2005). Although dendritic spines are mainly located in the proximal 
dendrite (< 50 µm from the soma), they can also be found in distal segments of the neuron in the 
mouse (Herde and Herbison, 2015). For the majority of neurons in the forebrain, actions potentials 
are usually initiated in the proximal segments of axons, which possess a high density of voltage-
activated ion channels to trigger neuron firing (Scholz et al., 1993; Hu et al., 2009). On-cell 
recording in GnRH neuron dendrites coupled with whole-cell path clamp at the cell body revealed 
that their dendrites bear the spike initiation site and are capable of propagating spikes (Roberts, 
Hemond and Suter, 2008). Further characterization using calcium (Ca2+) imaging and electrical 
recordings in brain slices of GnRH-GFP mice confirmed the dendrites as the neuronal structure 
responsible for the generation of action potentials (Iremonger and Herbison, 2012).  
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Morphological studies presented that around 2/3 of axons of GnRH neurons are originated 
from dendritic segments (Herde and Herbison, 2015). Additionally, the same work showed that the 
detection of Ankyrin G, a marker of action potential initiation site, is mostly present at dendrites 
and ~14% of the GnRH neurons displayed Ankyrin G in axons. Together, these reports elucidate 
that GnRH neuron axons are not the most common site generating neuronal spiking, which seems 
to be dictated by dendrites. Remarkably, reports using a series of morphological and 
electrophysiological tools showed that GnRH neuron dendrites possess an exquisite hybrid 
structure, capable of receiving and propagating action potentials referred as dendron (Herde et al., 
2013; Iremonger and Herbison, 2015). In addition, biocytin cell filling technique in mouse brain 
slices revealed that GnRH neuron dendrites intertwine, show dendro-dendritic associations and 
receive shared synapses from afferent neurons (Campbell et al., 2009). Together, these findings 
show that GnRH neurons are outfitted with a long and active dendrite (or dendron), which can 
receive and integrate a vast network of inputs (Figure 1.4).  
Axonal projections of GnRH neurons are located in the OVLT and ME and the majority of 
axons rise from distal dendrites (Herde and Herbison, 2015). In the ME, GnRH neuron processes 
branch out from dendritic trees toward the output zone, which contacts fenestrated vessels due to 
the absence of blood brain barrier (BBB) (Pelletier et al., 1974; Silverman and Desnoyers, 1976; 
Herde et al., 2011). Glial interactions occur with GnRH neurons in the ME to control their axonal 
access to the hypophyseal portal system. Tanycytes, a specialized ependymal cell located at the 
base of the third ventricle (3V) of the brain, regulates the retraction or ensheathment of GnRH 
neuron terminals through semaphoring7A signaling, which in turn, is dependent on ovarian steroid 
hormone modulation (Parkash et al., 2015). Therefore, glia-GnRH neuron interaction might be 
important to control the hypophysiotropic demands of different patterns of GnRH secretion 
throughout the female reproductive cycle (Figure 1.4).  
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Figure 1.4. Morphological features of GnRH neurons.  This scheme shows a model 
presented by Campbell, R.E. to decipher the morphological features of GnRH neurons in the 
different regions of the hypothalamus. GnRH neuron cell bodies are mostly found throughout 
the hypothalamus being distributed in a scattered way in the medial sept um (MS; neurons in 
blue), in the rostral preoptic area (rPOA; neurons in pink) and anterior hypothalamic (AHA; 
neurons in yellow). GnRH neuron processes are mainly found in the organum vasculosum of 
the lamina terminalis (OVLT) and in the median eminence (ME). (A) GnRH neurons can be 
classified into “spiny” and “smooth” according to the presence or absence, respectively, of 
neuronal spines which decorate the soma and dendrites. (B) GnRH neuron dendrites can 
extend over 1000 µm from the MS/rPOA toward the ME. Dendrites are the main site of 
action potential initiation (green glowing line) and have been recently referred as dendrons. 
(C) Around 20% of GnRH neurons project dendritic trees, which branch out in more than 
two processes and axonal-like structures in the OVLT. (D) GnRH neuron dendrites also 
intertwine, show dendro-dendritic associations and receive shared synapses from afferent 
neurons. (E) Axons raise from dendrons and are mostly found in the external layer of the 
ME. (F) GnRH neuron dendrites often project in different directions and fairly often display 
a “hair-pin” loop toward the ME.          
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1.3.1.2 Functional aspects of GnRH neurons & gonadotropin secretion 
Reproductive function is dependent upon pulsatile secretion of GnRH, which coordinates and 
drives the secretion of gonadotropins. Seminal studies in non-human primates revealed that the 
secretion pattern of LH is pulsatile (Dierschke et al., 1970), and that continuous administration of 
GnRH silences gonadotropin secretion (Belchetz et al., 1978). Using a push-pull technique in the 
portal vasculature in ovariectomized sheep, researchers were able to measure and show that GnRH 
and LH secretion are paired at a pulse relation rate of 1:1 ratio (Clarke and Cummins, 1982) 
(Figure 1.5). In contrast, FSH secretion does not show a direct correlation with or dependence 
upon GnRH pulses as demonstrated in gonadectomised ewes which had a hypothalamic-pituitary 
disconnection and were treated with exogenous GnRH (Clarke et al., 1986). Although FSH 
secretion is uncoupled from GnRH pulses, FSH synthesis is dependent upon GnRH receptor 
(GnRH-R) signaling in gonadotropes through a constitutive secretory pathway (Thompson and 
Kaiser, 2014).  
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Figure 1.5. The pulse profile of GnRH and LH peptides in the hypophyseal portal 
and systemic blood of ovariectomized ewes.  The pattern of GnRH and LH release 
showed a 1:1 relationship with the detection of one GnRH/LH pulse per hour in the absence 
of negative feedback from ovarian steroid hormones. The arrows show larger GnRH pulses, 
which correlate with LH pulses and point out small magnitude pulses that are not paired 
with LH release. GnRH levels were obtained with a push -pull perfusion technique in the 
basal hypothalamus in conscious sheep. LH levels were concomitantly measure through 
cannulation of jugular vein (Figure adaptated from Clarke and Cummins, 1982) .  
 
The pulse relation rate of 1:1 of GnRH:LH ratio determines the LH pulse frequency 
secretion and, in females, whereby measurements of LH pulse frequency in the systemic blood is 
used as a proxy for GnRH pulse frequency in the hypophyseal portal blood (Clarke and Cummins, 
1982). The amplitude of LH secretion is also determined by the GnRH pulse frequency but in an 
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inversely proportional manner. This means that low-frequency of GnRH pulses induce high LH 
pulse amplitude, and high-frequency GnRH pulses generates a reduced LH pulse amplitude (Clarke 
and Cummins, 1985). These findings suggest that the releasable pool of LH-containing secretory 
granules in the pituitary, which underpins the pulse amplitude, is determined by frequency of 
GnRH stimulation in the gland. The GnRH pulsatile release drives two distinguished types of LH 
secretion: LH pulses in both sexes and a pre-ovulatory LH surge, which is only present in females. 
During the transition from follicular phase to the luteal phase of the female reproductive cycle 
GnRH/LH pulse frequency increases significantly culminating in the detection of a LH surge 
release, which is critical for ovulation (Smith, Freeman and Neill, 1975; Karsch et al., 1997; 
Czieselsky et al., 2016).  
Intrinsic pulsatile electrical pattern can be detected in GnRH neurons in certain 
circumstances. Ex vivo studies using cell cultures of embryonic olfactory placode explants or 
immortalized cell cultures (termed GT1-7 cells), found that GnRH neurons display intrinsic burst 
firing (Funabashi et al., 2001; Nunemaker et al., 2001), synchronized Ca2+ oscillations (Terasawa, 
Schanhofer, et al., 1999) and pulsatile GnRH release (Terasawa, Keen, et al., 1999). Although ex 
vivo preparations are useful to understand the innate mechanisms of GnRH neuron activity, they 
do not possess the complexity of an entire adult neuronal network. To date, intrinsic pulsatile firing 
activity for the majority of adult GnRH neurons recorded in vivo has not been shown. Considering 
that GnRH neurons share more synapses with non-GnRH neuron than with themselves (Campbell 
et al., 2009), it is possible that synchronized pulsatile GnRH secretion might be the result of the 
action of upstream afferent neurons. Therefore, extrinsic factors might be fundamental for the 
functioning of the GnRH neuron network, as seen in other brain cells such as in oxytocin neurons, 
which allow to coordinate burst firing and peptide release (Ludwig and Leng, 2006).   
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Attempts to unveil the endogenous pattern of GnRH neuron electrical activity and make 
associations with GnRH release have used electrophysiological recordings of GnRH-GFP neurons 
in brain slices (Spergel et al., 1999; Suter et al., 2000). Reports showed that some GnRH neurons 
exhibit sustained bursting activity with bursting interval values that can vary from seconds to 
several minutes (Nunemaker, DeFazio and Moenter, 2002; K. Lee et al., 2010). However, GnRH 
interval of hormone release has been found to be longer, from minutes to hours, making it difficult 
to understand how the cellular electrical behavior is coupled with the episodic release of GnRH. In 
vivo recordings in GnRH-GFP mice reported that 86% of the GnRH neurons displayed spontaneous 
activity; however, only a small portion of these active neurons (~15%) exhibited burst firing 
(Constantin, Iremonger and Herbison, 2013). The requirement of a burst firing pattern to induce 
pulsatile release of GnRH/LH was recently addressed using an optogenetic approach in mice 
(Campos and Herbison, 2014). This study demonstrated that a continuous optical stimulation of 10 
Hz over 2 min, which activated a small number of GnRH neurons (~5%), can induce pulse-like 
LH secretion in vivo. In contrast, a burst pattern of optogenetic stimulation did not elicit any LH 
release. Therefore, these data suggest that burst firing activity of GnRH neurons is not required to 
promote GnRH/LH pulse secretion. Together, these findings strengthen the idea that the control of 
synchronous pulsatile activity of GnRH neurons is upstream from GnRH neurons within their 
neuronal network.   
1.3.1.3 Gonadal steroid hormone feedback regulation in the female HPG axis 
For the majority of vertebrates, the variation of circulating gonadotropins and ovarian steroid 
hormones levels reflect the functioning of the HPG axis and define the female reproductive cycle 
(Figure 1.5A). In humans, as in rodents, low and tonic gonadotropins levels and increasing 
concentrations of estradiol determine the follicular phase (Smith, Freeman and Neill, 1975). 
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Estrogens are potent downregulators of the HPG axis exerting a negative feedback signal to 
ultimately decrease GnRH/LH secretion through direct actions in the GnRH neuronal network and 
the pituitary gland (Karsch et al., 1997; Goodman and Goodman, 2009). However, rising levels of 
estrogens induce a switch from negative to positive feedback at the end of the follicular phase 
(Yamaji et al., 1971), which increases the activity of GnRH neurons culminating in a LH surge in 
females (Figure 1.5B). The LH surge is critical for the occurrence of ovulation and subsequent 
rise in progesterone secretion from the corpus luteum in the ovary (Zeleznik and Plant, 2015). 
 
Figure 1.5: The female reproductive cycle & HPG axis in mammals.  (A) Diagram 
showing the female reproductive cycle. The follicular phase of the female reproductive 
cycle is characterized by low levels of follicle stimulating hormone (FSH) and luteinizing 
hormone (LH). Rising levels of estrogens take place from the mid follicular phase due to 
their elevated production by developing ovarian follicles. FSH biosynthesis and secretion is 
increased by activins, produced by the ovaries, during late follicular phase. FSH actions in 
the ovary are important for the selection of preovulatory follicles and expression of the LH 
receptor. Following the rising levels of estrogen, LH secretion is robustly increased, 
described as a surge, and is critical for ovulation ( dashed purple line). In humans, two days 
around the ovulation are defined as fertile period (yellow box). LH actions in the ovaries 
induce luteinization and progesterone synthesis, which is found at high concentration in the 
bloodstream. (B) Feedback mechanisms in the HPG axis. Gonadal  steroid hormones such 
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as estrogens and progesterone decrease the HPG axis activity via negative feedback 
regulation. At the level of the brain, these hormones act on steroid-sensitive afferent neurons 
to ultimately reduce the activity of GnRH neurons. At the  pituitary gland, steroid hormones 
are able to attenuate the biosynthesis and secretion of FSH and LH . However, rising 
estrogens induce a switch from negative to positive feedback leading to an increase in GnRH 
neuron activity and subsequent LH secretion.  
 
Ovarian steroid hormones are able to modulate GnRH/LH pulsatile release through 
different mechanisms in the brain. Investigating the negative feedback in gonadectomized ewes, 
evaluation of  the hypophyseal portal blood revealed that estrogen has a direct effect in the brain 
by supressing GnRH pulsatile secretion in a dose-dependent manner (Evans et al., 1994). Direct 
negative feedback in the pituitary gland can be observed in postmenopausal women treated with 
graded doses of exogenous GnRH and estrogen after depletion of endogenous GnRH (Shaw et al., 
2010). Interesting to note, this negative effect is stronger on FSH release when compared to LH, 
demonstrating a differential sensitivity to estrogen signaling in gonadotropes. The absence of 
gonadal steroid hormones drive a significant increase of GnRH pulses as it was demonstrated in 
intact and in gonadectomized male rats using a push-pull perfusion in hypophyseal portal blood 
(Levine and Duffy, 1988). In mice, recent advances in methods to measure pulsatile LH release 
replicated the enhanced LH pulse frequency induced by gonadectomy in both sexes, and the LH 
levels during the female estrous cycle, which follow similar pattern of other species (Czieselsky et 
al., 2016).  
1.3.1.3.1 Estrogen signaling 
Estrogens exert their biological regulation through the activation of classical and non-classical 
pathways. To date, both classical and non-canonical estrogen receptors haven been identified to 
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mediate estrogenic effects. These include the classical estrogen receptor (ER)  and , which can 
act as transcriptional factors or trigger rapid signaling when located at the cell membrane; splice 
variant ER4; ER-X and a G-protein coupled estrogen receptor (GPER, previously named 
GPR30) (see reviews Kelly and Rønnekleiv, 2012; Micevych, Mermelstein and Sinchak, 2017). 
This literature review will focus on estrogen signaling pathways in the brain which are critical to 
assure proper GnRH/LH secretion and fertility.  
GnRH neurons express ERβ but do not contain ERα (Herbison and Pape, 2001), which 
indicated possible direct estrogenic actions in these neurons to control fertility. However, 
pharmacological blockade of ERβ in mice do not alter estrous cyclicity or feedback mechanisms 
(Cheong et al., 2014). The role of ERβ activation in GnRH neurons remains poorly understood, 
although some evidence suggest that this receptor is involved in the regulation of intracellular 
pathways such as the cAMP response element-binding protein (CREB) in these cells (Abrahám et 
al., 2003; Kwakowsky, Herbison and Ábrahám, 2012). Both global and neuron-specific deletion 
of ERα in mice leads to the absence of estrogen-mediated positive feedback, ovarian dysfunction 
and infertility (Wintermantel et al., 2006). In contrast, mutant mice with global loss of ERβ are 
fertile and able to mount a typical LH surge. In addition, by using inducible tamoxifen-based Cre-
LoxP approach, the deletion of ERα in adult neurons results infertile mice witch fails to respond 
to estrogen-mediated negative feedback (Cheong et al., 2014). Therefore, ERα-expressing afferent 
neurons are critical for reproduction but not direct estrogen actions in GnRH neurons. 
1.3.1.3.2 Progesterone signaling  
Progesterone signalling is also required for normal feedback control in the hypothalamus, 
providing strong restraint of GnRH/LH secretion during the luteal phase of female reproductive 
cycle (McCartney et al., 2002). Progesterone receptor knockout mice (PRKO) show chronic 
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anovulation, uterine hyperplasia, impairment of sexual behaviour and infertility (Lydon et al., 
1996). Additionally, PRKO mice exhibit 2-fold higher basal LH levels when compared to wild-
type animals, suggesting an impairment in negative feedback regulation of the HPG axis (Chappell 
et al., 1997). Although PRKO mice display normal estrogen-mediated negative feedback, PRKO 
females do not display a LH surge or show GnRH-induced self-priming, indicating that 
progesterone and estrogen signalling act in synergy to induce the gonadotropin surge (Chappell et 
al., 1999). Progesterone is known to potentiate positive feedback allowing the proper magnitude 
of LH surge following estrogenic priming in different species, such as in rodents (Kalra and Kalra, 
1983; Leite et al., 2016), non-human primates (Schenken et al., 1985) and humans (Hutchens et 
al., 2016).   
Similar to ER, GnRH neurons do not express the classical nuclear PRs, proposing that 
progesterone modulation of the HPG axis also occurs via the steroid-sensitive afferent neuronal 
network of GnRH neurons (Skinner, Caraty and Allingham, 2001). Interestingly, progesterone can 
signal directly onto GnRH neurons through non-classical membrane receptors such as the 
progesterone receptor membrane component 1 (PgRMC1) (Bashour and Wray, 2012). Using 
calcium imaging in primary cultures from mouse brain explants, researchers discovered that 
activation of PgRMC1 rapidly attenuate GnRH neuron activity (Bashour and Wray, 2012).  
1.3.1.3.3 Brain regions involved in the regulation of feedback mechanisms 
Neuroanatomical studies have elucidated two important sites for the regulation of the feedback 
mechanisms: the anteroventral periventricular nucleus (AVPV) and the arcuate nucleus (ARN) 
(Smith, Cunningham, et al., 2005; Smith, Dungan, et al., 2005). Genetic-induced retrograde tracing 
with pseudorabies virus (PRV) in mice defined that the majority of ERα-expressing primary 
afferents to GnRH neurons reside in the AVPV and ARN (Wintermantel et al., 2006). Neuron-
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specific ERα knockout mice do not display ERα expression in the AVPV, which is associated with 
total loss of c-fos expression in GnRH neurons and lack of LH release at the time of the LH surge 
(Wintermantel et al., 2006). Within the AVPV, neurons expressing the peptide kisspeptin are 
considered to be the primary mediators of positive feedback (Herbison, 2016). Kisspeptin neurons 
and kisspeptin signalling in GnRH neurons are critical for normal reproductive function and onset 
of puberty as demonstrated in humans (de Roux et al., 2003; Seminara et al., 2003; Topaloglu et 
al., 2012) and rodents (Funes et al., 2003; Seminara et al., 2003; Gottsch et al., 2004). A more 
detailed description of this important afferent neuronal group is addressed in the following section.  
 The excitability of GnRH neurons is highly regulated by neurotransmitter and neuropeptide 
transmission from the AVPV. Using parahorizontal brain slice preparation, which preserves the 
rPOA and AVPV connections in the mouse brain, researchers were able to show that AVPV 
neurons project functional monosynaptic connections to the majority of recorded GnRH neurons 
(Liu et al., 2011).  This work showed that AVPV neurons transmit GABA and glutamate fast 
synaptic currents with low frequency stimulations (< 1 Hz), and the majority of monosynaptic 
transmission is GABAergic. They also found that female mice present lower stimulus threshold 
required to synaptically activate a GnRH neuron than males and higher frequencies (5–10Hz) relied 
upon kisspeptin signaling in both sexes (Liu et al., 2011). AVPV neurons are known to show a 
peculiar dual-phenotype expressing both vesicular GABA transporter (VGAT) and vesicular 
glutamate transporter 2 (VGLUT2), markers of GABA and glutamate neurons, respectively (Ottem 
et al., 2004). Therefore, it does not come as surprise that conditional knockout of ERα of either 
glutamate or GABA neurons in the limbic brain ablates the normal LH surge in mice (Cheong et 
al., 2015).   
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The ARN is considered an important hypothalamic site for the regulation of GnRH/LH 
pulses. Early studies, placing estrogen microimplants in the caudal part of the mediobasal 
hypothalamus (MBH) in sheep, demonstrated a significant reduction of LH pulses following 
estrogen infusion (Caraty et al., 1998). The ARN, which resides within the MBH, receives a robust 
dopaminergic innervation from the retrochiasmatic region of the hypothalamus A15 and controls 
the GnRH/LH pulse frequency in ewes (Thiéry et al., 1995). Genetic retrograde tracing with PRV, 
also revealed that ERα-expressing neurons in the ARN make synaptic contact with GnRH neurons, 
suggesting that ARN neurons could directly regulate GnRH neuron activity (Wintermantel et al., 
2006). Electrical recordings of guinea pig brain slices revealed that estradiol treatment significantly 
decreased the activity of GnRH neuron fibers in the MBH and non-GnRH neurons residing in the 
ARN (Kelly, Ronnekleiv and Eskay, 1984). These findings indicate that estrogen acts as a strong 
downregulator of GnRH neurons through steroid-sensitive afferents residing in the ARN.   
Progesterone-sensitive neurons in the ARN are proposed to regulate the pulsatile release of 
GnRH/LH. Progesterone-treated female rats display the expected restrain of the LH secretion, 
however, intra-ARN administration of RU486, a PR antagonist, increases LH pulse frequency (He 
et al., 2017). PNA mice, a PCOS mouse model, displays an increased LH pulse frequency that is 
associated with decreased expression of PR in the ARN (Moore et al., 2015). This indicates that 
PR signaling in the ARN is required for the normal functioning of the GnRH pulse generator. 
Although the nature of those neurons remains to be defined, GABA actions in the ARN seems to 
be critical to reduce GnRH/LH pulsatility in ewes (Jackson and Kuehl, 2002). These evidence 
suggest that progesterone actions in the ARN are key for the control of steroid-mediated negative 
feedback in the hypothalamus and disturbances in this region drive abnormal LH pulse secretion.  
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1.3.1.4 The GnRH neuronal network 
GnRH receive a range of homeostatic cues through a diverse network of afferent neurons. The 
interaction of all these transynaptic inputs modulate GnRH neuron activity and to ultimately 
change GnRH/LH pulse secretion in order to orchestrate the control of fertility (Herbison, 2014). 
Although early morphological findings using electronic microscopy speculated that GnRH neurons 
displayed few synaptic inputs (Jennes, Stumpf and Sheedy, 1985), a genetic study using microarray 
profiling showed that GnRH neurons express at least 50 different receptors of neurotransmitters 
and neuropeptides (Todman, Han and Herbison, 2005). Multiple pharmacological studies 
investigating the effect of agonist and antagonist drugs of a variety of neurochemical molecules in 
the hypothalamic tissue or into the 3V, revealed that GnRH neuron activity is modulated by a vast 






                                           
 
Figure 1.7. An overview of the GnRH neuronal network.  Schematic view of 
gonadotropin releasing hormone (GnRH) neuron and its main afferent neurons.  The figure 
shows some of the recognized neuronal inputs on GnRH neurons based on morphological, 
pharmacological, electrophysiological and genetic studies. The transynaptic effect of each 
modulator is shown as activator (+) or inhibitor ( -), although differences in technical 
approach can vary among studies showing contradictory outcomes (e.g.: GABA, serotonin). 
The brain regions that are known to allocate some of these inputs are represented as full 
drawn neuron such as RP3V and ARN, for kisspeptin neurons, dorsal ra phe, for serotonin 
neurons, and locus coeruleus, for norepinephrine neurons. A more detailed description of 
the GnRH neuronal network can be found in Herbison, 2014. (Figure adapted from 




                                           
Although the GnRH neuronal network includes many different neuronal phenotypes and 
the interactions within this network is complex (Dudas and Merchenthaler, 2006; Herbison, 2014), 
the present literature review introduces the three major afferent neuronal components considered 
to be critical for fertility: glutamate, kisspeptin and GABA neurons. 
1.3.1.4.1 Glutamate neurons 
Glutamatergic fibres are found in close apposition with GnRH neuron soma and terminals (Eyigor 
and Jennes, 1996; Kawakami et al., 1998) and glutamate is recognized to excite GnRH neurons 
(Maffucci and Gore, 2009). Glutamate can directly signal to GnRH neurons through the kainate 
receptor, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor  (AMPA) and N-
methyl-D-aspartate receptor  (NMDA) (Spergel et al., 1999; Kuehl-Kovarik et al., 2002; Suter, 
2004). An early study reported that glutamatergic inputs on GnRH neurons play major role in the 
onset of puberty as daily injections of NMDA antagonists in prepubertal female rats are able to 
delay onset of puberty (Urbanski and Ojeda, 1990). Additional experiments found that infusion of 
NMDA antagonists blocked the estradiol-mediated LH surge in prepubertal ovariectomized rats 
(Urbanski and Ojeda, 1990). During the proestrus phase of the female rat estrous cycle, there is an 
increase of Ca2+-dependent glutamatergic transmission via AMPA receptors and blocking this 
synaptic transmission decreases the LH surge (Tada et al., 2013). Therefore, glutamate 
transmission might be involved in the pubertal onset and the capacity to mount the LH surge in 
females. 
Glutamate is also implicated in mediating estrogen-induced positive feedback in females. 
In proestrus phase of the estrous cycle, the administration of NMDA agonist increases GnRH 
mRNA levels in the rPOA of female rats (Gore et al., 2000). Likewise, the blockade of NMDA 
receptors attenuates gnrh gene expression and prevents the occurrence of the LH surge in female 
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rats (Suzuki, Nishihara and Takahashi, 1995). Estrogen actions decrease glutamatergic 
transmission to GnRH neurons during negative feedback by supressing glutamate postsynaptic 
currents (PSCs) in female mice (Christian, Pielecka-Fortuna and Moenter, 2009), suggesting that 
a downregulation of the glutamatergic tone is needed for negative feedback. The requirement of 
estrogen signalling in glutamate neurons was elucidated recently through the deletion of ER from 
glutamate neurons using Cre-LoxP technology in mice (Cheong et al., 2015). The researchers 
showed that ER deletion in glutamate neurons generates infertile female mice with high basal LH 
levels, disrupted estrous cyclicity and impaired positive and negative feedback. Nevertheless, it is 
needed to note a caveat in these findings as glutamatergic neurons co-express other essential 
peptides for reproduction such as kisspeptin (Cheong et al., 2015), meaning that the ER deletion 
from glutamate neurons has broad effects. So far, these evidence supports that glutamatergic inputs 
within the GnRH neuronal network are critical for HPG axis activation, regulation of GnRH levels 
and modulation of estrogen-mediated feedback mechanisms.  
1.3.1.4.2 Kisspeptin neurons 
The critical role of kisspeptin in reproduction was recognized after two independent clinical reports 
showing that mutations in the kisspeptin receptor GPR54 led to hypogonadotropic hypogonadism 
(de Roux et al., 2003; Seminara et al., 2003). Basic research studies ultimately showed that 
mutations leading to the loss of kisspeptin production or its receptor in GnRH neurons causes 
infertility in mice, recapitulating the human condition (d’Anglemont de Tassigny et al., 2007; 
Lapatto et al., 2007; Kirilov et al., 2013). Kisspeptin is mainly found in neurons of two 
hypothalamic regions, the AVPV and the ARN (Smith, Cunningham, et al., 2005; Smith, Dungan, 
et al., 2005; Clarkson and Herbison, 2006; Franceschini et al., 2006). Neuroanatomical studies 
using viral tracing technique in mice support the idea that AVPV kisspeptin neurons project to both 
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the GnRH neuron soma and dendrites, whereas ARN kisspeptin neurons project solely to the GnRH 
neuron terminal regions (Hoong Yip et al., 2015).  
Estrogen differently modulates the expression of the Kiss1 gene in the AVPV and ARN 
kisspeptin neuronal populations in females. The AVPV kisspeptin neurons show significant 
decrease of Kiss1 mRNA levels in gonadectomized female mice, while estrogen replacement 
significantly increases the levels of Kiss1 mRNA (Smith, Cunningham, et al., 2005). ERαKO mice 
do not exhibit the increase of kisspeptin content in AVPV following estradiol treatment to induce 
LH surge suggesting that  a direct estrogenic effect controlling kisspeptin in this region (Smith, 
Cunningham, et al., 2005). Compared to female mice, males display a significant reduction of the 
number of kisspeptin neurons, which is dependent of testosterone actions during perinatal period 
(Clarkson et al., 2014). Additionally, an injection of kisspeptin antisera into the POA blocks the 
preovulatory LH surge and disrupts estrous cyclicity in female rats (Kinoshita et al., 2005). Studies 
also showed that c-FOS-positive kisspeptin neurons are found in the AVPV in mice at times of the 
LH surge, and the number of c-FOS kisspeptin neurons is strongly correlated with the number of 
c-FOS-positive GnRH neurons (Clarkson et al., 2008). Therefore, these findings suggest that, to 
date, RP3V kisspeptin neurons are the strong candidates to mediate positive feedback actions in 
the GnRH neuronal network. 
In contrast to the findings for RP3V kisspeptin neurons, estrogen treatment decreases Kiss1 
mRNA levels and castration has an opposite effect by increasing Kiss1 mRNA levels leading to 
the assumption that ARN kisspeptin neurons could be the site of estrogen-mediated negative 
feedback (Smith, Cunningham, et al., 2005; Smith, Dungan, et al., 2005; Smith et al., 2007). 
However, a controversial evidence challenged this view by showing that kisspeptin cell-specific 
deletion of ERα in OVX mice treated with estradiol regime normally suppress LH levels (Dubois 
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et al., 2015) and perhaps other hypothalamic neuronal populations are important to rely estrogen-
mediated negative feedback. ARN kisspeptin neurons also express the tachykinin neurokinin B 
(NKB) and its receptor NK3. Both NKB and NK3 are critical to fertility since genetic studies 
showed that mutant patients for both genes exhibit hypogonadotropic hypogonadism (Topaloglu 
et al., 2009). ARN kisspeptin neurons also express dynorphin and its kappa opioid receptor (KOR), 
which inhibitory effects and were known to decrease LH secretion in female rats (Schulz et al., 
1981). Therefore, the ARN neurons, which now carry the name of KNDy (Kisspeptin-Neurokinin 
B-Dynorphin) neurons, are hypothesized to be the core of GnRH pulse generation to ultimately 
dictate the pace of GnRH pulses (Navarro et al., 2009; Lehman, Coolen and Goodman, 2010; 
Goodman, Hileman, Casey C. Nestor, et al., 2013).  
More recently, activation of ARN kisspeptin neurons with optogenetics revealed that 
specific activation of this population elicit pulse-like LH release (Han et al., 2015). This effect is 
found to be more pronounced in ovariectomized female mice than in diestrus females suggesting 
that ovarian steroid hormones are downregulators of the ARN kisspeptin neurons (Han et al., 
2015). Likewise, optogenetic inhibition of ARN kisspeptin neurons decreases LH pulse frequency 
in ovariectomized female mice (Clarkson et al., 2017). These KNDy neurons also show an increase 
in burst firing in brain slices of castrated male mice, while estrogen treatment decrease it to the 
levels of intact animals (Vanacker et al., 2017). In summary, the current idea in the field is that 
ARN kisspeptin neurons are the central regulators of GnRH/LH pulses and gonadal steroid-
mediated negative feedback. 
1.3.1.4.3 GABA neurons 
Among neurotransmitters, GABAergic neurons are a major source of inputs onto GnRH neurons, 
and virtually all GnRH neurons receive GABAergic innervation (Decavel and Van den Pol, 1990; 
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Hrabovszky et al., 2012). The role of GABAergic signalling in GnRH neurons has been extensively 
investigated since seminal work showing that injection of GABA into the third ventricle of the 
brain stimulated LH secretion without changing circulating FSH levels in male rats (Ondo, 1974). 
Following study demonstrated similar effect of GABA actions leading to LH release in female rats 
(Vijayan and McCann, 1978). Conversely, later investigations showed that bilateral injection of 
GABA into the medial preoptic area (mPOA) blocks the LH surge in female rats (Herbison and 
Dyer, 1991). Additionally, intravenous injection of muscimol, a GABA type A receptor 
(GABAAR) agonist, decreases the basal multiunit activity (MUA) volley of neurons in the ARN, 
whereas bicuculline, GABAAR antagonist, increases GnRH neuron activity and LH secretion 
(Hiruma, Sano and Kimura, 1994). In support of an inhibiting role for GABA on GnRH neurons, 
a decline in GABA release in the POA precedes the LH surge in rodents (Jarry, Perschl and Wuttke, 
1988).  
Introducing a detour in the field, electrophysiological studies using brain slices of GnRH-
GFP mice defined a clear depolarizing effect of GABA and GABAAR in GnRH neurons (DeFazio 
et al., 2002). Although these findings diverged from earlier reports, it is important to note that 
different experimental approaches could explain the divergent outcomes. Differences in GABA 
actions have been seen in in vitro versus in vivo techniques (Herbison and Moenter, 2011; 
Constantin et al., 2012; Constantin, Iremonger and Herbison, 2013). Furthermore, the origin of 
GABAergic inputs and the expression of neuropeptides within the GABA neurons might be 
important factors determining the response of GnRH neurons since GABA can facilitate or 
attenuate the transmission of other neuromodulators (Roberts, Hemond and Suter, 2008; 
Glanowska and Moenter, 2011; DeFazio, Elias and Moenter, 2014). Considering the extensive 
research on this subject, a more detailed literature about the importance of GABA-to-GnRH neuron 
circuit in reproduction is presented in the following review. 
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1.4 The GABA-to-GnRH neuron network 
In the hypothalamus, the neurotransmitter GABA is present in around 50% of all synaptic inputs, 
and frequently colocalized with different neuropeptides (Decavel and Van den Pol, 1990). 
GABAergic transmission to GnRH neurons changes in different physiological conditions to 
guarantee reliable GnRH secretion (Leranth et al., 1985; Sim et al., 2000; Sullivan and Moenter, 
2005). Therefore, it is not surprising that GABAergic signalling affects GnRH neurons at all stages 
of life, from developmental cell migration, through pubertal development adult regulation of 
fertility. A summary of the main findings featuring these aspects are discussed in the present 
section. 
1.4.1 The GABA system & the developing GnRH neurons 
Two homologous enzymes catalyse the synthesis of GABA, glutamate decarboxylase (GAD) 65 
and GAD67. In the course of mouse embryonic development, GAD67 is expressed in the 
nonsensory epithelium/vomeronasal organ epithelium region, in which GnRH progenitor cells 
arise, while GAD65 is expressed mainly in the sensory proliferative zones (Vastagh et al., 2015). 
During early development a small population of GnRH neurons (~ 30%) produce GABA but cease 
the neurotransmitter production after the first day of postnatal development in rodents (Tobet et 
al., 1996). The overexpression of GAD67 in GnRH neurons leads to a misguided migration of 
GnRH cells inside the forebrain leading to disrupted of estrous cyclicity and fertility in adult mouse 
(Heger et al., 2003). According to these data, we can infer that GABA actions on immature GnRH 
neurons and the downregulation of the GABAergic signalling tone during development are crucial 
for a normal neuronal migration into the hypothalamus.   
Chapter One 
46 
                                           
Downstream effects of the two main GABA receptors, GABAAR and GABABR, also play 
a role in GnRH neuron migration. A pharmacological study in mice showed that treatment with 
GABAAR agonist muscimol during the 10
th to the 15th day of pregnancy inhibits GnRH neuron 
migration and attenuates GnRH neuron fibre extension (Bless et al., 2000). In the same work, they 
reported that antagonizing GABAAR with bicuculline leads to an incorrect distribution of GnRH 
neurons in the basal forebrain. In addition, time-lapse analysis in mouse hypothalamic explants 
showed that GABAAR signalling is important to slowdown GnRH neuron migration in order to 
refine their directional movement and final organization in the hypothalamus (Casoni et al., 2012). 
Therefore, GABAAR-mediated actions in developing GnRH neurons define how these neurons 
travel from the nasal placode to the forebrain, extending their projections towards important target 
regions such as the ME.  
1.4.2 GABA receptors & in the adult GnRH neuron 
Two distinct classes of receptors, defined by their molecular nature and downstream cellular 
cascades, are the main targets of GABA. Firstly, GABAAR, a ligand-gated ion channel, and 
secondly the GABABR, a metabotropic transmembrane receptor. Both GABA receptors are found 
in postsynaptic sites and GABABR is also found at the presynaptic membrane (Bowery, 1989; Otis, 
Staley and Mody, 1991). GABAAR is composed by five protein subunits that can belong to16 
different molecular categories (α1–6, β1–3, γ1–3, δ, ε, θ, π), and functions as a selective channel 
for chloride ions (Cl-) (Olsen and Sieghart, 2009). Distinctively, GABABR is associated with Gi/o 
proteins and regulates mainly inwardly rectifying potassium (K+) channels (GIRK), voltage-gated 
Ca2+ channels and adenylyl cyclase-mediated pathways (Kandel et al., 2014). Notably, GnRH 




                                           
1.4.2.1 GABAAR- mediated actions in GnRH neurons  
Using the expression of LacZ reporter technology to identify GnRH neurons in mice, a report 
showed that GnRH neurons undergo region-dependent changes in the GABAAR subunit 
composition from birth to adult life (Simonian et al., 2000). These changes in GABAAR subunit 
expression over the course of postnatal development may affect neuronal migration and electrical 
behavior (Jung et al., 1998). Specifically, with post hoc identification of GnRH neurons by single 
cell RT-PCR, a great heterogeneity was found for  and  subunits of GABAAR in juvenile male 
and female mice (Sim et al., 2000). Although the combinations 51, 52, 12 and 512 are 
unchanged during postnatal development, the expression of 2, 4 and 3 decreases toward 
adulthood, while a marked elevation of 2 expression takes place in adult GnRH neurons (Sim et 
al., 2000). The relevance of 2 expression remains unclear since the genetic deletion of this subunit 
in GnRH neurons with a Cre-LoxP strategy has minimal impact on the reproductive function of 
female mice (Kiho Lee et al., 2010). 
In most mature forebrain neurons, the activation of GABAAR leads to inhibition of neuronal 
activity. GABAAR are Cl
- channels known for their inhibitory effects through the increase of Cl- 
conductance which hyperpolarizes the neuronal membrane (Baumann, Baur and Sigel, 2003). The 
main factor dictating the neuronal response to GABAAR activation and channel opening in neurons 
is the intracellular Cl- concentration, which is dependent upon the expression of Na+–K+ –2Cl- co-
transporters (NKCCs) and K+–Cl- co-transporters (KCCs) (Ben-Ari, 2002). In most instances, 
immature neurons show higher expression of NKCC1, which leads to the accumulation of 
intracellular Cl-. This process generates a more depolarising reversal potential for Cl- when 
compared to the resting membrane potential and increases neuronal excitation when GABA binds 
to GABAAR. During the development of many neurons in the brain, there is a molecular switch 
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leading to a decreased expression NKCC1 and an increase of the expression of KCC2, which 
ultimately drives an outward flux of Cl- and a decline in intracellular Cl- concentration (Herbison 
and Moenter, 2011). Accordingly, in this case the resulting effect of GABA biding to the GABAAR 
is a hyperpolarization of the neuronal membrane (Figure 1.8). 
 
Figure 1.8. Depolarizing and hyperpolarizing GABAAR effects in neurons.  
Intracellular Cl- concentration drives the direction of the neuronal response by GABA 
binding to GABAAR. The expression of Cl - cotransporters in neurons dictates the 
intracellular chloride concentration. NKCC1 is able to increase Cl - inward flux, which 
brings the membrane potential to the depolarized reversal potential for Cl - and, 
consequently, setting a depolarized membrane potential for GABA (green outlined box). In 
contrast, KCC2 can trigger Cl - outward flux, leading to a significant decrease of intracellular 
Cl- concentration and hyperpolarization of the neuronal membrane (red outlined box). The 
balance of NKCC1 and KCC2 seems to be a definitive charact eristic by which GnRH neurons 
may respond differently to GABAAR activation when compared to other mature neurons in 
the forebrain. (Figure modified from Herbison and Moenter, 2011) . 
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In contrast to most of mature neurons, adult GnRH neurons maintain a Cl- homeostasis 
similar to immature neurons due to high expression of Cl- accumulator proteins, such as NKCC1 
anion exchanger 2 (AE2), and low levels of KCC2 (DeFazio et al., 2002; Taylor-Burds, Cheng and 
Wray, 2015). Early studies using GnRH-secreting immortalized neurons (GT1-7) report that 
GABAAR activation induces increased intracellular Ca
2+ concentration and high frequency of Ca2+ 
oscillations (Hales, Sanderson and Charles, 1994). An influential study from DeFazio and 
colleagues, using GnRH-GFP mice, showed that activation of GABAAR leads to depolarization of 
GnRH neurons, independently of age, sex or gonadal steroid levels in female mice (DeFazio et al., 
2002). In addition, important in vivo electrophysiological findings revealed that GnRH neuron 
firing and the different firing patterns that these neurons display are dependent upon GABAAR 
signaling (Constantin, Iremonger and Herbison, 2013). 
1.4.2.2 GABABR- mediated actions in GnRH neurons  
The role of GABABR has not been as extensively investigated as GABAAR activation effects on 
GnRH neurons. Heretodimerization of R1 and R2 subunits allow the functioning of GABABR and, 
as mentioned above, this receptor mainly regulates neuronal activity by postsynaptic activation of 
GIRK channels or presynaptic inhibition of Ca2+ channels (Bowery, 1993). Electrophysiological 
recordings coupled with single cell RT-PCR revealed that R1 and R2 subunits are expressed in ~ 
93% and 56%of GnRH neurons, respectively, in adult mice (Zhang et al., 2009). Constitutive loss 
of GABABR R1 generates mice with normal pubertal onset and basal LH levels, but disrupted 
estrous cyclicity and a significant decrease in female fertility (Catalano et al., 2005). The absence 
of functional GABABR in mice leads elevated GnRH secretion pulse frequency in hypothalamic 
explants from females but not males (Catalano et al., 2010). Together, these data indicate that 
GABABR is required for normal GnRH pulses and fertility in females. 
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Pharmacological in vitro studies elucidated the functional role of GABABR activation in 
GnRH neurons. The administration of baclofen, a GABABR agonist drug, induces a marked 
postsynaptic hyperpolarization of GnRH neurons through the activation of GIRK channels in a 
concentration-dependent manner (Zhang et al., 2009; Liu and Herbison, 2011). As mentioned in 
previous sections, with the development of a parahorizontal slice preparation in GnRH-GFP mice 
brains, which preserves the rPOA and AVPV regions, study showed that inputs from the AVPV 
are a source of GABAergic inputs onto  GABABR in GnRH neurons (Liu and Herbison, 2011). 
Interestingly, using this brain slice preparation, just 22% of GnRH neurons from males exhibit 
GABABR inhibitory postsynaptic currents (iPSCs) whereas a larger number of neurons (70%) in 
diestrus females show the same response (Liu and Herbison, 2011). When looking at the effect of 
GABABR activation in different GnRH neurons according to their location in the mouse brain, 
baclofen induces a strong decrease of spontaneous firing in neurons from the rPOA or AHA 
(Constantin et al., 2012). These studies suggest that GABABR signaling is required in arresting the 
GnRH neuronal activity leading to a decrease in GnRH/LH pulses mainly in females.  
1.4.3 GABAergic transmission in GnRH neurons 
In mammals, the majority of synaptic inputs on GnRH neurons are GABAergic, defining a pivotal 
role of this neurotransmitter to regulate GnRH neuronal activity (Jennes, Stumpf and Sheedy, 1985; 
Jansen et al., 2003; Hrabovszky et al., 2012). Initially, GABAergic transmission to GnRH neurons 
was reported to be via phasic fast activation of GABAAR making GABA actions the main 
neurotransmitter component regulating the resting membrane of these neurons (Spergel et al., 
1999; Sullivan, DeFazio and Moenter, 2003). Further studies using mouse brain slice preparation 
and the combination of different GABAAR blockers (gabazine ≤1µM, which blocks phasic 
currents; and bicuculline 20µM, which blocks all GABA currents), revealed that the majority of 
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GnRH neurons (> 90%) exhibit tonic GABAAR-mediated currents and it is mandatory for GnRH 
neuron excitability (Bhattarai et al., 2011). This tonic GABAergic transmission leads to the 
hyperpolarization of GnRH neurons, it is mediated by extrasynpatic expression GABAAR 
activation and partially controlled by the activity of glial and neuronal GABA transporters 
(Bhattarai et al., 2011). Even though both receptors can mediate GABAergic transmission, 
GABAAR postsynaptic currents (PSCs) are the main contributors for information processing in 
GnRH neurons.   
The expression of GABAAR and GABABR might be differently positioned throughout the 
extent of GnRH neuron soma and dendrites. The full length of GnRH neurons seems to receive 
GABAergic contact, which has been investigated using transgenic GnRH-GFP mice and labelling 
of vesicular GABA transporter in  order to visualize GABA inputs (Campbell, Han and Herbison, 
2005; Moore et al., 2015). Keeping in mind that GnRH neurons can generate action potentials in 
dendrites, the integration of afferent inputs has been investigated in animal models and with 
computational modelling. A study comparing coronal (preserving the rPOA region) and thick near-
horizontal (preserving the AHA region) mouse brain slices showed that stimulatory responses from 
GABAAR are mainly observed in the coronal sections, whereas  GABABR- mediated inhibitory 
actions are present in both slice preparations (Constantin et al., 2012). Therefore, the differential 
expression of GABAAR and GABABR may drive a net excitation or a net inhibition in GnRH 
neurons (↑GABAAR:↓ GABABR expression in the cell body and proximal dendrites; and 
↓GABAAR:↑GABABR in the distal dendrite toward the ME).  
Changes in miniature PSCs (mPSCs), which relate to action-potential independent 
neurotransmitter release, can be modulated by the gonadal steroid hormone milieu. These changes 
in GABA mPSCs in GnRH neurons are due to modifications in the rate of action potential 
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independent release of GABA with little effect observed on action potential-driven release 
(Sullivan and Moenter, 2005; Penatti et al., 2010; Pielecka-Fortuna and Moenter, 2010). This 
indicates that gonadal steroid actions are likely to modulate GABAergic transmission by changing 
the anatomical contact of GABA inputs to GnRH neurons rather than changing the activity of these 
GABAergic cells (Herbison and Moenter, 2011). These findings can be illustrated in the 
pathological scenario of a PCOS mouse model that presents impairment of negative feedback. As 
referenced in previous sections, PNA mice display chronic androgen excess, which is associated 
with increased GABAergic contact on GnRH neurons (Moore et al., 2015).    
1.4.4 PCOS & GABA-to-GnRH circuit abnormalities 
Evidence from clinical and pre-clinical models of PCOS indicate that PCOS is a neuroendocrine 
disorder. As reviewed in previous sections, the majority of PCOS patients (~ 70%) show increased 
LH secretion with a decreased sensitivity to ovarian steroids to decrease the circulating 
gonadotropin levels in blood (Manieri et al., 1992; Berga, Guzick and Winters, 1993; Pastor et al., 
1998). This suggests that an impairment of negative feedback mechanism that is established in the 
context of androgen excess in PCOS drives an overactivation of GnRH neurons. It is suspected 
that increased GnRH neuronal activity leads to high GnRH pulsatile release causing enhanced LH 
pulse frequency secretion from the pituitary gland. Overstimulation of theca cells in the ovary by 
LH increases androgen production and disrupts ovarian follicular development. At the same time, 
androgen actions in the periphery leads to the development of PCOS symptoms such as hirsutism 
and acne, and influence the development of associated disorders, for instance, the metabolic 
syndrome (Dumesic et al., 2016; Moore and Campbell, 2017) (Figure 1.9).        
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Figure 1.9. An overview of the hypothalamic-pituitary-gonadal (HPG) axis in the 
pathophysiology of PCOS.  (A) A neuroendocrine disorder: Clinical and basic science 
studies have considered PCOS as a neuroendocrine disorder according to its clinical 
manifestation. Impairment of steroid-mediated negative feedback can induce high frequency 
luteinizing hormone (LH) secretion, which is prevalent in PCOS patients and observed in 
animal models of the disease. Enhanced LH actions in the ovaries will increase ovarian 
androgen production and ovarian dysfunction. Evidence suggests that inappropriately high 
levels of androgens indirectly establish impaired negative feedback  through steroid-
sensitive hormones in the brain, which control gonadotropin -releasing hormone (GnRH) 
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neuron activity. Supporting evidence has shown that altered GABAergic drive and 
innervation onto GnRH neurons may underlie some of these pathological and ontogenetic 
features of PCOS (Figure adapted from Moore and Campbell, 2017 ). (B) PCOS women 
present increased LH secretion: Representative traces of pulsatile LH secretion from (i) 
normal woman (eumenorrheic) and (ii) PCOS woman (anovulatory hyperandrogenic) studied 
during 24-h of the follicular phase of menstrual cycle. The X axis shows clock time and the 
Y axis shows circulating LH levels in the blood. (Graphical data adapted from Berga, Guzick 
and Winters, 1993).     
 
The evidence that androgen excess is highly associated with menstrual irregularities and 
ovarian dysfunction (Hatch et al., 1981; Fauser et al., 2012) indicates that, although GnRH neurons 
do not express the classical AR, the GnRH neuronal network can detect elevated levels of 
androgens in the blood and impact female fertility. Evidence from animal studies demonstrates that 
GABA neurons are able to sense circulating androgen levels and transmit this information to GnRH 
neurons. Studies using mouse brain slices showed that DHT, which has potent androgenic actions, 
enhances GABAAR-mediated PSCs to GnRH neurons (Sullivan and Moenter, 2004) by increasing 
the number of synaptic contact between GABA neurons and GnRH neurons (Moore et al., 2015). 
Although progesterone is able to decrease GnRH neuron firing through GABAergic transmission, 
DHT disrupts progesterone actions and elevates neuronal excitation (Sullivan and Moenter, 2005; 
Pielecka, Quaynor and Moenter, 2006). Therefore, GABA neurons within the GnRH neuronal 
network might be important to convey feedback signals from steroid hormones and regulate GnRH 
neuron activity. Furthermore, chronic androgen excess, which is observed in PCOS women and 
animal models, may establish and maintain GABA-to-GnRH neuron circuitry abnormalities. It 
remains to be determined the ontogeny of the brain circuit abnormalities and whether GABAergic 
contact on GnRH neurons can be attenuated by AR signaling blockade.  
Chapter One 
55 
                                           
A decreased sensitivity to progesterone administration to lower LH levels is also typical in 
PCOS women suggesting an impairment in negative feedback mechanisms (Pastor et al., 1998). 
PNA mice also display a desensitization of the GnRH pulse generator by showing a decreased 
post-castration response to inhibitory effects of progesterone (Moore et al., 2015). This correlates 
with a dramatic decrease of progesterone receptor (PR) expression in GABA neurons located in 
the ARN (Moore et al., 2015). Our research group discovered a novel pathway of ARN GABA 
neurons contacting GnRH neurons in the rPOA with additional evidence that ARN GABAergic 
wiring onto GnRH neurons was robustly increased in PNA mice (Moore et al., 2015). These 
morphological findings suggested that decreased PR expression in ARN GABA neurons might 
lead to an overactivation of GnRH neurons and, therefore, high LH pulse frequency, which underlie 
the pathophysiology of PCOS. It remains unknown when these changes in GABAergic wiring 
occur in relation to the pubertal onset, and whether these circuit abnormalities are dependent on 
circulating androgen levels during adulthood in PNA mice. The evidence that enhanced 
GABAergic contact on GnRH neurons might lead to abnormal LH secretion leads to the hypothesis 
that ARN GABA-to-GnRH neuron is a functional circuit, although further experimental work is 




                                           
1.5 Thesis rational and aims 
PCOS is a highly prevalent endocrine disorder leading to female infertility, yet it is poorly 
understood. Impairment of the neuroendocrine regulation within the GnRH neuronal network may 
underlie the pathogenesis of PCOS, suggesting that brain circuit abnormalities are the culprit for 
the manifestation of the disease. Androgen excess during intrauterine life may induce a biological 
program in neural circuits which control GnRH neuron activity to manifest later in adult 
reproductive life. Accordingly, PCOS can be model by prenatal androgen exposure, which 
generates female offspring that present PCOS-like reproductive impairment as we observe in PNA 
mice. Transgenic technology and brain circuit tracing made possible to identify that GABAergic 
transmission and contact on GnRH neurons are enhanced in PNA and that is associated with high 
LH secretion, impaired negative feedback, and irregular reproductive cycles. My thesis aimed to 
address two main questions. Firstly, I interrogated the developmental timing of brain circuit 
abnormalities in relation to the development of PCOS and its dependency of androgen receptor 
signaling. Secondly, I aimed to investigate the functional relevance of the ARN GABA-to-GnRH 
neuron circuit for LH secretion in PCOS-like and reproductively fit conditions.  
 Therefore, my PhD specific objectives included: 
1) Determine whether altered GABAergic wiring is established before the onset of puberty. 
2) Examine the developmental timing of androgen excess (testosterone blood levels) in PNA 
mice. 
3) Investigate the effect of long-term androgen signaling blockade on GABAergic contact on 




                                           
4) Interrogate the functional role ARN GABA neurons in the regulation of LH secretion in 
mice. 
5) Dissect the effect of activating ARN GABA neurons on LH secretion in PNA mice.  
1.6 Hypothesis and objectives of the study 
Firstly, I hypothesized that GABA-to-GnRH neuron circuit abnormalities take place before the 
onset of puberty in PNA mice. During the initial steps of my PhD project, I aimed to determine the 
ontogeny of brain circuit abnormalities that may underlie the pathogenesis of PCOS. Hence, I 
applied immunolabeling to identify GABAergic contact on GnRH-GFP neurons in PNA mice 
during prepubertal stage at postnatal day (PND) 25 in comparison to normal females (Chapter 3). 
Secondly, I hypothesized that brain circuit abnormalities are programmed by prenatal androgen 
insult but not from postnatal actions of androgen excess or the activation of hyperandrogenic 
ovaries during puberty. Therefore, I further characterized the time of increased testosterone levels 
in PNA mice and the requirement of hyperandrogenic ovaries during adulthood (Chapter 4). The 
third objective of my PhD project tests the hypothesis that long-term androgen receptor signaling 
blockade can reverse GABA-to-GnRH neuron circuit abnormalities and restore reproductive 
cycles in PNA mice (Chapter 5). Despite anatomical evidence that enhanced GABAergic wiring 
on GnRH neurons may be critical for the pathogenesis and maintenance of reproductive 
impairment, it remains unclear whether the activation of specific ARN GABA neurons has a 
functional role on GnRH/LH secretion. Finally, I hypothesized that the ARN GABA-to-GnRH 
neuron circuit is biologically functional to trigger LH secretion and that the activation of this circuit 
drives abnormal LH release in PNA mice (Chapters 6).
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2 Chapter Two:  
General Materials and Methods 
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2.1 Animals 
All protocols were approved by the University of Otago Animal Ethics Committee (Dunedin, New 
Zealand) under the protocol approval number 07/15.  All mice (Mus musculus) were bred and 
housed at University of Otago - Hercus Taieri Resource Unit (Dunedin, New Zealand). Animals 
were housed with ad libitum access to water and food, under 12h: 12h light-dark cycles (lights on 
at 0700h) and at 21ºC. All wild-type and transgenic mouse lines had a genetic background of 
C57BL/6(B6) inbred strain. Transgenic lines used in this study were GnRH-GFP mice (Spergel et 
al., 1999), vesicular GABA transporter (VGAT)-cre (Vong et al., 2011) and GnRH-cre 
(Wintermantel et al., 2006). To confirm the genotype of transgenic mice lines, PCR was performed 
by Ms. Mel Prescott, the Associate Research Fellow in the Campbell Laboratory.  
2.2 Mouse models of PCOS: Prenatally androgenized (PNA) mice 
In order to generate PNA female mice, pregnant dams were treated with 250μg of 
dihydrotestosterone (DHT; s.c. 100 µL of solution) during late pregnancy (days 16, 17 and18). 
Briefly, DHT was previously prepared by dissolving 25 mg of the solute (Sigma-Aldrich, St Louis, 
MO, USA) into 1 mL of absolute ethanol to make up a 10x stock solution. On the day of injection, 
one part of the DHT ethanol solution was diluted in nine parts of sesame oil to create 1x solution 
for use. Control groups were injected with 100 µL of vehicle sesame oil at the same period during 
late pregnancy (Sullivan and Moenter, 2004; Moore, Prescott and Campbell, 2013). Offspring were 
weaned at the day 21 and separated by sex into different cages until experimentation.  
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2.3 Estrous cycle monitoring 
Daily monitoring of vaginal smears was performed from 0700h to 0900h with a looped wire to 
collect aqueous vaginal cytology smears on glass slides. Smears were left to dry and stained with 
toluidine blue (0.5% v/v) for one minute. Using a light microscope with 10X and 20X objectives, 
vaginal cytology was examined to identify estrous cycle stages. Briefly, proestrous smears 
presented nucleated clustered cells without any presence of leucocytes; the estrous smears 
displayed only anucleated cornified epithelial cells; the metestrous stage presented a combination 
of cornified, leucocytes and few nucleated cells; and finally, the diestrous stage was identified as 
having high number of leucocytes without any cornified cells  (Caligioni, 2009). 
2.4 Pharmacological treatment: Long-term AR signaling blockade with 
flutamide 
Pharmacological treatment with flutamide (Flut), an androgen receptor (AR) antagonist, was 
performed in studies shown in Chapter 5. Female mice were injected daily with 50 μL of Flut (Flut; 
Sigma-Aldrich, St Louis, MO, USA) 25 mg/kg/day for 20-22 days (Chapter 5). Animals received 
injections from postnatal day (PND) 40 up to at least PND 60, after which mice were euthanized 
in diestrous stage of their cycle. Briefly, 0.10 g of Flut was diluted in 1 mL of absolute ethanol to 
make up a 10x stock solution in an Eppendorf tube. On a daily basis, one part of Flut ethanol 
solution was diluted in nine parts of sesame oil to create a 1x solution for use. Control vehicle mice 
received 50 μL of sesame oil during the same period. All calculations were based on mice with an 
average weight of 20g. In order to determine the effect of Flut treatment, all female mice had 
estrous cyclicity followed daily. The dose of Flut used here was determined based on previous 
optimization in our laboratory and studies elsewhere (S Luo et al., 1997; Sullivan and Moenter, 
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For experiments that determined the effect of ovariectomy on LH secretion in control and PNA 
mice (Chapter 4), ovariectomy surgery was performed as approved by the University of Otago 
Animal Ethics Committee. Female mice were anesthetized with 2% isoflurane and bilateral 
excision of the ovaries. Experiments were performed with sterile instruments and aseptic 
conditions. Mice were given a s.c. injection of carprofen (5 mg/kg body weight) after anesthesia 
was confirmed. Mice were place in the prone position on a heating pad and the area of incision was 
prepared by shaving the hair and applying hibitane solution 4% to the skin. A dorsal midline 
incision was made through the skin below the ribs and followed by two small internal incisions 
through the muscular layer of the body wall bilateral to the backbone. The ovaries were exteriorized 
and the distal uterine horn was clamped just below the ovary. The ovaries were excised and the 
uterine horn was gently moved back into the body cavity. The skin incision was sutured and closed 
with one wound staple. The surgical procedure had an average duration of six minutes and 
approved post-surgical care was performed.  
2.5.2 Stereotaxic intracerebral injections 
Mice were anesthetized with 2% isoflurane and placed in a stereotaxic apparatus (Stoeling®, 
Digital Lab Standard). The area of incision was prepared by removal of hair from the head, between 
the ears, and application of hibitane solution 4% to the skin. The eyes were kept protected with 
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lubricant mineral oil to avoid keratitis during surgery. Experiments were performed with sterile 
instruments and aseptic conditions. Mice were given a s.c. injection of carprofen (5 mg/kg body 
weight) after anesthesia was confirmed. A small midline incision was made through the skin with 
scalpel blade and the connective membranes were removed from the skull with a sterile cotton bud 
for better visualization of skull landmarks. The top of the mouse skull was positioned in horizontal 
plane by aligning the nasal suture, bregma and lambda using a dissection microscope (20X; 
Leica®, Wetzlar, Germany). Bregma position was used as stereotaxic reference zero and X and Y 
coordinates were calculated according to the desired target. Anterior-posterior (A/P), medial-
lateral (M/L) and dorsal-ventral (D/V) measures were based on the mouse brain atlas (Paxinos and 
Franklin, 2004). 
Experiments that performed viral injections used coordinates for the arcuate nucleus (ARN) 
and median eminence (ME) of the hypothalamus. Optogenetic experiments used coordinates for 
the rostral preoptic area (rPOA) in order to place optical fiber in the vicinity of GnRH neurons 
(Table 2.1). 
Target A/P M/L D/V 
ARN BILATERAL  - 0.9 mm  ± 0.3 mm - 6.0 mm (from the dura 
mater). 
ME BILATERAL  - 1.0 mm  ± 0.3 mm - 6.2 mm (from the dura 
mater). 
rPOA + 0.9 mm 0 (pulling the sagittal sinus to 
the lateral side while injecting) 
4.2 mm (from the dura 
mater). 
 
Table 2.1. Coordinates for stereotaxic intracerebral injections. Bregma position 
was used as stereotaxic reference zero and X and Y coordinates were calculated according 
to the target. Measurements were used with mice displaying 22 -25g of body weight and 
adaptations of coordinates were made when animal weight were outsi de of this range.  
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A small hole in the skull was made with surgical drill marking the injection site without 
damaging the brain parenchyma. Customized bilateral Hamilton needles or an optical fiber 
(Chapter 6) were lowered with D/V coordinates from the level of the dura mater. When performing 
viral transfections, needles were left in the site for five minutes prior to the injection. The injection 
rate was 50 nL per minute and needles were left in the target area for ten minutes following 
injection. Slow withdrawal of needles was performed after viral injections and any local bleeding 
was contained with sterile cotton swaps and saline. The skin was closed with surgical sutures and 
mice were place in temperature-controlled cages for post-operative management according to 
approved procedures by University of Otago Animal Ethics Committee. When performing 
optogenetic experiments, optical fiber was placed in the brain target thirty to forty minutes before 
the optogenetic protocol was initiated in anesthetized mice. Mice were euthanized at the end of all 
protocols with a lethal dose of pentobarbital (i.p. 3 mg/mL) and perfused with 20 mL of 4% 
paraformaldehyde (4% PFA) solution. 
2.6 Serial blood sample collection 
Mice were habituated with daily handling to avoid further distress during blood sampling. Blood 
samples were collected from a small cut in the mouse tail-tip. When performing sampling to 
determine the developmental timing of testosterone levels (Chapter 4), ~ 50 µL of blood was 
collected into glass capillary tubes at the same time in the morning (0900h to 1000h). Blood 
samples were spun at 4 G for 10 min at room temperature, and plasma was collected and kept at -
20 ºC until the day of hormone measurement. When collecting blood to measure pulsatile LH 
secretion (Chapters 4 and 6), mice were kept in a quiet room in the presence of two experimenters. 
As previously reported (Steyn et al., 2013; Czieselsky et al., 2016), 3 µL of blood were collected 
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every 6 min for 2 h. Whole blood was diluted in 57 µL of 0.1 M phosphate buffered saline-tween 
(PBS-T) pH 7.4, frozen in dry ice and stored at -20 ºC for subsequent hormone measurement. 
2.7 Hormone measurements 
2.7.1 Testosterone levels with enzyme-linked immunosorbent (ELISA)  
Plasma testosterone levels were determined using a commercially available rat/mouse ELISA kit 
(LDN GmbH&Co.KG, Nordhorn, Germany). Briefly, the testosterone mouse ELISA is based on 
the principle of competitive binding. A defined amount of testosterone conjugated with horseradish 
peroxidase and the steroid from the sample compete for a binding site in the coated testosterone 
antiserum present in the plate. The assay was performed with a sensitivity of 0.05 ng/mL and the 
intra-assay coefficient of variation for testosterone was 11.4 %.  
2.7.2 LH sandwich ELISA method 
A well establish sandwich ELISA method was used to determine pulsatile LH secretion in mice 
(Steyn et al., 2013; Czieselsky et al., 2016). Briefly, a 96-well high affinity binding plate 
(Corning®) was coated with 50 µL per well with bovine LH518B7 monoclonal antibody (1:1,000 
in 1X PBS). Following an overnight incubation, plates received 200 µL per well of blocking buffer 
solution (5 % skim milk power in 0.05% PBS-Tween) and were incubate for 2h in a humidified 
chamber on an orbital shaker at room temperature. After incubation, plates were washed with 
0.05% PBS-Tween (3 x 3 min washes). A standard curve for the detection of LH concentration 
was generated using serial dilutions of mouse LH-RP reference peptide provided by A. F. Parlow 
(National Hormone ad Pituitary Program, Torrance, CA, USA). Standards, positive controls and 
samples were incubated in the plates for 2h in a humidified chamber on an orbital shaker at room 
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temperature. At the end of this period, plates were washed and incubated with 50 µL per well of 
rabbit polyclonal LH detection primary antibody (1:10,000 in blocking buffer solution; rabbit 
antiserum AFP240580Rb, National Hormone and Peptide Program, USA) for 90 min in a 
humidified chamber on an orbital shaker at room temperature. After washing the plates, the next 
step was performed with incubation of 50 µL per well of horseradish peroxidase conjugated 
polyclonal goat anti-rabbit IgG secondary antibody (1:1,000 in 50% blocking – 50% PBS-tween 
buffer solution; DAKO) for 90 min in a humidified chamber on an orbital shaker at room 
temperature. Following washings, wells were incubated with 100 µL of solution containing 0.1% 
H2O2, citrate buffer (pH = 5.0) and o-phenylenediamine (OPD capsules; Invitrogen) for 30 min on 
an orbital shaker at room temperature protected from light. The reaction was stopped with 50 µL 
per well of 3M hydrochloric acid and LH levels were determined using an absorbance plate reader 
at 490 nm and 650 nm wavelengths. The sensitivity of this routine LH ELISA assay was 0.002 
ng/mL.  
2.8 Immunohistochemistry  
2.8.1 Preparation of tissue perfusion and fixation 
Mice were anesthetized with 100 µL of lethal dose injection of pentobarbital (i.p. 3 mg/mL) until 
animal lacked a pedal reflex upon pinching the paws. Animals were placed in the supine position 
and the abdominal cavity was opened and exposed. A larger incision was made to expose the heart. 
The apex of the heart, aiming the left ventricle, was inserted with a 23 gauge needle and 20 mL of 
paraformaldehyde 4% (PFA 4%) solution was slowly injected to perfuse the tissues. Following 
perfusion, brains and ovaries were dissected and post-fixed in the same PFA 4% fixative solution 
for 1 hour or overnight, respectively, at room temperature. Brains were placed in a sucrose 
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cryoprotectant solution at 4ºC overnight. Coronal brain sections were cut into three series of 30-
µm thick sections using a microtome (Leica®, Wetzlar, Germany). Brain sections were kept in 
cryoprotectant solution (pH = 7.6) at -20ºC until the immunohistochemistry protocol was 
performed.  Following post-fixation, ovaries were kept in a 70% ethanol solution until paraffin 
embedding. Ovarian sections of 5 μm-thickness were collected in 50-μm intervals from one 
randomly chosen ovary. All ovarian sections were stained with hematoxylin and eosin. A detailed 
list of chemical reagents for each solution is provided in Appendix I.   
2.8.2 Dual-label immunofluorescence 
Brain sections were washed three times (10 min each washing) in 0.05M Tris-buffered saline 
(TBS) to remove cryoprotectant from the tissue. Sections were incubated with blocking solution 
(2% normal serum of the species in which secondary antibody was made) for 30 min in order to 
reduce non-specific binding. Next, sections were incubated with primary antibodies in incubation 
solution for 48h at 4ºC. After the incubation period, sections were washed in TBS and placed in 
secondary antibody incubation solution. The protocol used biotinylated secondary IgG raised 
against the species of the primary antibodies. Tissues were incubated in 1:200 dilution of secondary 
antibodies for 90 min at room temperature on an orbital shaker. Next, sections were incubated with 
fluorophore-conjugated streptavidin at a 1:200 dilution in incubation solution for 3h at room 
temperature. After incubation, sections were washed with TBS (four times; 10 min each washing), 
mounted on glass slides, air-dried and coverslipped with CC/mounting medium (Sigma-Aldrich, 
St Louis, MO, USA).  
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2.8.3 Controls for the immunohistochemistry protocol 
Validations of primary antibodies used in the project were found in the scientific literature and are 
listed in appendix II. The absence of primary antibody during first incubation procedure served to 
test the specificity of primary antibodies labeling and the background produced by secondary 
antibodies alone.   
2.9 Image acquisition and analysis 
Confocal imaging was performed using a Nikon A1R Multi-photon confocal microscope with 488, 
543 and 647 nm diode lasers. Brain sections were imaged using a Plan NeoFluor 20X or 40X oil 
objective (1.30 NA), taking Z-stacks of 0.5 μm steps (pinhole at 1 AU) and analyzed with software 
NIS-Elements AR 4.00.00 (Nikon® Instruments Inc.). Specific confocal image acquisitions 
procedures and 3D reconstruction are referenced in each chapter separately. The ovarian sections 
were imaged using light microscope (Olympus Bx-51; Olympus Optical, Hamburg, Germany) with 
bright-field mode and SPOT advance camera software (Diagnostic Instruments, Inc.) for image 
acquisition. Images were analyzed using ImageJ software (National Institutes of Health, Bethesda, 
Maryland).  
2.10 Statistical analysis 
Statistical analysis was performed with PRISM software 7.0 (GraphPad Software, La Jolla, San 
Diego, CA, USA). All statistical tests are present in the methods section within each chapter. All 
data are represented as mean ± SEM. Statistical significance was accepted when P < 0.05. 
Graphical representation to display significant different are shown as * P < 0.05, ** P < 0.01, *** 
P < 0.001 and **** P < 0.0001.
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3.1 Introduction 
The pathogenesis of polycystic ovary syndrome (PCOS) is likely to involve both genetic and in 
utero environmental factors. Although the etiology of PCOS is undefined and likely to be 
multivariate (Barber et al., 2015; Azziz et al., 2016), exposure to elevated androgens in early 
development is known to trigger reproductive and metabolic traits of PCOS during adult life in 
both humans (Hague et al., 1990; Barnes et al., 1994) and in a variety of animal models (Dumesic 
et al., 1997; McNeilly and Duncan, 2013; Padmanabhan and Veiga-Lopez, 2013a).Clinical 
findings have found that daughters of PCOS mothers, who most likely have elevated androgen 
levels during pregnancy, are at higher risk of developing PCOS features from early to late puberty 
(Sir-Petermann et al., 2009; Maliqueo et al., 2012). This is also a significant association between 
women with congenital adrenal hyperplasia (CAH) and the development of PCOS. CAH women 
exhibit abnormal overfunction of adrenal gland leading to elevated prenatal androgen levels and, 
during adulthood, display PCOS symptoms such as polycystic ovaries, hyperandrogenism and 
elevated LH levels (Hague et al., 1990; Barnes et al., 1994).  
Evidence suggests that inappropriately high levels of androgens indirectly establish 
impaired negative feedback in PCOS patients. Acute testosterone administration does not increase 
pulsatile LH levels in healthy women (Dunaif, 1986). Likewise, acute blockade of the androgen 
receptor (AR) antagonist does not restore normal LH secretion in women with PCOS (Eagleson et 
al., 2000). However, long-term treatment with an AR antagonist is able to re-establish the ability 
of estradiol and progesterone to suppress LH pulse frequency (Eagleson et al., 2000). This implies 
that chronic androgen excess does not directly drive LH hypersecretion, but instead interferes with 
the ability of estradiol and progesterone to relay negative feedback signals within the GnRH neuron 
network, and leads to regulate high GnRH/LH release.  
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Prenatally androgenized (PNA) mice recapitulate the clinical features of PCOS, including 
androgen excess, impaired sex hormone feedback and enhanced LH secretion (Sullivan and 
Moenter, 2004; Roland and Moenter, 2011; Moore, Prescott and Campbell, 2013). Considering 
that hypothalamic brain circuits are highly shaped by steroid actions during prenatal development 
(Nuñez, Alt and McCarthy, 2003; McCarthy, Nugent and Lenz, 2017), prenatal androgen excess 
may drive the neuroendocrine impairment within the gonadotropin releasing hormone (GnRH) 
neuronal network in a PCOS-like condition. PNA mice also enable the use of transgenic tools to 
investigate the impact of androgen actions in the brain. Evidence to date has identified that PCOS 
traits in PNA mice are coincident with modifications in the GnRH neuronal network. GnRH 
neurons have significantly enhanced GABAergic transmission (Sullivan and Moenter, 2004) due 
to an increased GABA innervation (Moore et al., 2015; Moore and Campbell, 2016). In support of 
these pre-clinical findings, PCOS women exhibit elevated GABA levels in the cerebrospinal fluid 
(Hu et al., 2011; Kawwass et al., 2017) and larger serum concentrations of positive modulators of 
GABAA receptor (GABAAR) activity such as allopregnanolone (Hedström et al., 2015). Whereas 
GABA typically acts as an inhibitory neurotransmitter, GnRH neurons can respond to GABA with 
depolarization via GABAAR activation (DeFazio et al., 2002; Herbison and Moenter, 2011). These 
observations suggest that increased GABA signaling in PCOS may be responsible for driving the 
hyperactive GnRH/LH system, which in turn overstimulates androgen production by the ovaries. 
However, little is known about the temporal mechanisms mediating this vicious cycle of brain 
abnormalities and androgen excess in the development and pathophysiology of PCOS.   
These findings have led to important questions about the development and maintenance of 
identified PCOS-associated brain circuit abnormalities. It is unclear whether altered brain 
innervation is driven directly by PNA or indirectly by hyperandrogenism in adulthood. The present 
Chapter aimed to test the hypothesis that GABAergic contact on GnRH neurons is already altered 
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before pubertal onset in PNA mice. Immunolabeling of vesicular GABA transporter (VGAT) 
appositions to GnRH neurons in GnRH-GFP mice was used to visualize GABA inputs on GnRH 
neurons and investigate the timing of PNA-induced brain wiring remodeling. I also aimed to 
determine whether GABA-to-GnRH neuron abnormalities require prepubertal androgen excess. 
Therefore, circulating testosterone plasma levels were measured on postnatal day 25, prior to the 
onset of puberty in control and PNA mice.  
3.2 Methods 
3.2.1 Animals 
Prepubertal GnRH- GFP mice at postnatal day (PND) 25 were used in all of experiments. GnRH-
GFP mice express green fluorescent protein (GFP) under the control of GnRH promoter (Spergel 
et al., 1999) and have been broadly used to investigate developmental and electrophysiological 
aspects of GnRH neurons (Suter et al., 2000; Constantin, Iremonger and Herbison, 2013; Moore 
et al., 2015). Mice were housed at the Hercus Resource Unit (University of Otago - Dunedin) under 
12h: 12h light-dark cycles (lights on at 0700h) with ad libitum access to water and food. To 
generate PNA mice, we used established protocols as previously described in the General Methods 
Chapter and from studies elsewhere (Sullivan and Moenter, 2004; Moore, Prescott and Campbell, 
2013). Briefly, time-mated pregnant dams were injected with 100 µL of dihydrotestosterone (250 
µg) in oil, or oil alone to serve as a control, on gestational days 16, 17 and 18. 
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3.2.2 Blood sampling and hormone measurements 
3.2.2.1 Blood collection and tissue preparation 
At PND 25, control (N = 8) and PNA (N = 13) GnRH-GFP female mice were euthanized by an 
overdose of sodium pentobarbital (30 mg/mL). Blood was collected from the vena cava just prior 
to transcardial perfusion with buffered-paraformaldehyde 4% (0.1 M phosphate buffer-PFA 4%; 
pH 7.6). Brains were dissected, post-fixed for 1 h at room temperature, and saturated in 30% Tris-
buffered sucrose at -4 °C until processed for immunohistochemistry. Fixed brain tissue was cut 
into three series of 30-µm-thick coronal sections using a freezing microtome (Leica®, Wetzlar, 
Germany). 
3.2.2.2 ELISA 
Testosterone plasma levels were determined using a commercially available ELISA kit (LDN 
GmbH&Co.KG, Nordhorn, Germany). This assay is a well-established mouse/rat ELISA with 
reported specificity and reproducibility (found at LDN Immunoassays and Services reference: AR 
E-8000). Intra-assay coefficient of variation for testosterone was 11.4 %. LH levels were 
determined using well-established ELISA method as previously reported (Steyn et al., 2013; 
Moore et al., 2015; Czieselsky et al., 2016). A mouse LH-RP reference was provided by A. F. 
Parlow (National Hormone and Pituitary Program, Torrance, CA). The assay sensitivity of the LH 
ELISA was 0.002 ng/mL and intra-assay coefficient of variation was 6.2%. 
3.2.3 Immunohistochemistry 
Coronal brain sections throughout the rostral preoptic area (rPOA) and containing the organum 
vasculosum of lamina terminalis (OVLT) of the hypothalamus were identified according to the 
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mouse brain atlas (Paxinos and Franklin, 2004). Free-floating immunohistochemistry was 
performed as previously described (Cottrell et al., 2006; Moore et al., 2015). Primary antibodies 
were used in the respective concentrations: polyclonal chicken anti-GFP (1:2,500, Aves Labs Inc.) 
and polyclonal rabbit anti-VGAT (1:750, Synaptic Systems). Brain sections were incubated with 
both primary antibodies in cocktail with 2% normal goat serum for 48 h at -4 °C. AlexaFluor488 
goat anti-chicken (1:200) and Streptavidin568 (1:200, Molecular Probes, Invitrogen) secondary 
antibodies were used. Primary antibody omission served as a negative control. 
3.2.4 Confocal imaging acquisition and analysis 
Confocal imaging was obtained with a Nikon A1R Multi-photon confocal microscope with 488 
and 543 nm diode lasers. Brain sections were imaged using Plan NeoFluor 40 x oil objective (1.30 
NA), taking Z-stacks of 0.5 μm (pinhole at 1 AU) and analyzed with software NIS-Elements AR 
4.00.00 (Nikon® Instruments Inc.). GnRH neurons and VGAT-immunoreactive (ir) puncta were 
better visualized with 3x zoom function (Nikon® Instruments Inc.) Following double 
immunofluorescence (VGAT-ir/GFP-ir) protocol, quantification of VGAT appositions on GnRH 
neurons was performed in two representative sections from the rPOA/OVLT region of the 
hypothalamus of control (N = 4) and PNA (N = 5) mice. From each animal, 10 to 12 GnRH neurons 
were randomly selected across 2 sections and scanned for analysis. Unipolar and bipolar GnRH 
neurons were selected randomly, and multipolar GnRH neurons were excluded from this analysis. 
VGAT apposition density contacting GnRH neuron soma and along 75 µm of the dendritic length 
were performed as previously reported (Moore et al., 2015). Briefly, the number of VGAT contact 
was counted manually and the density is calculated by considering the number of appositions per 




                                           
3.2.5 Statistical analysis 
Statistical analysis was performed with PRISM software 7.0 (GraphPad Software, San Diego, CA, 
USA). Serum testosterone level values were first tested for normal distribution with D'Agostino-
Pearson’s normality test. Further evaluation of prepubertal PND 25 testosterone levels between 
control and PNA mice was performed with a two-tailed Student’s t test. Analysis of VGAT 
appositions onto GnRH neurons from prepubertal control and PNA mice used a Mann-Whitney U 
test. Graphical representation to display significant different are shown as * P < 0.05, ** P < 0.01, 
*** P < 0.001 and **** P < 0.0001. 
3.3 Results 
3.3.1 Circulating testosterone levels are normal prior to the onset of puberty in PNA mice 
Confirming that PND 25 animals were prepubertal, all control and PNA mice exhibited a complete 
absence of vaginal opening and LH levels were undetectable (<0.04 ng/mL). In order to determine 
whether PNA treatment induces early androgen excess, testosterone plasma levels were measured 
before pubertal onset at PND 25 from control (N = 8) and PNA (N = 13) mice with ELISA. In 
addition, circulating testosterone levels were not different between PNA and control groups (PNA: 
0.20 ± 0.01 vs. control: 0.22 ± 0.03 ng/mL; Student’s t test) (Figure 3.1).  
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Figure 3.1. Prepubertal PNA mice have similar testosterone blood levels.  
Testosterone blood levels from control (N = 8) and PNA (N = 13) mice at PND 25. Two -
tailed Student’s t-test. 
3.3.2 Morphological criteria to identify GABAergic inputs on GnRH-GFP neurons 
Morphological analysis was performed with confocal projections of 45 GnRH-GFP neurons from 
control (N = 4) and 51 GnRH-GFP neurons from PNA (N= 5) mice. In agreement with other studies 
(Jennes, Stumpf and Sheedy, 1985; Herde and Herbison, 2015), GnRH neurons were mainly found 
to be unipolar or bipolar. Dendrites of bipolar GnRH neurons were classified as primary or 
secondary dendrites based on previous reports (Herde and Herbison, 2015; Moore et al., 2015). 
Briefly, thicker dendrites with larger cross-sectional area leaving from the point of origin at the 
soma were classified as primary dendrites. Typically, on the opposite pole of the cell from the 
primary, the secondary dendrite were identified as the thinner process, with smaller cross-sectional 
area when compared to primary dendrite (Figure 3.2).  
GABAergic contact on GnRH neurons was identified with immunostaining of VGAT 
puncta in contact with the GnRH-GFP membrane. Confocal analysis showed that all scanned 
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GnRH neurons showed VGAT appositions at the soma and dendrites. Close appositions of VGAT 
immunoreactive (-ir) puncta to GFP-ir GnRH neurons in the rostral preoptic area (rPOA) of the 
hypothalamus, indicated putative GABA synaptic inputs (Edwards et al., 1997; Cottrell et al., 
2006). The locations of putative GABA synapses were classified as onto spines, crucial membrane 
structures which harbor excitatory inputs (Harris et al., 2013; Oh et al., 2016), or onto the somatic 
or dendritic shaft membrane without spines, here classified as non-spiny membrane (Figure 3.2).  
 
Figure 3.2. GABA inputs on prepubertal GnRH neurons.  Representative example of 
confocal image acquisition of a prepubertal GnRH neuron from a control mouse. In PND 25 
mice GnRH neurons were mostly unipolar or bipolar neurons. Overlap of red (VGAT) and 
green (GnRH-GFP) provides yellow puncta, which indicates putative contact.  The image on 
the right depicts the neuronal compartments of bipolar GnRH neurons. The thicker dendrite 
(with largest cross-sectional area leaving the soma) is classified as primary dendrite and the 
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thinner dendrite is classified as the secondary dendrite (Scale bar = 10 µm). In the second 
column, high magnification images show putative GABA inputs onto GnRH neuron spines 
(blue arrow head) and onto the non-spiny membrane (white arrow heads). GABA inputs are 
evident on the distal (I) and proximal (II) primary dendrite, soma (II I) and secondary 
dendrite (IV) (Scale bar = 2 µm).      
3.3.3 GnRH neurons receive increased GABAergic innervation in prepubertal PNA female 
mice 
As reported previously (Moore et al., 2015), the total density of VGAT-ir appositions to GnRH 
neurons within each neuronal compartment and the number of GnRH neuron spines were evaluated 
in control and PNA  mice (Figure 3.3 A). At PND 25, the total density of VGAT appositions to 
GnRH neurons was significantly increased in PNA mice when compared to controls (P < 0.05; 
Mann-Whitney U test; Figure 3.3 B). In addition, the densities of VGAT appositions to GnRH 
neurons in all three neuronal compartments were significantly elevated (P < 0.05; Figure 3.3 C). 
The total number of GABA inputs to the non-spiny membrane of the soma and dendrites were also 
significantly higher in prepubertal PNA mice than in controls (P < 0.05; Figure 3.3 D), and 
specifically at the level of the soma (P < 0.05) and primary dendrite (P < 0.05) (Figure 3.3 E). The 
total density of VGAT appositions to GnRH neuron spines was similar between groups (P = 0.19; 
Figure 3.3 F); however, a greater number of GABAergic inputs on GnRH neuron somatic spines 
was detected in prepubertal PNA mice when compared to controls (P < 0.05; Figure 3.3 G). The 
total number of GnRH neuron spines was evaluated and results showed that it was similar between 
groups (PNA: 0.24 ± 0.01 vs. control: 0.23 ± 0.03 spines/µm). These findings revealed that prenatal 
androgen exposure is sufficient to program circuitry changes in the female GnRH neuronal network 
prior to the postpubertal development of androgen excess and reproductive deficits in PNA mice.  
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Figure 3.3. Increased GABAergic contact to GnRH neurons is present in 
prepubertal PNA mice. (A) Examples of confocal images of control (N = 4  / 45 neurons) 
and PNA (N = 5 / 51 neurons) mice displaying GnRH-GFP neurons (green) and VGAT-ir 
(red puncta) in the rPOA (Scale bar = 10 µm). Overlap of red and green provides yellow 
puncta, which indicates putative contact.  Projected confocal images show 1.15 μm -thick 
stack details of VGAT appositions at the level of GnRH neuron soma ( I) and dendrite (II 
and III). White arrowheads point to putative GABA inputs onto the non-spiny GnRH neuron 
membrane and blue arrowheads show GABA inputs onto spines (Scale bar = 5 μm). 
Histograms depict total VGAT-ir apposition density on GnRH neurons (B) and per neuronal 
compartment (C). Total VGAT-ir apposition density onto the non-spiny GnRH neuron 
membrane (D), and per neuronal compartment (E). Total VGAT-ir apposition density onto 
GnRH neuron spines (F), and per neuronal compartment (G). Histogram values are 
represented as mean ± SEM with dot plot of individual values. *P < 0.05; Mann-Whitney U 
test. 
3.4 Discussion 
The present study aimed to unveil the ontogeny of altered brain wiring in relation to the onset of 
puberty in a PCOS-like condition as recapitulated in PNA mice. Clinical and pre-clinical studies 
have shown that prenatal androgen exposure results in impaired adult reproductive function during. 
However, it is unclear how this dysfunction develops and whether changes in the HPG axis occur 
before pubertal onset and the manifestation of hyperandrogenism. These present findings indicate 
that a short prenatal androgen insult induces an abnormal increase in GABAergic innervation to 
GnRH neurons prior to pubertal development. These data also suggest that GABA-to-GnRH 
neuron abnormalities might be independent of elevated circulating levels of testosterone in PNA 
mice. With increasing evidence that the brain might be the primary site of PCOS pathogenesis 
(Moore and Campbell, 2017), the present discovery suggests that in utero androgen actions lead to 
the installation of a biological program in the female brain to develop the disease during adulthood.  
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Clinical studies have shown that the placenta of PCOS women exhibit alterations such as 
increased activity of 3β-hydroxysteroid dehydrogenase type 1 and decreased P450 aromatase 
activity (Maliqueo et al., 2013) allowing the establishment of elevated androgen levels during late 
gestation (Sir-Petermann et al., 2002). In addition, altered androgen milieu caused by CAH, which 
generates a hyperandrogenic in utero condition, induces PCOS features later in life (Hague et al., 
1990; Barnes et al., 1994). Therefore, androgen actions in the prenatal brain may induce the 
development of PCOS. Our laboratory and others have used PNA treatment to induce PCOS-like 
condition in mice, which enable us to evaluate the impaired reproductive function without major 
metabolic traits associated with the disease (Sullivan and Moenter, 2004; Roland et al., 2010; 
Moore, Prescott and Campbell, 2013). Although there is evidence that prepubertal androgen 
exposure in non-human primates promote hyperandrogenism and elevated LH secretion during 
early adulthood (McGee et al., 2012), our findings suggest that this might not be the case for PNA 
mice. Similar to clinical studies (Crisosto et al., 2007; Villarroel et al., 2015) and consortium 
update (Ibáñez et al., 2017), these findings suggest that androgen excess may occur during pubertal 
development and maturation of the HPG axis but not prior to pubertal onset.       
Our research group previously reported that  adult PNA mice exhibit enhanced steroid-
sensitive GABAergic innervation onto GnRH neurons, which is associated with high LH pulse 
secretion and impaired ovarian steroid-mediated negative feedback (Moore, Prescott and 
Campbell, 2013; Moore and Campbell, 2016). In the same manner, PCOS women display similar 
neuroendocrine disturbances which reflect a desensitization of the pulse generator driving 
GnRH/LH secretion to steroid hormone feedback (Blank, Mccartney and Marshall, 2006). 
Importantly, a clinical study showed that hyperandrogenic girls with PCOS exhibit a reduced 
sensitivity to decrease LH pulsatile secretion, which is associated but not dependent of testosterone 
plasma levels (Blank et al., 2009). Therefore, the present results with previous findings suggest 
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that the origin of the disease precedes the pubertal development and the postpubertal rise of 
androgen levels may sustain the neuroendocrine and reproductive pathological features of PCOS. 
Fertility is relied upon the proper functioning of GnRH neurons and the GnRH neuron 
activity is dependent upon synaptic transmission from afferent inputs such as GABA neurons. To 
identify putative GABA inputs on GnRH neurons, I have used immunohistochemical labeling of 
VGAT, which accumulates GABA into the presynaptic vesicles (McIntire et al., 1997). VGAT-ir 
could be identified in virtually all analyzed GnRH-GFP neurons, reaffirming that GABA is a major 
input to GnRH neurons (Cottrell et al., 2006; Hrabovszky et al., 2012). Although better resolution 
of GnRH morphological features might be achieved with other techniques such as biocytin filling 
(Campbell, Han and Herbison, 2005; Cottrell et al., 2006), using the present immunohistochemical 
labeling of VGAT enabled the examination of the whole population of GnRH neurons in the 
rPOA/OVLT region. High resolution confocal imaging made possible the visualization and 
quantification of VGAT contact onto GnRH neuron spines and onto GnRH neuron non-spiny 
membrane. Future studies may address the functional relevance of GABA inputs on GnRH during 
prepubertal life and whether altered GABA inputs in this developmental stage may directly alter 
GnRH neuron functioning in PNA mice. It is important to note that VGAT-expressing neurons are 
also glycinergic (Chaudhry et al., 1998), and additional studies could define in the future whether 
glycinergic inputs to GnRH neurons undergo remodeling in a PCOS-like condition.  
Increased GABA innervation may play a role in GnRH/LH hyperactivity in the PCOS 
condition as GnRH neurons can respond to GABA with excitation (DeFazio et al., 2002; Herbison 
and Moenter, 2011). In vitro studies have shown that androgens enhance GnRH neuron activity 
through increase GABA transmission to these neurons in adult mice (Pielecka, Quaynor and 
Moenter, 2006). The idea of GnRH neurons being quiescent during prepubertal life was recently 
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addressed by researchers, who showed that prepubertal GnRH neurons are surprisingly active in 
mice (Dulka and Moenter, 2017). In addition, they observed that PNA treatment attenuates the 
activity of GnRH neurons leading to an abnormal firing rate pattern (Dulka and Moenter, 2017). 
Remarkably, the present results showed that an abnormal increase of GABAergic innervation onto 
GnRH neurons occurs during the prepubertal age (PND 25) in PNA mice, and it might contribute 
to the altered GnRH neuron activity. However, it seems contradictory that increased GABAergic 
innervation and lower GnRH neuron activity during prepubertal life may promote an elevated 
GnRH neuron activity during adulthood. Clinical evidence from cross-sectional study revealed that 
obese girls exhibit low levels of nocturnal LH pulse frequency associated with high free 
testosterone levels during early puberty (Tanner 1-2), whereas non-obese girls display the normal 
increase of nocturnal LH pulses (McCartney et al., 2009). Interestingly, an opposite outcome was 
found during late puberty, which obese girls (Tanner 3-5) displayed both higher LH pulse 
frequency and testosterone levels when compared to normal subjects (McCartney et al., 2009). 
These findings suggest that a biological programing controlling GnRH neuron activity during early 
puberty may induce a “neuroendocrine switch” altering the postpubertal GnRH/LH secretion. 
During prenatal and early postnatal life, GABA actions via GABAAR in immature neurons 
are mainly excitatory through a differential chloride (Cl-) homeostasis; by which cells maintain 
high intracellular Cl- concentration and a more depolarizing reversal potential for Cl- than the 
resting membrane potential (Ben-Ari, 2002). Prepubertal PNA mice exhibited enhanced 
GABAergic contact on non-spiny membrane but also at somatic spines, which harbor excitatory 
inputs in neurons, suggesting an altered regulation of GnRH neuron activity in a PCOS-like 
condition. Excitatory actions of GABA during early development are critical to induce de novo 
synapse formation and increase the number of dendritic spines through the regulation of 
intracellular calcium (Ca2+) signaling in the mouse brain (Kirmse et al., 2015; Oh et al., 2016). In 
Chapter Three 
83 
                                           
addition, juvenile GnRH neurons can be excited by activation of GABAAR (DeFazio et al., 2002). 
Therefore, increased GABAergic innervation may drive abnormal synaptic pruning in GnRH 
neurons during prepubertal life, which also may dictate their postpubertal electrical behavior. 
However, it is still not clear whether GABAergic overdrive in prepubertal GnRH neurons is the 
definitive cause of a later manifestation of PCOS-like traits in PNA mice. Future experiments will 
define the direct effect and timing of elevated GABA contact on GnRH neuronal activity. 
The present findings postulate that prenatal androgen exposure induces prepubertal 
abnormalities in brain wiring, which may trigger the neuroendocrine impairment of PCOS 
following the pubertal activation of the HPG axis. This new insight is critical to better understand 
the developmental origin of PCOS, which seems highly dependent on androgen excess in utero. In 
addition, these findings opened that opportunity to investigate the developmental timing of 
androgen excess in PNA mice and whether hyperandrogenic ovaries are required to maintain the 
impaired LH secretion (Chapter 4). Considering that GABA-to-GnRH neuron abnormalities 
seemed programmed in utero and hardwired before pubertal onset, I will also address whether the 
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4.1 Introduction 
Female androgen excess during reproductive life is a hallmark of polycystic ovary syndrome 
(PCOS), affecting 60-80% of PCOS patients worldwide (Azziz et al., 2009; Ibáñez et al., 2017). 
Evidence from PCOS animal model studies suggest that overstimulation of theca cells in the 
ovaries mediated by luteinizing hormone (LH) drives the excessive androgen production (Eisner 
et al., 2002). There is compelling evidence that the establishment of hyperandrogenic ovaries 
during adult life sustains the neuroendocrine impairment of PCOS by impairing the sex steroid-
mediated negative feedback mechanism. This leads to continuous cycle that promotes increased 
androgen levels, menstrual irregularities and, ultimately, infertility (Pastor et al., 1998; Azziz et 
al., 2009). However, little is known about the temporal and dynamics of androgen excess during 
pubertal development in a PCOS. 
Although not included for diagnostic screening of PCOS, neuroendocrine derangements 
generating abnormal luteinizing hormone (LH) secretion are present in the majority of PCOS 
women (Manieri et al., 1992; Berga, Guzick and Winters, 1993; Dumesic et al., 2015). PCOS 
patients are reported to exhibit elevated LH pulse frequency and/or amplitude associated with 
ovulatory dysfunction (Rebar et al., 1976; Taylor et al., 1997; Azziz et al., 2016). Chronically 
elevated LH levels may be the result of an intrinsic elevated GnRH pulse frequency. Clinical study 
showed that administration of estrogens and progestin in PCOS women did not decrease LH levels 
in the same magnitude as in normal women, although testosterone levels were normalized by the 
oral contraceptives (Daniels and Berga, 1997). These data suggest the idea that postpubertal 
androgen excess does not directly drive high LH secretion but instead sustains the impaired sex 
steroid-negative feedback.  
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  Such as in the human condition, adult prenatally androgenized (PNA) mice present 
elevated circulating testosterone levels (Sullivan and Moenter, 2004; Moore, Prescott and 
Campbell, 2013). PNA mice also display high LH pulse frequency and impaired estradiol- and 
progesterone-mediated negative feedback (Moore, Prescott and Campbell, 2013; Moore et al., 
2015). Interestingly, PNA mice exhibit a smaller rise in LH levels following castration when 
compared to control animals (Moore, Prescott and Campbell, 2013). This may indicate a reduced 
GnRH/LH pulse responsiveness to the sex steroid hormone negative feedback withdraw in a 
PCOS-like condition. As mentioned in previous chapters, this desensitization of the GnRH pulse 
generator may be the result of changes in brain circuits within the GnRH neuronal network. The 
first findings of the present PhD project elucidated the time which brain wiring abnormalities are 
present that is before of the onset of puberty (Chapter 3). It was also clear that the installation of 
altered GABA-to-GnRH neuron circuit was not dependent on earlier rise of circulating testosterone 
levels in the blood. Together, this evidence suggests that in utero androgen excess imprinting of 
hypothalamic circuits controlling GnRH/LH pulsatility is a forerunner in PCOS pathophysiology, 
whereas defects in the classical negative feedback and ovarian dysfunction are secondary features. 
The present study aimed to further investigate the developmental timing of androgen excess 
in PNA mice to establish when hyperandrogenism is present in relation to brain circuit 
abnormalities and pubertal onset. To test both hypothesis, assessment of circulating testosterone 
levels, estrous cyclicity and analysis of post-castration LH pulsatility were all performed in the 
same cohort of animals, which followed from peripubertal stage into adulthood. In addition, I 
hypothesized that short-term withdraw of androgen excess by the removal of hyperandrogenic 
ovaries for 7 days is not able to fully restore normal LH pulse secretion in PNA mice.  The “ideal” 
experiment would be to compare the LH pulse secretion before and after ovariectomy and normal 
and PNA female mice. However, due to animal ethics constraints, herein, I present the results of 
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LH pulse secretion profile of ovariectomized normal and PNA mice, which were previously used 
to determine the timing of androgen excess in PNA mice.   
4.2 Methods 
4.2.1 Animals 
Control and PNA C57BL/6(B6) mice were housed at the Hercus Resource Unit (University of 
Otago - Dunedin) under 12h: 12h light-dark cycles (lights on at 0700h) with ad libitum access to 
water and food. To generate PNA mice, we used established protocol as previously described 
(Sullivan and Moenter, 2004; Moore, Prescott and Campbell, 2013). Briefly, time-mated pregnant 
dams were injected with 100 µL of dihydrotestosterone (250 µg) in oil, or oil alone to serve as a 
control, on gestational days 16, 17 and 18. All protocols were approved by the University of Otago 
Animal Ethics Committee (Dunedin, New Zealand). 
4.2.2 Experiment 1: Developmental timing of plasma testosterone and assessment of estrous 
cyclicity 
At postnatal day (PND) 30, 40, 50 and 60, control (N = 10) and PNA (N = 9) mice were handled 
and blood collection from the tail-tip was performed from 0900h to 1000h. Blood samples were 
spun at 4 G for 10 min at room temperature and plasma was collected and kept at -20 ºC until the 
day of hormone measurement. From PND 60 to PND 80, estrous cyclicity was followed by daily 
vaginal smears and examination of the vaginal cytology (Caligioni, 2009) (Figure 4.1). 
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4.2.3 Experiment 2: Effect of ovariectomy on pulsatile LH secretion of control and PNA 
mice 
Using the same cohort of animals from Experiment 1, control (N = 7) and PNA (N = 8) mice, 
underwent ovariectomy surgery (surgical approach described in detail in Chapter 2) (Figure 4.1). 
Animals were left to recover seven days post-surgery and a bleeding protocol to assess LH pulsatile 
secretion was performed as previously reported (Czieselsky et al., 2016). Briefly, mice were kept 
in quiet room and habituated with daily handling to avoid further distress during blood sampling. 
During bleeding, 3 µL of blood was collected every 6 min for 2 h. Whole blood was diluted in 57 
µL of 0.1 M phosphate buffered saline-tween (PBS-T) pH 7.4, frozen in dry ice and stored at -20 
ºC for subsequent hormone measurements. 
 
Figure 4.1. Experimental design to assess the timing of testosterone excess and 
LH pulse frequency following castration in PNA mice.  Control and PNA mice were 
followed from postnatal day (PND) 30 to PND 90. Blood samples were collected via 
hematocrit tube at PND 30, 40, 50 and 60. From PND 60 to PND 80, estrous cyclicity was 
followed by daily vaginal smears and examination of the vaginal cytology . On PND 83, 
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control and PNA mice were ovariectomized and left to recover for 7 days. On PND 90, LH 
pulse secretion was assessed using bleeding protocol.  
4.2.4 Hormone measurements 
Circulating testosterone levels were determined in blood collected in a single time point (PND 30, 
40, 50 and 60) using 50µl of whole blood via hematocrit tube to obtain 10µl of plasma to be used 
in the assay. Testosterone plasma levels were determined using a commercially available mouse/rat 
ELISA kit (LDN GmbH&Co.KG, Nordhorn, Germany). Intra-assay coefficient of variation for 
testosterone was 10.3 % and inter-assay coefficient of variation was 11.0%.  
LH levels were determined in serially blood samples using well-established ELISA method 
as previously reported (Steyn et al., 2013; Moore et al., 2015; Czieselsky et al., 2016). A mouse 
LH-RP reference was provided by A. F. Parlow (National Hormone and Pituitary Program, 
Torrance, CA). The assay sensitivity of the LH ELISA was 0.002 ng/mL. The assay sensitivity of 
the LH ELISA was 0.04 ng/mL and intra-assay coefficient of variation was 4.3%. 
4.2.5 Analysis of LH pulsatility 
Post-castration LH levels measured by ELISA were plotted on XY-graph using PRISM software 
7.0 (GraphPad Software, San Diego, CA, USA). LH pulses were identified using pulse peaks above 
10% of the preceding values and examination of pulse shape as previously reported (Clarkson et 
al., 2017). The software DynPeak (Vidal et al., 2012) was used to confirm LH pulses and identify 
LH pulse peak values (Figure 4.2 A). Mean LH levels were calculated by averaging all LH values 
collected during the serial bleeding. Mean basal LH levels were determined by the average of the 
lowest points identified in the plotted graph for each animal (Figure 4.2 A). The pulse interval was 
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determined by the time from the lowest point prior to the LH pulse peak to the next lowest point 
after the peak (base to base) (Figure 4.2 B). LH pulse frequency was determined by counting the 
number of LH peak values identified as LH pulses within the 2-h bleeding session. The LH pulse 
amplitude was measured by the calculation of the LH pulse peak value mines the lowest LH value 
prior to the peak (Figure 4.2 C). As a measure of the integrated LH release to GnRH pulses, the 
area under the curve (AUC) was determined. The mean basal LH was set as the baseline for the 
plotted graph and PRISM software was able to calculate the AUC (Figure 4.2 D). 
 
Figure 4.2. Method for analysis of LH pulsatility.  Representative profile of pulsatile 
LH secretion from ovariectomized female mice. (A) LH pulse was determined by LH pulse 
peak value that were above 10% of the preceding value  and examination of pulse shape (blue 
asterisks). High LH peak values either at the starting point (time 0min) or at the end point 
(time 120min) were not considered to be a LH pulse. Basal LH values were identified as the 
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lowest values plotted on the graph (red circles). (B) LH pulse interval was determined by 
the time (X; in min) between the lowest points before and after a LH pulse. All individual 
intervals (green double arrows) were averaged to determine the mean LH pulse interval. (C) 
LH pulse amplitude was calculated by taking each LH pulse peak value minus the lowest LH 
level prior to the peak (green double arrows). (D) The area under the curve (AUC; light blue 
shade) was determined by PRISM software using the mean basal LH level as the baseline 
(blue dashed line) for the calculation.   
4.2.6 Statistical analysis 
Statistical analysis was performed with PRISM software 7.0 (GraphPad Software, San Diego, CA, 
USA). Testosterone and LH level values were firstly tested for normal distribution with 
D'Agostino-Pearson’s normality test. Testosterone levels throughout pubertal development of 
control and PNA mice were compared using repeated-measures two-way ANOVA with Sidak’s 
multiple comparison post hoc test. Evaluation of the percentage of days spent in each day of the 
estrous cycle of either control or PNA mice was analyzed with one-way ANOVA with Tukey’s 
post hoc test. Comparisons between the groups to determine differences in the percentage of days 
spent in each stage of the estrous cycle were analyzed with two-way ANOVA with Sidak’s post 
hoc test. Pulsatile LH profile parameters were analyzed by comparing control and PNA mice using 
two-tailed Student’s t test. Statistical significance was accepted when P < 0.05. Graphical 
representation to display significant different are shown as * P < 0.05, ** P < 0.01, *** P < 0.001 




                                           
4.3 Results 
4.3.1 Androgen excess occurs during early adulthood in PNA mice 
To determine the developmental timeline of androgen excess in our PCOS-like mouse model, 
circulating levels of testosterone were measured throughout peripubertal development and into 
adulthood, from postnatal day (PND) 30 to PND 60. Testosterone levels were similar between 
groups at PND 30 (PNA: 0.11 ± 0.03 vs. control: 0.10 ± 0.02 ng/mL) and PND 40 (PNA: 0.14 ± 
0.03 vs. control: 0.15 ± 0.03 ng/mL) corresponding to early and mid-pubertal stages (Figure 4.3). 
In contrast, by early adulthood at PND 50, average circulating testosterone levels of PNA mice 
were significantly elevated compared to controls (0.24 ± 0.06 vs. 0.06 ± 0.01 ng/mL; P < 0.01). 
Mean testosterone levels remained higher in adult PNA mice at PND 60 when compared to control 
mice (Figure 4.3; 0.24 ± 0.06 vs. 0.08 ± 0.01 ng/mL; P < 0.05; F3,51(interaction) = 6.2; 
F1,17(phenotype) = 7.3; repeated-measures two-way ANOVA with Sidak’s post hoc test;).  
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Figure 4.3. Temporal assessment of blood testosterone levels revealed that 
androgen excess occurs during early adulthood in PNA mice.  Circulating 
testosterone levels from postnatal day (PND) 30 to PND 60 in control (N = 10) and PNA (N 
= 9) mice. Data are shown as dot plots for each time point and bars represent mean ± SEM. 
Dashed blue lines indicate testosterone levels of control mice and red full lines indicate 
PNA mice. Handling of mice occurred just at PND 30, 40, 50 and 60. Differences between 
the groups are reported as *P < 0.05; **P < 0.01 and differences within each groups are 
reported as #P < 0.05. Data analysis was performed with repeated measures two -way ANOVA 
with Sidak’s post hoc test.  
 
Analysis of testosterone fluctuations over the pubertal transition into adulthood in control 
animals demonstrated peak testosterone levels occur at PND 40, with levels falling significantly 
into adulthood (PND 50-60) (P < 0.05). In contrast, in PNA mice, peak testosterone levels were 
significantly higher at PND 50, when compared with peripubertal levels at PND 30 (P < 0.05) 
(Figure 4.3). While control mice all exhibited relatively low circulating testosterone in adulthood, 
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testosterone levels in PNA mice were highly variable. These data demonstrate that a short prenatal 
androgen exposure in female mice induces the development of high circulating testosterone levels 
that begin after pubertal onset and continue into adulthood.  
4.3.2 PNA mice exhibit disrupted estrous cyclicity during adulthood 
Control (N = 10) and PNA (N = 9) mice Estrous cycles of both groups were followed from PND 
60 to PND 80. Despite variable testosterone levels at PND 50 and 60 in PNA mice, vaginal 
cytology confirmed that all PNA animals displayed a significant disruption of estrous cyclicity 
with a complete absence of proestrous smears, indicating the absence of ovulation (Figure 4.4) in 




                                           
 
Figure 4.4. PNA mice exhibit significant disruption of reproductive cycles during 
adult life.   Estrous cycles from control (N = 10) and PNA (N = 9) from postnatal day (PND) 
60 to PND 80. Vaginal smears and cytological evaluation were used to identify the estrous 
stages proestrus (P), diestrus (D), metestrus (M) and estrus (E). All mice here presented are 
the same animals used to measure testosterone blood levels from PND 30 to PND  60 (data 
in figure 4.3) . The code above each panel indicates the original identification number of 




                                           
Estrous cycle was further investigated by analyzing the percentage of days spent in each 
cycle stage. Results showed that control mice spent a significant different time in each stage of the 
cycle (diestrus: 29.0 ± 1.4; proestrus: 22.0 ± 1.1; estrus: 43.5 ± 2.1; metestrus: 5.5 ± 2.2 %; F3, 36 = 
79.73; P < 0.0001) (Figure 4.5 A). Conversely, PNA mice spent an increased and similar 
percentage of time in estrus and metestrus (estrus: 39.4 ± 3.6; metestrus: 45.0 ± 6.5 %) when 
compared to diestrus and proestrus (diestrus: 15.6 ± 4.7; proestrus: 0.0 ± 0.0 %) (F3, 32 = 22.9; P < 
0.0001) (Figure 4.5 A).  Comparisons between the groups revealed that PNA mice exhibited a 
significant decreased in the percentage of time spent in diestrus (P < 0.05) and proestrus (P < 
0.0001) when compared to controls (Figure 4.5 B). In contrast, PNA spent a significant increase 
in the amount of time spent in metestrus (P < 0.0001) in comparison with control mice, while no 
differences were identified for the estrous stage (Figure 4.5 B).  Together, these data illustrate the 
direct evidence that postpubertal androgen excess during is associated with chronic anovulation 
during adult life by disrupting the normal profile of estrous cyclicity in PNA mice.  
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Figure 4.5. PNA mice exhibits significant disruption of estrous cycles.  Estrous 
cyclicity of control (N = 10) and PNA (N = 9) mice from postnatal day (PND) 60 to PND 
80. All mice belong to the same cohort of animals which were previously bled to assess 
development timing of circulating testosterone levels (data in figure 4.3). (A) Histograms 
show mean ± SEM percentage of days spent in each stage of the estrous cycle of either 
control or PNA mice. Different letters indicate significant differences (P < 0.05); one-way 
ANOVA with Tukey’s post hoc test. (B) Comparison between control and PNA mice 
analyzing the time spent in each stage of the estrous cycle. * P < 0.05; ****P < 0.0001; two-
way ANOVA with Sidak’s post hoc test. (ND = not detected).   
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4.3.3 Deranged LH regulation persists after castration in PNA mice 
The majority of androgen excess in PCOS patients and PNA animal models originate from the 
ovary (Eisner et al., 2002; McCartney et al., 2004). In addition, diestrous PNA mice display 
significant increase of LH pulse frequency and decrease of LH pulse amplitude associated with 
elevated testosterone levels (Moore et al., 2015). To investigate the requirement of 
hyperandrogenic ovaries to the neuroendocrine impairment in PNA mice, LH pulse secretion was 
determined in control (N = 7) and PNA (N = 8) mice 7 days post-ovariectomy (OVX) on PND 90. 
The LH profile of each group was assessed (Figure 4.6A) and analysis of pulsatile LH secretion 
was performed. Results showed that OVX control and OVX PNA mice exhibit similar values of 
mean LH and basal levels (Figure 4.6 B and C).  
In addition, OVX control and OVX PNA mice presented similar LH pulse frequency 
(control: 7.00 ± 0.44 vs. PNA: 7.12 ± 0.35 No. of pulses/2h; Figure 4.6 D) and pulse duration 
(control: 17.15 ± 1.08 vs. PNA: 16.32 ± 0.59 min; Figure 4.6 E). However, OVX PNA mice 
exhibited a significant increased LH pulse amplitude compared to OVX control mice (PNA: 3.82 
± 0.15 vs. control: 2.70 ± 0.12 ng/mL; P < 0.0001; Figure 4.6 F). The integrated LH response to 
GnRH pulses, as determined by the area under the curve  (AUC) based on previous report (Patel 
et al., 2004), was significantly greater in OVX PNA mice than OVX controls (PNA: 237.4 ± 10.9 
vs. control: 181.4 ± 6.6; P < 0.001; Figure 4.6 F). These data suggest that PNA mouse ovaries are 
important for sustaining the postpubertal neuroendocrine impairment of GnRH/LH pulse 
frequency. However, in the absence of ovarian hyperandrogenism, altered gonadotropin regulation 
persists, suggesting an increased gonadotrope responsiveness to GnRH pulses, as illustrate by 
enhanced LH pulse amplitude and AUC following OVX.  
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Figure 4.6. Amplitude of LH secretion remains increased after the removal of 
hyperandrogenic ovaries in PNA mice.  (A)  Examples of pulsatile LH levels in the 
blood from control (N = 7) and PNA (N = 8) mice after 7 days after ovariectomy on postnatal 
day (PND) 90. Asterisks indicate LH pulse peaks. Control and PNA mice belong to the same 
cohort of mice, which were followed from PND 30 to PND 60 to assess circulating 
testosterone levels (data in figure 4.3). Histograms show mean LH levels (B), mean basal 
LH levels (C), LH pulse frequency (D), LH pulse duration (E), LH pulse amplitude (F), and 
area under the curve (AUC) (G). Values are shown as mean ± SEM. Unpaired two-tailed 
Student’s t test; ***P < 0.001; ****P < 0.0001. 
 
4.4 Discussion 
Prenatal programing androgen excess promotes ovarian hyperandrogenism and abnormally 
elevated LH pulse frequency during adulthood in PNA animal models. Firstly, the present chapter 
aimed to elucidate the developmental timing of androgen excess in PNA mice. Our data showed 
that androgen excess in PNA mice was evident after pubertal development into adulthood at PND 
50 and PND 60. Follow-up experiments demonstrated a direct association of androgen excess 
during early adulthood with the disruption of reproductive cycles. In particular, PNA mice did not 
display proestrous stage and spent more time in estrus and metestrus compared to controls. Lastly, 
the requirement of ovarian androgen production to sustain altered LH secretion was tested by the 
removal of hyperandrogenic ovaries in PNA mice. The results of this study showed that OVX 
promoted similar increase in LH pulse frequency in both control and PNA mice. However, the LH 
pulse amplitude and the magnitude of LH response, as determined by the AUC, were significantly 
elevated in OVX PNA mice. 
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In chapter 3, our data showed that control and PNA mice exhibit similar circulating 
testosterone blood levels before the onset of puberty at PND 25. Serial measurements of blood 
testosterone levels in PNA mice indicated that circulating androgen excess does not develop until 
PND 50. As the manifestation of PCOS is linked to the onset of puberty, it could be the case that 
PNA mice might display pubertal onset after PND 50 due to androgen excess. However, it does 
not seem to be the case as all mice from this study displayed vaginal opening by PND 40. In 
addition, our PNA mice exhibit first estrous by ≤ PND 40 as shown by previous work from our 
laboratory (Moore, Prescott and Campbell, 2013). These findings together with the results from 
Chapter 3 suggest that androgen excess is likely to be a downstream outcome from altered 
GnRH/LH secretion as it is manifested following pubertal onset. In girls, prepubertal adrenarche 
correlates with a higher risk of developing PCOS and hyperandrogenic ovaries due to precocious 
exposure to increased androgen levels (Vuguin et al., 1999; Silfen et al., 2002). In contrast, rodent 
adrenal glands do not possess the molecular machinery necessary to synthesize androgens (van 
Weerden et al., 1992) implying that PNA-induced androgen excess develops from an ovarian 
source. Another important source of androgens is the brain itself, which express significant amount 
of P450 aromatase converting estrogens into testosterone in situ. Changes in brain androgen levels 
are more dramatic during perinatal period tissue levels remain low during postnatal life in female 
rodents (Konkle and McCarthy, 2011); however, it is unknown whether prenatal androgen excess 
may induce prepubertal high brain androgen levels in PNA mice. Adult PCOS show elevated levels 
of a 53% increase in testosterone levels, which is associated with high GABA in the cerebrospinal 
fluid (Kawwass et al., 2017). Therefore, remains to be investigated whether an abnormal in situ 
steroidogenesis may still occur after the removal of hyperandrogenic ovaries in PNA mice. 
Regardless of the source, precocious exposure to androgens appears promote the development of 
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hyperandrogenic ovaries and is suggestive of a developmental programming of disease 
progression.  
Previous reports have shown PNA treatment results in disruption of estrous cycles and 
infertility (Sullivan and Moenter, 2004; Moore, Prescott and Campbell, 2013).The present study 
showed a direct evidence between androgen excess taking place during early adulthood and 
irregular estrous cyclicity at reproductive age in PNA mice. Specifically, whereas normal female 
mice spent a varied amount of time in each estrous cycle stages, PNA mice lacked the detection of 
proestrus, an indicative of ovulation, and exhibited a significant longer time in estrus and metestrus. 
Female rodents typically present a short luteal phase and the metestrus stage which usually lasts 
few hours (Smith, Freeman and Neill, 1975). The vaginal cytology of metestrus stage is 
characterized by a pronounced number of cornified epithelial cells along with leucocytes. Neonatal 
female mice treated with testosterone display persistent vaginal cornification and leucocyte 
infiltration associated with ovarian dysfunction leading to total absence of corpora lutea during 
adulthood (Kimura, Nandi and Deome, 1967). Interestingly, adult neonatally testosterone-treated 
mice can also exhibit persistent vaginal cornification after ovariectomy, posing the possibility an 
ovarian-independent persistent metestrus (Kimura, Basu and Nandi, 1967). These evidence 
together with the present findings suggest that perinatal androgen excess may promote 
organizational upstream derangements in the HPG axis, which persists until postpubertal androgen 
excess occurs to trigger ovarian dysfunction and irregular cycles.  
The present findings also elucidated the dynamics of pulsatile LH secretion pattern in the 
absence of hyperandrogenic ovaries in PNA mice. Previous work in our laboratory showed that 
PNA mice exhibit elevated LH pulse frequency and significant decrease of LH pulse amplitude 
without changes in the mean LH baseline (Moore et al., 2015). In that study, high LH pulse 
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frequency was associated with hyperandrogenemia and impaired progesterone-mediated negative 
feedback in the brain. In the absence of negative feedback by ovarian steroid hormones, LH mean 
levels and LH pulse frequency increase in OVX mice (Moore, Prescott and Campbell, 2013; 
Czieselsky et al., 2016). Our results suggest that PCOS-like ovaries may be required to sustain 
altered LH pulse frequency in PNA mice since OVX was able to show similar LH values between 
the groups. Alternatively, it is also possible that this result may represent a physiological limit by 
which a higher LH pulse frequency cannot be achieved even in PCOS-like condition. Due to ethical 
limitations with our protocol, I could not demonstrate that this cohort of PNA mice exhibited higher 
LH pulse frequency prior to OVX procedure. However, this is well documented in previous reports 
(Moore, Prescott and Campbell, 2013; Moore et al., 2015).  
 The altered profile of LH pulsatile secretion is considered a direct readout of abnormal 
GnRH pulses and pituitary LH responsiveness in PCOS (Rebar et al., 1976; Patel et al., 2004). In 
the absence of hyperandrogenic ovaries, the LH pulse amplitude and the magnitude of LH release, 
as determined by the area under the curve, were significantly elevated in OVX PNA mice. Previous 
results showed that intact PNA mice display decreased LH pulse amplitude (Moore et al., 2015), 
which may be due to a high GnRH frequency release that reduces the readily releasable LH pool 
in the pituitary gland. Although it is reported that high GnRH frequency induces lower LH 
amplitude (Clarke and Cummins, 1985), long-term GnRH self-priming effect in the pituitary 
enhances the gonadotrope responsiveness  (Hoff, Lasley and Yen, 1979). In addition, PCOS 
women exhibit greater LH amplitude release following intravenous administration of GnRH when 
compared to normal subjects without changes in LH frequency (Patel et al., 2004). This indicates 
that the gonadotrope responsiveness was dictated by a pre-exposure to higher GnRH actions in the 
pituitary gland, which was likely established in a scenario of hyperandrogenism in adulthood. 
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These results suggest that altered gonadotropin secretion was programed due to pre-exposure to 
high GnRH pulses during adulthood and this remains after castration.   
Clinical evidence suggest that the impaired negative feedback is indirectly established by 
androgen excess in PCOS. Long-term treatment with androgen receptor (AR) blocker is able to re-
instate the ability of ovarian hormones to decrease LH pulse frequency in PCOS women (Eagleson 
et al., 2000). However, acute administration of testosterone does not enhance pulsatile LH 
secretion or change the LH sensitivity to exogenous GnRH in healthy women (Dunaif, 1986). This 
indicates that chronic androgen exposure might the culprit of altered regulation of GnRH neuron 
activity and gonadotropin secretion. Because the removal of hyperandrogenic ovaries did not fully 
restore LH secretion in our experiments, it could be possible that prenatal-mediated organizational 
androgen actions within the GnRH neuronal network remains after 7 days post-castration in PNA 
mice. Another possibility is that ovariectomy and the removal of ovarian steroid negative feedback 
might have a greater impact on control animals than PNA mice. In fact, after 3 days post-castration, 
control mice exhibit greater mean LH levels compared to PNA mice (Moore, Prescott and 
Campbell, 2013). Therefore, PNA treatment might promote profound organizational changes in 
brain circuits involved in the control of ovarian steroid-mediate negative feedback, which persists 




                                           
 
Figure 4.7. Deranged LH regulation persists after castration in PNA mice.  (A) 
Based on previous reports, intact PNA mice exhibit high LH pulse frequency and decreased 
LH pulse amplitude compared to diestrus control mice (Moore et al., 2015). High GnRH/LH 
pulse frequency, in detriment of an impaired negative feedback mechanism, might 
overstimulate androgen production by the ovaries in PNA mice . Consequently, 
hyperandrogenic ovaries allow the installation of postpubertal androgen excess, which in 
turn, sustain a continuous cycle of impaired reproductive function in the PCOS -like 
condition. (B) The present findings showed that following ovariecto my, LH pulse frequency 
is high and similar in both control and PNA mice. Conversely, PNA mice still displays 
altered gonadotropin secretion exhibiting elevated magnitude of LH pulse amplitude, 
suggesting that neuroendocrine impairments remained after the r emoval of hyperandrogenic 
ovaries. Red (PNA) and blue (control) dashed traces in the graph indicate pulsatile LH 




                                           
 In conclusion, these findings elucidated the developmental timing of androgen excess in 
PNA mice, which occurs during early adulthood and has an important predicative value of 
disruption of reproductive cycles. Prenatal androgen programing of abnormal LH secretion, which 
may a primary result from altered brain wiring within the GnRH neuronal network, cannot be fully 
rescued by the removal of hyperandrogenic ovaries. Considering that chronic androgen actions 
may sustain brain circuit abnormalities in PCOS, pharmacological target of androgen actions from 
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Reversal of GABA-to-GnRH circuit 




                                           
5.1 Introduction 
The results presented in this PhD thesis have demonstrated that a prenatal androgen insult programs 
an abnormal GABAergic innervation to GnRH neurons prior to pubertal onset in PNA mice 
(Chapter 3). These findings suggested that enhanced GABA inputs on GnRH neurons might 
contribute to altered GnRH neuron activity during prepubertal stages (Dulka and Moenter, 2017), 
which remains until adult life (Sullivan and Moenter, 2004). The present results also elucidated 
that androgen excess takes place from early adulthood in PNA mice that is associated with 
pronounced disruption of estrous cyclicity (Chapter 4). Additionally, a short-term absence of 
hyperandrogenic ovaries did not fully restore the neuroendocrine impairment in PNA mice 
(Chapter 4). Therefore, prenatal androgen programing might promote hard wired changes in the 
brain in PCOS, which manifests earlier in life and may drive an abnormal activation of the HPG 
axis and, subsequently, the manifestation of postpubertal androgen excess. However, it remains 
unclear whether prenatal androgen excess and postpubertal androgen excess may contribute 
differently for the pathophysiology of PCOS.  
Findings from clinical studies support the idea that elevated prenatal testosterone levels are 
associated with the development of PCOS in the female progeny (Sir-Petermann et al., 2009; 
Maliqueo et al., 2013; Caanen et al., 2016). The ability to recapitulate the neuroendocrine 
impairment of PCOS in various PNA animal models (Roland and Moenter, 2014) indicates that 
androgen actions in the prenatal brain might promote organizational changes that perpetuates until 
reproductive maturation. The mammalian brain is highly sensitive to ovarian steroid actions during 
perinatal life, which is critical for appropriate organization of hypothalamic circuits controlling 
reproduction (McCarthy, 2010). Prenatal androgen actions in the developing brain of ewes reduced 
the number of GABAergic and glutamatergic inputs on GnRH neurons and decrease glia-GnRH 
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neuron interactions (Jansen et al., 2011). These changes in synaptic input number can also be 
observed in PNA mice with enhanced steroid-sensitive GABAergic innervation on GnRH neurons 
(Moore et al., 2015). Therefore, prenatal androgen excess may contribute for the in utero 
pathogenesis of PCOS by promoting changes in hypothalamic circuits which control GnRH neuron 
activity.  
 On the other hand, postpubertal androgen excess may provide activational effects on the 
prenatally programmed brain circuitry. Clinical studies show that short-term administration of 
androgen receptor (AR) antagonist does not restore normal LH secretion in PCOS women 
(Eagleson et al., 2000).  However, long-term treatment with an AR antagonist is able to re-establish 
the ability of estradiol and progesterone to suppress LH pulse frequency (Eagleson et al., 2000). 
Considering that PCOS women presents a decreased hypothalamic sensitivity to progesterone-
mediated negative feedback (Chhabra et al., 2005), hyperandrogenemia may contribute to the 
perpetuation of an abnormal hypothalamic sensitivity to feedback inhibition by sex steroids. In 
fact, AR signaling is known to interfere with progesterone-sensitive GABAergic transmission in 
GnRH neurons, which ultimately leads to a hyperactive state of GnRH neurons (Sullivan and 
Moenter, 2005). These findings along with the results present so far (Chapter 3), indicate that 
organizational and activational effects of androgens in the female brain may allow the perpetuation 
of altered GABA-to-GnRH neuron abnormalities underlying the neuroendocrine dysfunction in 
PCOS.  
 Based on the evidence that long-term AR antagonist treatment is able to rescue normal 
functioning of ovarian steroid-mediated negative feedback (Eagleson et al., 2000), the present 
study investigated whether this might be the result of the reversal of GABA-to-GnRH neuron 
abnormalities. Specifically, I hypothesized that AR signaling blockade from late puberty (PND 40) 
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to adulthood (PND 60) is able to reverse altered GABA-to-GnRH neuron wiring, which in turn 
may change the associated PCOS reproductive phenotype in PNA mice.   
5.2 Methods 
5.2.1 Animals 
Female GnRH-GFP mice (Spergel et al., 1999) were housed with ad libitum access to water and 
food, and under 12:12 h light-dark cycle (lights on at 0700h). To generate PNA mice, we used 
established protocol as previously described (Sullivan and Moenter, 2004; Moore, Prescott and 
Campbell, 2013). Briefly, time-mated pregnant dams were injected with 100 µL of 
dihydrotestosterone (250 µg) in oil, or oil alone to serve as a control, on gestational days 16, 17 
and 18. All protocols were approved by the University of Otago Animal Ethics Committee 
(Dunedin, New Zealand).   
5.2.2 Androgen receptor signaling blockade protocol 
Control and PNA GnRH-GFP mice received daily 50 μL injections of either Flut (Sigma; s.c. 25 
mg/kg/day) or a vehicle control (sesame oil) for 20 days from PND 40 to PND 60. The dose of 
Flut was based on previous studies in our laboratory and in a small pilot study performed at the 
beginning of my PhD project (for more details see Appendix III). Groups were identified as 
control+oil (N = 6), control+Flut (N = 7), PNA+oil (N = 5) and PNA+Flut (N = 7). All mice were 
monitored daily for estrous cyclicity through vaginal smears. Following at least 20 days of 
treatment, animals were euthanized when in the diestrous stage of their reproductive cycle. Mice 
were euthanized with an overdose of sodium pentobarbital (30 mg/mL) followed by transcardial 
perfusion with buffered-paraformaldehyde 4% (0.1 M phosphate buffer-PFA 4%; pH 7.6). Brains 
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were dissected and post-fixed for 1 h at room temperature following saturation in a 30 % sucrose 
made up in Tris buffer saline (TBS) and stored at -4 °C. Ovaries were post-fixed for 24 h at room 
temperature and transferred to ethanol 70% solution at -4 °C until the day of inclusion in paraffin.  
5.2.3 Immunohistochemistry 
Fixed brain tissue was cut into 3 sets of 30-µm-thick coronal sections using a freezing microtome. 
Coronal sections covering the rostral preoptic area (rPOA) and organum vasculosum of lamina 
terminalis (OVLT) of the hypothalamus were chosen according to the mouse brain atlas (Paxinos 
and Franklin, 2004). Free-floating immunohistochemistry was performed as previously described 
in Chapter 3 and elsewhere (Cottrell et al., 2006; Moore et al., 2015) on one set of sections 
(including every third brain section). Primary antibodies were used in the following concentrations: 
polyclonal chicken anti-GFP (1:2,500, Aves Labs Inc.) and polyclonal rabbit anti-vesicular GABA 
transporter (VGAT) (1:750, Synaptic Systems). Brain sections were incubated with a primary 
antibody cocktail and 2% normal goat serum for 48 h at -4 °C. AlexaFluor488 goat anti-chicken 
(1:200) and Streptavidin568 (1:200, Molecular Probes, Invitrogen) were used as secondary 
antibodies. Primary antibody omission served as a negative control of the procedure. 
5.2.4 Confocal imaging acquisition and morphological analysis 
Confocal imaging was obtained with a Nikon A1R Multi-photon confocal microscope with 488 
and 543 nm diode lasers. Brain sections were imaged using Plan NeoFluor 40 x oil objective (1.30 
NA), taking Z-stacks of 0.5 μm (pinhole at 1 AU) and analyzed with software NIS-Elements AR 
4.00.00 (Nikon® Instruments Inc.). Following double immunofluorescent labeling (VGAT-
ir/GFP-ir), VGAT appositions to GnRH neurons were quantified in two representative sections 
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from the rPOA/OVLT region of the hypothalamus of treated control and PNA groups. Ten to 
twelve GnRH neurons from each animal were randomly selected and scanned for analysis. VGAT 
apposition density was quantified at the level of GnRH neuron soma and along 75 µm of the 
primary and secondary dendrites as previously reported (Moore et al., 2015).   
In order to evaluate GABA inputs on GnRH neurons, confocal imaging and analysis were 
performed as previously shown in Chapter 3 and elsewhere (Moore et al., 2015). Briefly, close 
appositions of VGAT immunoreactive (-ir) puncta to GFP-ir GnRH neurons indicated putative 
GABA synaptic input (Edwards et al., 1997; Cottrell et al., 2006) and were quantified with confocal 
microscopy.  The dendrites of bipolar GnRH neurons were classified as either primary, the thicker 
dendrite (larger sectional area) at the point of origin from the soma, or secondary, the thinner 
dendrite, according to reported morphological criteria (Herde and Herbison, 2015). The locations 
of putative GABA synapses were classified as onto spines, crucial membrane structures which 
harbor excitatory inputs (Harris et al., 2013; Oh et al., 2016), or onto the somatic or dendritic shaft 
membrane without spines, here referenced as non-spiny membrane 
5.2.5 Morphological preparation and analysis of mouse ovaries 
Ovaries were collected from diestrus control and diestrus PNA mice and one ovary was randomly 
chosen for morphological analysis as previously reported (Moore, Prescott and Campbell, 2013). 
Briefly, ovarian sections of 5 μm-thickness were collected every 50-μm interval and stained with 
hematoxylin and eosin. The number and type of ovarian follicles were determined throughout 
sections from the whole ovary as formerly described by others (Myers et al., 2004). Ovarian 
sections were visualized with light microscope (Olympus Bx-51; Olympus Optical, Hamburg, 
Germany) using 10X and 20X objectives. Ovarian sections were imaged with a 4X objective to 
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quantify the area of the section. Follicle wall thickness was determined in the largest preovulatory 
follicle from the ovarian section with the largest radius. The total follicle wall area and the area 
made up of granulosa or theca cell layers were defined using ImageJ software (National Institutes 
of Health, Bethesda, Maryland) and the percentage of the layer thickness in relation to the total 
follicle area was calculated.  
5.2.6 Statistical analysis 
Statistical analysis was performed with PRISM software 7.0 (GraphPad Software, La Jolla, CA, 
USA). Adult control and PNA mice were compared using two-way ANOVA with a Tukey’s post 
hoc test when analyzing GABA inputs on GnRH neurons and ovarian morphology features. A two-
way ANOVA with a Bonferroni’s post hoc test was used to compare prepubertal and adult groups. 
All data are represented as mean ± SEM. Statistical significance was accepted when P < 0.05. 
Graphical representation to display significant different are shown as * P < 0.05, ** P < 0.01, *** 





                                           
5.3 Results 
5.3.1 Long-term AR blockade reverses GnRH neuron circuit abnormalities in adult PNA 
mice 
Control and PNA mice were treated with Flut (25 mg/kg/day) or an oil vehicle from PND 40 to 
PND 60 to determine the density of VGAT contact to GnRH neurons. By PND 40, all mice 
presented vaginal opening as a marker of pubertal onset. GABAergic contacts were assessed in 61 
GnRH neurons from control+oil (N = 6), 72 GnRH neurons control+Flut (N = 7), 53 GnRH 
neurons from PNA+oil (N = 5), and 72 GnRH neurons from PNA+Flut (N = 7). Virtually all 
analyzed GnRH neurons presented VGAT appositions in the rPOA/OVLT region.  Projected 
confocal images were analyzed using the same approach as for prepubertal mice in Chapter 3 




                                           
 
Figure 5.1. Projected confocal images of GABA inputs on GnRH neurons in adult 
control and PNA mice. (A)  Examples of confocal images of diestrus control and PNA 
mice showing GnRH-GFP neurons (green) and VGAT-ir contacts representing GABA inputs 
(red puncta) in the rPOA. Analysis proceeded with 10-12 GnRH-GFP neurons from each 
animal.  Each column shows a representative GnRH neuron from control+oil (N = 6 / 61 
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neurons), control+Flut (N = 7 / 72 neurons), PNA+oil (N = 5 / 53 neurons) and PNA+Flut 
(N = 7 / 72 neurons) groups. White arrowheads indicate putative GABAergic inputs to GnRH 
neurons (scale bar = 10 μm). (B) Projected 3D reconstruction of a GnRH-GFP neuron from 
an adult PNA mouse illustrating VGAT-ir puncta contacts with white arrowheads indicating 
VGAT contact onto non-spiny GnRH neuron membrane and blue arrowheads indicating 
inputs onto somatic and dendritic spines. Rotated and zoomed images of VGAT contact with 
a somatic spine (I), front and back views of dendritic spines in the distal dendrite covered 
with GABA inputs (II and III), and VGAT contacts onto the proximal dendrite of a GnRH 
neuron (IV). 
As reported previously (Moore et al., 2015), PNA mice receiving an oil vehicle (PNA+oil) 
exhibited significantly increased VGAT appositions to GnRH neurons at the soma (P < 0.0001), 
primary dendrite (P < 0.0001) and secondary dendrite (P < 0.001) compared to control mice 
(Figure 5.2 A). Remarkably, AR blockade with Flut robustly decreased the total density of GABA 
inputs to GnRH neurons in PNA mice to levels found in control+oil and control+Flut groups 
(Figure 5.2 A). VGAT contacts onto the non-spiny membrane of PNA+oil was also increased at 
the cell body (P < 0.0001) and primary dendrite (P < 0.001), whereas PNA+Flut group exhibited 
similar VGAT apposition density to both control groups (Figure 5.2 B). The density of VGAT 
appositions onto the GnRH neuron non-spiny membrane of secondary dendrites was not different 
among the groups (F1, 21 (treatment) = 0.70; P = 0.41) (Figure 5.2 B). Greater increases of GABA 
inputs onto the GnRH neuron spines were observed at the three neuronal compartments in PNA+oil 
group, while PNA+Flut, control+oil and control+Flut groups displayed lower values (Figure 5.2 
C). These findings suggest that blockade of AR signaling can induce plasticity within the GABA-
to-GnRH neuron circuit and reverse circuit abnormalities to control levels.  
Spine density, used as a general index of synaptic input, was also remodeled by long-term 
AR blockade in PNA mice. GnRH neuron spine density in PNA+Flut was significantly decreased 
when compared to the PNA+oil group (soma: P < 0.05; primary dendrite: P < 0.01; secondary 
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dendrite: P < 0.01) (Figure 5.2 D). When comparisons were made among the four groups, spine 
density was not statistically different between control+oil and PNA+oil groups, although PNA+oil 
mice displayed greater density than control+Flut group at the soma (P < 0.01) and primary dendrite 
(P < 0.05) (Figure 5.2 D). These morphological evidence suggest that remodeling of GABAergic 
induced by AR blockade might influence and rescue normal GnRH neuron activity in PNA mice 
as observed by others (Sullivan and Moenter, 2004). 
 
Figure 5.2. Androgen receptor (AR) blockade reverse the altered GABAergic 
wiring onto GnRH neurons. Assessment of GABA inputs on GnRH-GFP neurons from 
control+oil (N = 6; 61 neurons), control+Flut (N = 7; 72 neurons), PNA+oil (N = 5; 53 
neurons) and PNA+Flut (N = 7; 72 neurons) groups. VGAT appositions are shown for each 
neuronal compartment. (A) Total VGAT-ir density on GnRH neurons. (B) Total VGAT 
apposition density onto non-spiny GnRH neuron membrane. (C) Total VGAT-ir apposition 
density onto GnRH neuron spines. (D) Number of GnRH neuron spines. Histogram values 
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are represented by mean ± SEM with dot plots of individual values. *P < 0.05; **P < 0.01; 
***P < 0.001; ****P < 0.01; two-way ANOVA with Tukey’s post hoc test.  
A comparison was made between VGAT density in adult animals described here and the 
prepubertal mice (PND 25) presented in Chapter 3. Analysis revealed that PNA treatment was the 
major determinant for GABA-to-GnRH neuron circuit abnormalities (phenotype: PNA vs. control; 
F (1, 16) = 29.96; P < 0.0001; two-way ANOVA with Bonferroni’s post hoc test), but not age in 
relation to puberty (age: PNA vs. control; F (1, 16) = 0.38; P = 0.55) (Figure 5.3). In addition, 
total VGAT apposition density on GnRH neurons in Flut treated mice was reduced by 53 % to 
levels not different to controls (Figure 5.3). This result illustrates that the enhanced GABAergic 
innervation to GnRH neurons in PCOS-like mice is programed during prenatal androgen insult but 
remains plastic in adulthood through AR signaling blockade.  
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Figure 5.3. PNA mice show similar amount of GABA inputs onto GnRH neurons 
across pubertal development.  Total VGAT appositions onto GnRH neuron were 
compared among prepubertal control (N = 4) and PNA (N = 5) mice, and adult oil -vehicle 
control (N = 6) and oil-vehicle PNA (N = 5) mice. Histogram values are represented as mean 
± SEM. Different letters indicate significant statistical differences with P < 0.05; two-way 
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ANOVA with Bonferroni`s post hoc test. Graphical representation illustrates the effect of 
androgen receptor (AR) blockade attenuating GABA inputs o nto GnRH neurons (percentage 
of decrease) in PNA+Flut mice when compared to PNA+oil group.  
5.3.2 Long-term AR blockade restores estrous cyclicity in PNA mice 
Estrous cycles were followed during the 20-day treatment to determine whether changes in brain 
wiring would be associated with an improvement of reproductive cycles. Cycle stage 
characterization showed that all PNA+oil mice were acyclic with a complete absence of proestrus 
stage vaginal smears (Figure 5.4 A). In contrast, PNA+flut group displayed recurrent proestrus 
stage similar to control groups (Figure 5.4 A). Examination of the percentage of days in each stage 
cycle showed that while PNA+oil did not show evidence of ovulation through vaginal smear 
examination, control groups and PNA+flut groups presented proestrus smear at a similar frequency 
during the 20-days of treatment (Figure 5.4 B). These data together illustrate that androgen 
signaling blockade was able to overcome PNA-programed disruption of fertility and restore 
reproductive cycles in parallel with anatomical changes in the brain. 
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Figure 5.4. Blockade of androgen receptor (AR) signaling restores reproductive 
cycles in PNA mice.  AR signaling blockade was achieved with the administration of 
flutamide (Flut) s.c. 25 mg/kg/day during 20 days. (A) Representative estrous cycle plots 
over 20 days from control+oil (N = 6), control+Flut (N = 7), PNA+oil (N = 5) and PNA+Flut 
(N = 6) groups. P: proestrus; D: diestrus; M: metestrus; E: estrus. (B) Histogram showing 
mean ± SEM percentage of days spent in each stage of the estrous cycle (ND = not 
detected).*P < 0.05; two-way ANOVA with Tukey’s post hoc test.  
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5.3.3 Long-term blockade of AR signaling improves the recruitment of preovulatory 
follicles and their morphological features in PNA mice 
Ovarian morphology was investigated to determine whether restoration of normal brain circuitry 
following AR blockade was also able to improve ovarian function (Figure 5.5 A). PNA mice 
presented a greater number of primordial follicles than controls and this was not modified by Flut 
treatment (effect of the phenotype: P < 0.001; F 1, 21 = 23.84; effect of treatment: P = 0.89; F1, 21 = 
0.02; two-way ANOVA with Tukey’s post hoc test) (Figure 5.5 B). PNA mice groups show 
significantly fewer primary follicles when compared to the control+oil group (Figure 5.5 B). 
Although, not restored completely to control levels, flutamide treatment in PNA mice increased 
the number of primary follicles to levels similar to the control+Flut group (control+oil: 39.00 ± 
3.56; control+Flut: 35.71 ± 3.30; PNA+oil: 16.60 ± 0.75; PNA+Flut: 26.17 ± 3.55 primary follicles 
per ovary). The number of secondary follicles, early antral follicles and total atretic follicles were 
not different across the four groups (Figure 5.5 B). These results reaffirm that PNA mice exhibit 
altered folliculogenesis and suggest that pharmacological blockade of androgen-mediated actions 
has minimal impact on the arrest of small follicles.  
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Figure 5.5. Androgen receptor (AR) blockade improves the recruit ment of 
preovulatory follicles and their features in PNA mice.  Ovarian morphology of adult 
control and PNA mice undergoing s.c. injection with oil -vehicle or flutamide (Flut) 25 
mg/kg/day from PND 40 to PND 60. (A) First row: 5-μm thick ovarian sections from control 
and PNA mice in diestrus. Corpora lutea are indicated by black asterisks; (scale bar = 500 
μm). Second row: representative images of a preovulatory follicle wall from each group; 
yellow dashed lines delineate the theca cell layer (TLC) from granulosa cell layer (GCL); 
(scale bar = 50 μm).  (B) Total number of primordial, primary, secondary, early antral and 
atretic follicles. (C) Total number of preovulatory follicles and corpora lutea. (D) Percentage 
of the ovarian follicle area made up of corpora lutea.   (E) Percentage of the follicle wall 
area made up of GCL and TLC from the largest preovulatory follicle. Different letters 
indicate significant statistical differences with P < 0.05; two-way ANOVA followed by 
Tukey’s post hoc test. Histograms show mean ± SEM data from control+oil (N = 6), 
control+Flut (N = 7), PNA+oil (N = 5) and PNA+Flut (N = 6) groups.   
 
Competent preovulatory follicles are able to ovulate in response to coordinated 
gonadotropin actions and an LH surge which occurs on the evening of the proestrus stage in mice. 
PNA+oil mice had significantly fewer preovulatory follicles compared to control+oil mice 
(PNA+oil: 7.40 ± 2.89 vs. control+oil: 26.86 ± 3.15 follicles per ovary; P < 0.001; Figure 5.5 C). 
Flut treatment resulted in divergent effects in PNA and control animals. Flut increased the number 
of preovulatory follicles of PNA mice (P < 0.01), whereas it attenuated the number of preovulatory 
follicles in diestrus control mice when compared to controls treated with oil (P < 0.01) (Figure 5.5 
C). Thus, AR signaling blockade can restore the number of preovulatory follicles in a 
hyperandrogenic state, however direct androgen actions in the ovaries are also critical for the 
normal final steps of folliculogenesis.  
In line with an absence of the proestrous cycle stage detected by vaginal cytology, most 
PNA mice showed dramatically fewer or a complete absence of corpora lutea (CL) compared to 
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control mice (PNA+oil: 0.60 ± 0.24 vs. control+oil: 9.57 ± 1.09 CL per ovary; P < 0.0001; Figure 
5.5 C). Although not significantly different, PNA+Flut mice displayed a ~ 4-fold increase in the 
number of CL when compared to the PNA+oil group (PNA+oil: 0.6 ± 0.24 vs. PNA+Flut: 3.79 ± 
0.8 CL per ovary; Figure 5.5 C). Quantification of the percentage of ovarian area containing 
corpora lutea was significantly decreased in PNA+oil group when compared with control+oil (P < 
0.001) and control+Flut groups (P < 0.05), whereas PNA+Flut exhibit a  trend of increase toward 
similar values of control groups (Figure 5.5 D). Together, these data suggest that long-term AR 
signaling blockade, associated with changes in brain wiring, is able to increase the recruitment of 
preovulatory follicles, and ultimately support the return of ovulation and the capacity for fertility.  
The composition of the preovulatory follicle wall thickness is indicative of gonadotropin-
mediated actions in the ovaries (Gilling-Smith et al., 1994; Moore, Prescott and Campbell, 2013). 
Hence, the thickness of the granulosa cell layer (as a mean of determining FSH actions) and the 
theca cell layer (as a mean of determining LH actions) were measured. The granulosa cell layer 
was significantly thinner in PNA+oil mice compared to control groups (P < 0.05). Flutamide 
treatment restored the granulosa cell layer thickness to levels not different to controls (Figure 5.5 
E). The theca cell layer was significantly thicker in PNA+oil mice compared to controls (PNA+oil: 
18.60 ± 1.51 vs. control+oil: 12.21 ± 0.57 vs. control+Flut: 12.51 ± 0.82 % of percentage of the 
preovulatory follicle wall area; P < 0.05). AR signaling blockade significantly reduced the 
thickness of the theca cell layer in PNA mice to control levels (11.06 ± 0.97 %; Figure 5.5 E), 
suggesting that long-term androgen receptor blockade leads to the normalization of gonadotropin-
mediated actions in the ovary.  
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5.4 Discussion 
Previous results elucidated that altered GABA-to-GnRH neuron circuit in the brain is present prior 
to puberty (Chapter 3) and androgen excess occurs during early adulthood in a PCOS-like condition 
(Chapter 4). Those findings suggested that PNA treatment promoted an abnormal and hard wired 
GABAergic innervation to GnRH neurons, leading to the neuroendocrine and reproductive 
impairment following the activation of the HPG axis. However, clinical evidence demonstrated 
that chronic Flut treatment is able to restore normal neuroendocrine regulation of LH secretion in 
PCOS women (Eagleson et al., 2000). This implied that a certain degree of plasticity within the 
GnRH neuronal network might be achieved by blocking androgen-mediated actions in PCOS. 
Therefore, the present study tested the hypothesis that this recovery of normal neuroendocrine 
function driven by Flut actions could be associated with the rescue of normal GABAergic wiring 
on GnRH neurons. The present results revealed that long-term blockade of AR signaling is 
sufficient to reverse abnormal GABAergic innervation to GnRH neurons. Flut treatment in PNA 
mice was able to reduce GABA inputs on different GnRH neuron compartments and membrane 
sites leading to a similar pattern of diestrus control animals. In addition, rescuing of altered brain 
wiring was followed by an improvement of estrous cyclicity and an increase in the recruitment of 
preovulatory follicles in PNA mice.  
 Androgens can induce synaptogenesis in the female brain and modify pre-established 
circuits through neuronal plasticity mechanisms (Leranth, Hajszan and MacLusky, 2004a). 
Elevated androgen levels negatively impact the female brain and the reproductive function as 
observed with anabolic steroid abuse animals models (Penatti et al., 2011) and in PCOS models 
(Roland and Moenter, 2014). AR is expressed in the hypothalamus of adult female rodents (Roselli, 
Handa and Resko, 1989; Brock, De Mees and Bakker, 2015) and humans (Fernández-Guasti et al., 
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2000); nevertheless, and the biological relevance of AR signaling during adulthood is better 
characterized in pathological states. The requirement of AR signaling for the development of PCOS 
was recently addressed using a postpubertal androgenized (PPA) mouse model (Caldwell et al., 
2017). This study reported that a neuron-specific deletion of AR protects mice from developing 
the reproductive impairment of PCOS induced by PPA treatment (Caldwell et al., 2017). In 
contrast, granulosa-specific AR knockout, which targets androgen actions in the ovary, was not 
sufficient to protect mice from presenting PCOS-like traits (Caldwell et al., 2017). These data 
indicated that androgen actions in neurons are implicated in the full manifestation of PCOS. The 
present findings suggest that Flut treatment might have a direct impact on female brain wiring, 
which ultimately led to the improvement of reproductive cycles and ovarian function in PNA mice.  
 Although GnRH neurons do not express AR (Huang and Harlan, 1993; Herbison et al., 
1996), central actions of androgens, which impact reproduction, are place upstream in steroid-
sensitive afferent neurons. GABA neurons are considered important afferent neurons capable of 
integrating sex steroid-mediated feedbacks to GnRH neurons and regulate GnRH neuron activity. 
Specifically, DHT-induced hyperandrogenemia in adult female mice increases GABAergic 
transmission to GnRH neurons and disrupts progesterone-mediated feedback (Sullivan and 
Moenter, 2005). In addition, transgenic approaches using PNA mice have identified greater 
GABAergic transmission (Sullivan and Moenter, 2004) and innervation (Moore et al., 2015) to 
GnRH neurons that may underlie the pathophysiology of PCOS. Considering that GABA actions 
on GABAA receptors are mainly depolarizing in GnRH neurons (DeFazio et al., 2002), enhanced 
GABA actions may ultimately increase GnRH/LH release. The downstream response of enhanced 
LH actions on theca cells in the ovaries is an elevated androgen production, which in turn, may act 
back upstream in androgen-sensitive GABA neurons to increase GABAergic transmission to 
GnRH neurons. The results presented in this chapter illustrate that chronic AR signaling blockade 
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might be a potential therapeutic target to cease this continuous cycle in PCOS by rescuing altered 
neuroendocrine brain circuits. Current work in our laboratory is investigating the expression of AR 
in GABA neurons in the hypothalamus in normal and PNA female mice to determine whether Flut 
treatment could directly signal to these neurons.  
In the clinic, chronic flutamide (Flut) treatment is able to restore progesterone sensitivity 
to decrease abnormal LH pulses (Eagleson et al., 2000), improve menstrual regularities (Paradisi 
et al., 2013) and rescue normal levels of circulating testosterone (De Leo et al., 1998) in PCOS 
patients. In the present study Flut treatment was also able to restore estrous cyclicity and improve 
the recruitment of preovulatory follicles in PNA mice. These findings suggest that these 
improvements may be downstream from Flut-induced changes in the neuroendocrine wiring in the 
brain. In fact, studies using brain slices have shown that Flut treatment reduce action-potential-
independent GABAergic transmission to GnRH neurons in adult PNA mice (Sullivan and Moenter, 
2004), suggesting that Flut treatment is able to induce structural changes within the GnRH neuronal 
network. The ability of AR blockade to restore normal GABA-to-GnRH innervation and rescue 
downstream reproductive function indicate that circuit abnormalities remain plastic in adulthood 
and are dependent upon on-going androgen signaling. Future studies in our laboratory will 
investigate whether these changes in brain wiring can remain following the cessation of Flut 
treatment.  
   Prenatal exposure to androgens ultimately leads to ovarian dysfunction later in life as it 
is evident in women with congenital adrenal hyperplasia (Hague et al., 1990), PCOS daughters 
(Sir-Petermann et al., 2009) and PCOS animal models (Dumesic et al., 1997; Smith et al., 2009; 
Moore, Prescott and Campbell, 2013). While AR blockade did not change the follicular arrest of 
small follicles (primordial and primary), a typical trait of PCOS ovaries (Webber et al., 2003), a 
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marked effect was observed in recovering the number of preovulatory follicles. Long-term 
blockade of AR signaling also promoted the recovery of normal granulosa and theca cell layer 
thickness in preovulatory follicles of PNA mice. LH overstimulation is a primary driver of a 
condition known as hyperthecosis, which mirrors the increased androgen synthesis by ovarian 
theca cells (Hughesdon, 1982; Eisner et al., 2002). The present results showed that long-term AR 
blockade reduced the thickness of the theca cell layer to control levels, probably reflecting a 
reduced LH pulse frequency drive. Granulosa cells are the main target of androgen actions in 
preovulatory follicles (Sen et al., 2014); however, granulosa cell specific AR knockout mice does 
not protect mice from developing the PCOS phenotype with chronic DHT administration (Caldwell 
et al., 2017). This indicates that the restoration of normal follicle morphology after AR blockade 
is more likely to be indirect, through the normalization of gonadotropin action, which may reflect 
normalized regulation of GnRH neuron activity by GABAergic neurons. In addition, Flut treatment 
significantly decreased the number of preovulatory follicles in control mice. This might be a direct 
effect of Flut in the ovaries as AR signaling in granulosa cells is known to decrease the expression 
of pro-apoptotic markers in antral follicles and Flut might be driving the apoptosis of preovulatory 
follicles in normal mice (Prizant, Gleicher and Sen, 2014; Sen et al., 2014).  
In summary, the present findings demonstrated that long-term AR signaling blockade rescues 
normal GABA-to-GnRH neuron innervation and the restoration of downstream reproductive 
function in a PCOS-like condition. These results also indicate that circuit abnormalities remain 
plastic in adulthood and are dependent upon on-going androgen excess in PCOS. Together, our 
observations suggest that early blockade of androgen signaling in PCOS might be able to restore a 
normal GnRH neuronal network and highlight AR antagonism as a therapeutic target.
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6.1 Introduction 
The central control of reproduction in mammals is highly dependent upon the proper functioning 
of gonadotropin-releasing hormone (GnRH) neurons. Brain circuits mediating gonadal steroid 
hormone feedback regulate GnRH neuron activity, which in turn, provides the pace of GnRH 
peptide secretion and the downstream performance of the hypothalamic-pituitary-gonadal (HPG) 
axis (Herbison, 2014). A series of studies and ongoing debate in the field indicates that regulatory 
mechanisms through upstream afferents define the pulsatile GnRH secretion defining the so-called 
GnRH pulse generator (Wuttke et al., 1996; Navarro et al., 2009; Goodman, Hileman, Casey C 
Nestor, et al., 2013). The location of the GnRH pulse generator was initially suggest in early studies 
using deafferentation of the medial basal hypothalamus (MBH) from the rostral hypothalamus in 
rats (Halász and Gorski, 1967; Taleisnik, Velasco and Astrada, 1970; Blake and Sawyer, 1974). 
Within the MBH, the arcuate nucleus (ARN) has been considered the central node of the pulsatile 
GnRH/LH secretion  as electrolytic lesion of the ARN completely blocks LH pulses in 
ovariectomized rats (Soper and Weick, 1980).  
 Early studies demonstrated that anterior hypothalamic deafferentation (AHD) did not 
change LH pulse frequency in ovariectomized or estradiol-treated ewes (Whisnant and Goodman, 
1994). In contrast, AHD ewes treated with progesterone significantly decrease the pulsatile LH 
secretion suggesting that progesterone-mediated negative feedback in the ARN regulate the 
GnRH/LH pulse frequency (Whisnant and Goodman, 1994). Additionally, placing microimplants 
in ewes (Goodman et al., 2011) or microinjections in rats (He et al., 2017) containing RU486, a 
progesterone receptor (PR) antagonist, disrupts progesterone-mediated attenuation of LH pulse 
frequency. Together, these data suggest that PR-expressing neurons in the ARN are required to 
restrain GnRH pulsatile release during times of negative feedback. 
Chapter Six 
131 
                                           
 An impairment of the negative feedback and, therefore, the desensitization of the GnRH 
pulse generator, is present in women with polycystic ovary syndrome (PCOS) (Daniels and Berga, 
1997; Pastor et al., 1998; Chhabra et al., 2005). Chronic pharmacological blockade of androgen 
receptor (AR) signaling can re-establish the ability of progesterone to attenuate LH pulse frequency 
in these patients (Eagleson et al., 2000). This indicates that AR and PR signaling may act 
antagonistically at the cellular level in the brain to regulate GnRH neuron activity. In fact, 
electrophysiological studies with mouse brain slice preparations demonstrated that AR signaling 
disrupts progesterone-mediated attenuation of GnRH neuron activity through GABAergic 
transmission (Sullivan and Moenter, 2005; Pielecka, Quaynor and Moenter, 2006). Therefore, 
progesterone-sensitive GABA neurons might be critical in mediating the PR signaling required to 
negative feedback and enhanced androgen signaling antagonizes progesterone as seen in PCOS.  
Previous work from our research group employed a viral-mediated tract-tracing technique 
and revealed that GABA neurons in the ARN (ARN GABA) innervate GnRH neurons and this 
afferent input  is significantly increased in PNA mice (Moore et al., 2015). In addition, PNA mice 
also displayed decreased PR expression in ARN GABA neurons and impaired progesterone-
mediated negative feedback associated with elevated LH pulse frequency (Moore et al., 2015). 
These data leads to the hypothesis that ARN GABA neurons may drive the excitation of GnRH 
neurons and modulate GnRH/LH secretion. Furthermore, these evidence raises the question 
whether the activation of ARN GABA neurons evokes enhanced LH secretion or whether the 
requirement to activate these neurons is modified in a PCOS-like condition. 
In Chapter 3 of the present thesis, my work revealed that this abnormal GABAergic 
innervation on GnRH neurons is established before the onset of puberty in PNA mice and these 
alterations are not dependent on prepubertal elevation of circulating androgen levels. Furthermore, 
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in Chapter 5 of this study, I presented that these circuit abnormalities remain plastic during 
adulthood and can be reversed by blocking androgen receptor signaling. These data, together with 
referenced literature, outline a potential circuit-mediated mechanism through which GABA actions 
are biologically meaningful to drive LH secretion. In this chapter, I aimed to specifically target and 
activate ARN GABA neurons by using an optogenetic strategy to express a type of 
channelrhodopisin-2 and follow LH secretion outcome in male, diestrus female and PNA female 
mice. In order to understand the dynamics and possible players modulating the LH response 
following optogenetic activation of ARN GABA neurons, two different frequencies of stimulation 
were applied: a small stimulation of 2 Hz, which may mainly drive fast-synaptic transmission via 
neurotransmitters such as GABA, and a ten-fold higher stimulation of 20 Hz, which may drive the 
release of neurotransmitters and other modulators such as neuropeptides (Liu et al., 2011). 
6.2 Methods 
6.2.1 Animals 
Adult male, diestrus female and diestrus PNA mice were used for all experiments. Transgenic and 
wild-type C57BL/6 mice (8-12 weeks) were housed at the Hercus Resource Unit (University of 
Otago - Dunedin) under 12h: 12h light-dark cycles (lights on at 0700h) with ad libitum access to 
water and food. Selective targeting of ARN GABA neurons was accomplished using VGAT-Cre 
mouse line (Vong et al., 2011). Homozygous VGAT-Cre (VGAT-Cre+/+) mice were crossed with 
TdTomato floxed-stoped reporter mice to generate VGAT-Cre+/--TdTomato male (N = 4) and 
female (N = 5) mice to evaluate efficacy of viral transfection. Optogenetic activation was 
performed in heterozygous VGAT-Cre (VGAT-Cre+/-) male (N = 6) and female (N = 7) mice, and 
Cre negative C57BL/6 (Control Cre-/-) mice (N = 4-5). Mouse lines were confirmed with 
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genotyping procedures performed by Mrs. Mell Prescott, the Assistant Research Fellow in our 
laboratory. PNA mice (N = 5) were generated as previously described in Chapter 2 and elsewhere 
(Sullivan and Moenter, 2004; Moore, Prescott and Campbell, 2013). Briefly, time-mated pregnant 
dams were injected with 100 µL of dihydrotestosterone (250 µg) in oil, or oil alone to serve as a 
control, on gestational days 16, 17 and 18. Control vehicle mice (N = 3) were grouped with non-
treated female mice (N = 7) to compose the VGAT-Cre+/- diestrus female group (N = 10) as LH 
release following optogenetic activation was similar among these animals. 
6.2.2 Viral transfection and stereotaxic intracerebral surgery 
6.2.2.1 Selective targeting and expression of Adeno-Associated Virus (AAV) in ARN GABA 
neurons 
To specifically activate ARN GABA neurons, VGAT-expressing neurons were transfected with a 
blue light-sensitive channelrhodopsin-2 (ChR-2), a Na+ channel that controls electrical excitability 
(Zhang et al., 2010). All optogenetic experiments used an engineered channelrhodopsin-2 E123T 
accelerated variant (ChETA). As previously characterized, ChETA is considered an optimized 
version of ChR-2 allowing high spike fidelity, decreased spurious depolarizations and faster 
recovery from post-stimulus inactivation (Gunaydin et al., 2010; Urban et al., 2012a). To express 
ChETA in ARN GABA neurons specifically, a Cre-Lox system was used including the Cre 
recombinase-dependent adeno-associated virus (AAV) with a ChETA-eYFP expression cassette 
under the control of an elongation factor 1 (EF1) promoter; and the expression driver transgenic 
VGAT-Cre mice (Figure 6.1 A). Briefly, within the AAV, the transgene ChETA-eYFP was 
inserted in a double-floxed inverted orientation (DIO) flanked by loxP and lox2272 sites. The viral 
vector used in all experiments was the AAV2/9-EF1α-DIO-ChETA-eYFP (AAV9-ChETA; 3.15 x 
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1013 GC/mL; PennVector Core). In the presence of Cre-recombinase enzyme, which is only present 
in VGAT-expressing neurons, the transgene is “flipped” to the right orientation to allow for the 
expression of ChETA-eYFP in GABA neurons with high spatial and temporal control. Under 
anesthesia, adult VGAT-Cre+/-mice were bilaterally injected with AAV9-ChETA into the ARN. 
The expression of the transgene could be visualized 2-3 weeks following injection. Diestrus female 
(N = 4) and male (N = 5) Cre-negative control (Cre-/-) mice were also injected with AAV9-ChETA. 
Additional control female VGAT-Cre+/-mice (N = 2) were injected with a control virus containing 
the reporter tag eYFP without ChETA expression (AAV2/9-EF1α-DIO-EYFP.WPRE.hGH; 6.69 




                                           
Figure 6.1. Cre-Lox recombinase technology and optogenetics to specifically 
activate ARN GABA neurons in vivo.  Schematic design showing how the Cre-Lox 
system is used to express the adeno-associated virus 2/9 (AAV2/9)-ChETA-eYFP in 
vesicular GABA transporter (VGAT) neurons.  A double-floxed inverted (DIO) ChETA-eYFP 
sequence cassette is flanked by loxP and lox2272 sites, under the control of the ubiquitous 
EF1α promoter. This genomic sequence is then packaged into the AAV2/9 vector to allow 
viral delivery and expression of ChETA-eYFP in the presence of Cre. When viral vector is 
injected into a Cre-driver mouse line, such as VGAT-cre mice, the Cre-dependent expression 
of ChETA-eYFP is driven exclusively in GABA neurons. ChETA is a blue light -sensitive 
channelrhodopsin that allows high fidelity optogenetic control of neuronal depolarization 
(Figure adapted from Urban et al., 2012).  
 
6.2.2.2 Surgical procedure of stereotaxic intracerebral injections 
Adult mice were anesthetized with 2% isoflurane and placed in a stereotaxic apparatus (Stoeling®, 
Digital Lab Standard) with head and nose fixed. All experiments were performed with sterile 
instruments and aseptic conditions. Mice were given s.c. injection of carprofen (5 mg/kg body 
weight) after anesthesia was confirmed. A small midline incision was made in the skin to expose 
the skull with scalpel blade. Connective tissue was removed from the bone to allow better 
visualization using a dissection microscope (20X; Leica®, Wetzlar, Germany). Bregma position 
was used as stereotaxic reference zero and X and Y coordinates were calculated to target the 
transition region from tuberal (a.k.a. middle) to caudal ARN (tARN-cARN) of the hypothalamus. 
Coordinates according to the mouse brain atlas (Paxinos and Franklin, 2004) were -0.9 mm 
anterior-posterior, ±0.3 mm medial-lateral and -6.0 mm dorsal-ventral from the dura mater layer. 
Mice were given simultaneous bilateral 200-nL injection of AAV9-ChETA or AAV9-eYFP into 
the ARN at a rate of 50 nL per minute. Syringes were left in situ for 5 minutes prior to injection 
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and for 10 minutes after injection. Mice were left to recover and to allow viral transfection for 3 
weeks. 
6.2.3 In vivo optogenetic activation protocol in unconscious mice 
6.2.3.1 Surgical procedure 
All surgical procedures for optical fiber implantation and the optogenetic activation protocol were 
modelled after previous reports (Campos and Herbison, 2014; Han et al., 2015) and following pilot 
studies from the initial stage of this PhD project (see more information in Appendix IV). Briefly, 
following 3 weeks post AAV injection, mice were given 2% isoflurane anesthesia, and head and 
nose were placed and fixed in stereotaxic apparatus (Stoeling®, Digital Lab Standard). Animals 
were positioned on a heat-pad and internal body temperature was kept at 35ºC during the whole 
procedure. A small midline incision was made in the skin to expose the skull with scalpel blade 
and craniotomy was performed with surgical drill. Cannula with a 100-μm diameter optical fiber 
(Thorlabs, Inc.) was implanted in the rostral preoptic area (rPOA) with the following mouse brain 
coordinates: +0.9 to +1.0 mm anterior-posterior, 0.0mm medial-lateral (pulling the sagittal sinus 
aside) and -4.2 mm dorsal-ventral (Paxinos and Franklin, 2004). The optical fiber was left in situ 
for at least 30 minutes before commencing serial blood collection as described below. Following 
the light activation protocol, pituitary responsiveness to GnRH was tested by administering GnRH 
(s.c. 200 ng/kg in 100-nL saline 0.9% solution) and collecting additional blood samples. At the end 
of the protocol, all mice underwent transcardial perfusion with paraformadehyde (PFA) 4% and 
brain tissue was collected for post-mortem examination as described in Chapter 2 (Figure 6.2). 
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Figure 6.2. In vivo optogenetic activation protocol in unconscious mice. (A) Mice 
were kept under isoflurane anesthesia (2%) with head and nose fixed in a stereotaxic frame 
during the whole protocol. Cannula with a 100-μm diameter optical fiber was implanted into 
the brain parenchyma aiming for the  arcuate nucleus of (ARN) of the hypothalamus in 
VGAT-Cre+/ - and Cre - / - control mice. Target was achieved based on coordinates identified 
in the mouse brain atlas (Paxinos and Franklin, 2004). Mice were kept on top of a heat -pad 
and the internal temperature was measured and controlled during protocol. (B) Following 
the implantation of the fiber, mice were kept at rest for at least 30 min before commencing 
blood sampling. Blood samples were taken every 6 minutes (black circles) in all times and 
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every 3 minutes (red circles) during and after blue light was turned on (blue bloxes). Blood 
samples were later used to measure LH pulsatile release following optogenetic activation of 
ARN GABA neurons. Following light stimulation, mice were injected with GnRH (200 
ng/kg) to test pituitary gland responsiveness. Animals were perfused with paraformadehyde 
(PFA) 4% at the end brain tissue was collected.          
 
6.2.3.2 Optical stimulation & serial blood sampling 
The light stimulation consisted of 5-ms blue light (473 nm) pulses using a diode-pumped solid-
state (DPSS) laser (IkeCool©) controlled by Grass S88X stimulator. The power light at the tip of 
the optical fiber was set at 5mW. Each mouse received two optical stimulations in a random order 
and delivered at 2 or 20 Hz for 10 minutes. Serial blood samples (3 µL each) were firstly collected 
at the baseline -13, -7 and -1minutes considering time 0 as the start of optical stimulation. Blood 
sample collection was performed every 3 minutes (at 2, 5, 8, 11, 14 and 17 minutes from time 0) 
followed by collection every 6 minutes until 75 minutes of optogenetic protocol. The a second both 
baseline and blood sample collection are performed with the second optical stimulation. Following 
light stimulation, mice were injected with GnRH (200 ng/kg) to test pituitary gland responsiveness, 
and blood samples were collected at – 5 (baseline), 0 and 15 minutes. Whole blood samples were 
diluted in 57 µL of 0.1 M phosphate buffered saline-tween (PBS-T) pH 7.4, frozen in dry ice and 
stored at -20 ºC for subsequent hormone measurement.  
6.2.4 Hormone measurement – LH ELISA 
A well-established ultrasensitive ELISA method was used to measure circulating LH in mice as 
previously reported (Steyn et al., 2013; Czieselsky et al., 2016). Briefly, 96-well high affinity 
binding plates (Corning®) were coated with a bovine LH518B7 monoclonal antibody (1:1,000 
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in 1X PBS; 50 µL per well). Circulating hormone levels were determined using a standard curve 
for LH generated with serial dilutions of a mouse LH-RP reference provided by A. F. Parlow 
(National Hormone ad Pituitary Program, Torrance, CA, USA). Standards, positive controls and 
samples were incubated in the plates for 2h in a humidified chamber on an orbital shaker at room 
temperature. A rabbit polyclonal primary antibody for LH (1:10,000; rabbit antiserum 
AFP240580Rb; National Hormone and Peptide Program, USA) and a polyclonal goat anti-rabbit 
IgG secondary antibody (1:1,000 in 50% blocking + 50% PBS-tween buffer solution; DAKO) were 
used for this assay. LH levels were determined using an absorbance plate reader at 490 nm and 650 
nm wavelengths (more details about the protocol can be found in Chapter 2). The sensitivity of this 
routine LH ELISA assay was 0.002 ng/mL. The average intra-assay coefficient of variation was 
3.1% and the inter-assay coefficient of variation was 10.7%.  
6.2.5 Brain slice electrophysiology (Spike fidelity) 
Acute coronal brain slices (250-µm thick) accommodating the ARN were prepared from either 
VGAT-Cre+/--TdTomato or VGAT Cre +/-   GnRH GFP male mice (N = 3 each, but pooled since 
no difference could be detected) injected with AVV9-ChETA-eYFP as reported elsewhere (de 
Croft et al., 2012; Han et al., 2015). These experiments were performed in collaboration with Dr 
Sabine Hessler, a postdoctoral fellow in our laboratory. Briefly, brain slices were kept at 32°C in 
95%/O2/CO2 artificial cerebrospinal fluid with (in mM) 120 NaCl, 3 KCl, 1 NaH2PO4, 26 
NaHCO3, 2.5 CaCl2, 1.2 MgCl2, 10 HEPES, and 10 glucose. Cell-attached voltage-clamp (10-30 
MΩ) recordings of ARN ChETA-expressing neurons were performed using an upright 
epifluorescence microscope (Olympus). Following brief illumination with green light, ARN 
ChETA-expressing neurons were patched using differential interference contrast optics. Blue light 
(473 nm) stimulation consisted of 5-ms blue light pulses using a Grass S88X stimulator controlled 
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by diode-pumped solid-state (DPSS) laser (IkeCool©). Light pulses were delivered at 2, 5, 10, 20, 
50 and 100 Hz, and power light at the tip of the optical fiber was set at 10% of the light (~ 5mW). 
Action potentials were recorded (3- to 5-MΩ pipettes) were recorded using 0-mV command 
voltage. Data acquisition used a Multiclamp 700B amplifier (Molecular Devices) coupled with 
Digidata 1322A. 
6.2.6 Immunohistochemistry 
Perfusion PFA 4%-fixed brains were saturated in a 30% sucrose-Tris buffer saline (TBS) solution 
overnight and cut into three series of 30-µm thick coronal sections using a freezing stage 
microtome (Leica®, Wetzlar, Germany). Coronal brain sections throughout the ARN and rostral 
preoptic area (rPOA) of the hypothalamus were chosen according to the mouse brain atlas (Paxinos 
and Franklin, 2004). To determine the proportion of ARN GABA neurons transfected with AAV9-
ChETA-eYFP, free-floating dual-label immunohistochemistry was performed using the primary 
antibodies polyclonal chicken anti-GFP (1:2,500, Aves Labs Inc.) and polyclonal rabbit anti-GnRH 
antiserum (1:5,000, gift from Dr Allan Herbison, University of Otago). Brain sections were 
incubated with the primary antibodies and 2% normal goat serum for 48 h at -4 °C. AlexaFluor488 
goat anti-chicken (1:200) and AlexaFluor647 Cy5 donkey anti-rabbit (1:500, Abcam®) were used 
as secondary antibodies. TdTomato reporter expression was visualized by its endogenous 
fluorescent signal without any immunolabeling. Primary antibody omission served as a negative 
control of the procedure.  
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6.2.7 Image acquisition and analysis 
Brain sections were imaged using a Nikon A1R Multi-photon confocal microscope with 488, 543 
and 647 nm diode lasers and a Plan NeoFluor 40X oil objective (1.30 NA). High magnification 
imagens were acquired using a 3x or 5.2x zoom function when suitable and taking Z-stacks of 0.5 
μm steps (pinhole at 1 AU). Two representative coronal sections from both the tARN and cARN 
were selected to determine the colocalization of TdTomato (GABA)- and eYFP (ChETA)-
expressing neurons in male (N = 4) and female (N = 5) VGAT-Cre+/--TdTomato mice and imaged 
using Plan NeoFluor 20X objective. As observed during imaging, the detection of TdTomato is 
mainly restricted to the nucleus and cell bodies, while eYFP immunostaining is prevalent at the 
cell membrane and neuronal fibers. Therefore, to confirm double labelled ARN GABA neurons, 
images were acquired with Z-stacks of 1-μm steps and analysis was undertaken identifying positive 
cells throughout the Z-stacks. Injection site in the ARN and optical fiber position in the rPOA were 
checked for all mice. Confocal images were analyzed with software NIS-Elements AR 4.00.00 
(Nikon® Instruments Inc.). Off-target injections or optical fiber placement outside the rPOA were 
excluded from data analysis. 
6.2.8 Statistical analysis 
Statistical analysis was performed with PRISM software 7.0 (GraphPad Software, San Diego, CA, 
USA) and IBM SPSS 24.0 Statistics software (IBM Corp., Armonk, NY, USA). Normal 
distribution was determined with D'Agostino-Pearson’s normality test. Statistical analysis of LH 
release values was analyzed with a one-way repeated measures ANOVA with Dunnet’s post hoc 
test to compare each point of blood sample collection to the baseline (average of -7 and -1minute 
time points). Fold-change in LH levels was calculated by subtracting the average baseline from the 
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average of the three highest amplitude values of the LH release curve (14, 17 and 23 minutes) 
following optogenetic activation as previously reported (Han et al., 2015). To calculate exogenous 
GnRH-evoked LH secretion (pituitary responsiveness test) average baseline values was subtracted 
from LH peak release at 15 minutes after s.c. injection of GnRH. Statistical analysis of change in 
LH and GnRH-evoked LH release among male, female and PNA mice used a one-way ANOVA 
with Tukey’s post hoc test. GnRH-evoked LH release between female and male Cre-/- mice was 
determined using Student’s t test. Analysis of optogenetic-evoked spike fidelity in ARN GABA 
neurons used Kruskal-Wallis H test with Dunn’s post hoc test. Exogenous GnRH-evoked LH 
secretion between Control Cre-/-male and female mice used Mann-Whitney U test. Statistical 
significance was accepted when P < 0.05. Graphical representation to display significant different 
are shown in figures as * P < 0.05, ** P < 0.01, *** P < 0.001 and **** P < 0.0001. 
6.3 Results 
6.3.1 Selective targeting and expression of ChETA in ARN GABA neurons 
Specific targeting and expression of ChETA in ARN GABA neurons was evaluated in bilaterally 
injected diestrus female (N = 5) and male (N = 4) VGAT-Cre+/--TdTomato mice. Three weeks 
following stereotaxic surgery, brains were analyzed, and confocal imaging revealed that expression 
of ChETA-eYFP was spread within the ARN (Figure 6.3 A). Viral transfection was present around 
the injection site (Figure 6.3 B) and also extended beyond this range throughout the ARN (Figure 
6.3 C) reflecting the anterograde and retrograde properties of the AAV2/9 in neurons  (Rothermel 
et al., 2013). Expression of ChETA-eYFP in the ARN was mainly observed in cell bodies and 
neuronal fibers, whereas TdTomato reporter expression was typically found around the nucleus of 
VGAT neurons (Figure 6.3 B and C). Interestingly, VGAT neurons, which were not transfected 
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with AAV9-ChETA, were observed receiving putative contact from ChETA-expressing fibers 
(Figure 6.3 D).  
 
Figure 6.3. Expression of AAV9-ChETA-eYFP in ARN GABA neurons.  Dual 
fluorescence images show ARN GABA neurons (TdTomato in red) expressing AA V9-ChETA 
(eYFP in green) in a representative section from a VGAT -cre+/ --TdTomato male mouse (A)  
(12.5- µm optical thickness) (scale bar = 100 µm). The site of injection is shown with white 
dotted lines. Viral transfection was observed around the site of injection in the dorsal part 
of the ARN (B) and spread widely throughout the nucleus reaching its ventral part (C) (scale 
bar = 10 µm). ARN GABA neurons also shared ChETA-expressing fibers as observed in 
neurons which were not transfected with AAV9-ChETA-eYFP but received putative contact 
(D). (White arrows) (Scale bar = 100 µm).  
Initial findings showed that viral injections into the rostral ARN (rARN) did not achieve 
significant viral transfection and did not present any effect of optogenetic activation protocol and 
were not included in this study. Hence, viral injections targeted the middle part, which represents 
the tuberal region of the ARN, and caudal part of the ARN (tARN↔cARN), which represents the 
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tuberal part of the arcuate nucleus (Figure 6.4 D i and D ii) and caudal aspect of the nucleus 
(Figure 6.4 D iii). Despite double labeled cells being strongly detected in the whole extension of 
tARN (Figure 6.4 D i and D ii), ChETA expression was restricted to the medial-ventral portion of 
the cARN with eYFP-expressing GABAergic fibers.  
 
Figure 6.4. Characterization of the selective targeting and expression of 
channelrhodopsin-2 E123T accelerated (ChETA) variant in ARN GABA neurons.  
(A) Sagittal view of the mouse brain showing the site of injection into the ARN to drive the 
expression of ChETA-eYFP in VGAT-Cre-TdTomato-expressing neurons. (B) Coronal view 
of the mouse brain with high magnification focus showing the bilateral ventral position of 
Chapter Six 
145 
                                           
the ARN along the third ventricle (3V) of the brain. (C) Representative photomicrographs 
showing VGAT-Cre-TdTomato (red) and ChETA-eYFP (green) expression and overlay 
image in the tARN (scale bar = 100 µm) (D) Double-labelled photomicrographs displaying 
viral transfection in the tuberal (i, ii) to caudal (iii) extension of the ARN (tARN↔cARN). 
Dashed white line delineates the lateral borders of the ARN (3V = third ventricle; scale bar 
= 100 µm).  
Immunohistochemical analysis revealed that ChETA-eYFP was expressed in the great 
majority of tARN GABA neurons in both diestrus female (93.3 ± 1.6%) and male (94.4 ± 1.5%) 
mice (Table 6.1). The proportion of GABA neurons within the cARN expressing eYFP was 
slightly lower than tARN yet with a satisfactory ChETA-eYFP expression of over 80 % in both 
sexes (Table 6.1). A very small number of neurons displayed a single eYFP signal without 
TdTomato co-expression (~ 1 %) in both sexes, confirming the specificity of transfection only in 
Cre+ cells. These results show that ChETA expression can be targeted in ARN GABA neurons 
using a Cre-dependent AAV to allow optogenetic control of these cells in mice.  
 
Table 6.1. Expression of channelrhodopsin-2 E123T accelerated (ChETA) variant 
in ARN GABA neurons of the mice.  The table provides mean ± SEM of the average 
number per section of single labelled vesicular GABA transporter (VGAT) neurons and 
ChETA-expressing neurons in the tARN and cARN from diestrus female (N = 5) and male 
(N = 4) mice. VGAT neurons were identified with the detection of TdTomato reporter gene 
(red fluorescent tag) present in these cells. The table also provides the mean ± SEM 
percentage of dual-labelled VGAT and ChETA neurons along the tARN and cARN extent 
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from both sexes. Colocalization analysis considered two representative sections of each 
tARN and cARN regions.  
6.3.2 ChETA-assisted circuit mapping: an optical strategy to activate ARN GABA 
neuronal fibers in the rPOA 
Next, we investigated whether ChETA-expressing neurons can faithfully be activated by blue light 
(473 nm) pulses. In collaboration with Dr Sabine Hessler, a postdoctoral fellow and 
electrophysiologist in our laboratory, we aimed to target and optogenetically activate ARN GABA 
neurons in vitro. Dr Hessler was able to show that these neurons can optogenetically respond with 
high spike fidelity at 2, 5, 10, 20 and 50 Hz with 5-ms blue laser pulses (N = 6/ 19 GABA neurons) 
(Silva, Hessler, Herbison and Campbell, unpublished data). When testing a high frequency 
stimulation of 100 Hz, the spike fidelity was significantly decreased when compared to lower 
frequencies (100 Hz: 72.5 ± 10.0 % vs. 2-50 Hz: 100.0 ± 0.0%; P < 0.001; Figure 6.5). 
 
Figure 6.5. Characterization of ARN GABA neurons transfected with ChETA-
eYFP. Histogram shows mean ± SEM evoked spike fidelity at 2, 5, 10, 20, 50 and 100 Hz 
of optogenetic activation from cell -attached voltage-clamp recordings in ChETA-expressing 
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ARN GABA neurons in vitro from VGAT-Cre+/-male mice (N = 6). Kruskal-Wallis H test 
with Dunn’s post hoc test; ***P < 0.001. (Silva, Hessler, Herbison and Campbell, 
unpublished data). 
To activate ARN GABA neuronal in vivo in the vicinity of GnRH neuron soma, a ChETA-
assisted circuit mapping based on previous reports (Petreanu et al., 2007) was performed. Briefly, 
VGAT-Cre+/-mice were bilaterally injected with AAV9-ChETA into ARN at the levels of ARN 
GABA neuron cell bodies, and the optical fiber was positioned in the rPOA above and around 
GnRH neurons (Figure 6.6 A and B). Confocal imaging revealed that GnRH neurons were densely 
innervated by ChETA-expressing fibers in the rPOA which originated in the ARN (Figure 6.6 C) 
as previously described (Moore et al., 2015).  Together, these data indicate that the expression of 
ChETA in ARN GABA neurons allow precise control of action potential firing in these neurons 
and that we can map and investigate the function of this specific GABAergic pathway using an 









                                           
 
 
Figure 6.6. ChETA-assisted circuit mapping. (A) Coronal mouse brain template 
showing the position of optical fiber in the rPOA. (B) Photomicrograph show optical fiber 
(white dashed lines) above GnRH neurons (in blue) and ARN GABA neuronal fibers (in 
green), which were transfected with AAV9-ChETA-eYFP (scale bar = 100 µm). (C) 
Projected confocal image and 3D reconstruction of GnRH neuron (in blue) in the rPOA being 
innervated by ChETA-expressing fibers (magenta arrowheads point putative contact) from 
ARN GABA neurons (scale bar = 10 µm). High -magnification 3D reconstruction shows 
ChETA-expressing fiber contact onto GnRH neuron soma  (i) and proximal dendrite (ii, iii) 
(scale bar = 1.5 µm). rPOA = rostral preoptic area; OVLT = organum vasculosum of the 





                                           
6.3.3 Optogenetic activation of ARN GABA neurons in vivo elicits LH secretion and reveals 
a different dynamic of LH release between diestrus female and PNA mice 
To determine whether ARN GABA-to-GnRH neuron circuit is functionally relevant to modulate 
LH secretion, ARN GABA neuronal fibers in the rPOA were activated in male (N = 6), diestrus 
female (N = 10) and diestrus female PNA (N = 5) VGAT-cre+/-mice using in vivo optogenetics. 
Previous studies have shown that mice under isoflurane anesthesia do not display LH pulsatile 
secretion and exhibit low circulating LH levels during the whole protocol (Campos and Herbison, 
2014; Han et al., 2015). Therefore, changes in LH release during light stimulation protocol in 
isoflurane-anesthetized mice are triggered by the stimulation of GnRH neurons. Optogenetic 
activation of ARN GABA neurons at 2 Hz for 10 minutes did not alter blood LH levels; however, 
20-Hz optical stimulation for the same period elicited a robust increase in LH levels as shown in 
representative examples in Figure 6.7 A. Increment changes were typically observed over ~ 10 
minutes from the start of the optical stimulation and remained higher after the blue light was turned 
off in all animals. In diestrus female (N = 4) and male (N = 5) Cre-/- control mice injected with 
AAV9-ChETA and in VGAT-Cre+/- female mice (N = 2) injected with AAV9-eYFP, blue light 
stimulation had no effect on LH secretion (Figure 6.7 B).    
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Figure 6.7. Optogenetic activation of ARN GABA neurons in vivo generates LH 
release in mice.  (A) Representative examples of circulating LH levels from VGAT -Cre+/ -
male (N = 6), diestrus female or female oil -vehicle (grouped together; see in methods 6.2.1) 
(N = 10), and diestrus female PNA (N = 5) mice during protocol to optogenetically activate 
ARN GABA neurons. Blue bars indicate 5-ms blue light stimulation delivered at 2 or 20 Hz 
during 10 minutes (B) Representative traces of LH levels from diestrus female (N = 4) and 
male (N = 5) Cre - / - control mice injected with AAV9-ChETA and in VGAT-Cre+/ - female 
mice (N = 2) injected with AAV9-eYFP. Blue bars indicate 5-ms blue light stimulation 




                                           
To investigate the dynamics of LH release in male, diestrus females and PNA mice, each 
time point was compared to baseline values. All three groups did not show any significant changes 
when 5-ms blue light pulses were delivered at 2 Hz (Figure 6.8 A). The activation of ARN GABA 
neurons at 20 Hz for 10 minutes in male and diestrus female groups generated robust increase in 
LH release, which typically started at 8 minutes from the start of optical stimulation and LH levels 
remained significantly higher than baseline values (P < 0.05) for over 50 minutes (Figure 6.8 B). 
Conversely, PNA mice exhibited a delayed rise in LH release, which occurred ~11 minutes 
following optogenetic activation of ARN GABA neurons and, despite LH levels being elevated for 





                                           
 
Figure 6.8. Dynamics of LH release following the activation in vivo of ARN GABA 
neurons. Effect of optogenetic activation of ARN GABA neurons on LH secretion in ma le 
(N = 6; blue circles), diestrus female (N = 10; red circles), diestrus PNA (N = 5; black 
circles). Cre - / - control male (N = 5) and female (N = 4) mice injected with AAV9 -ChETA 
are shown with respective gender matching groups (open black squares). Blue bars indicate 
5-ms blue light stimulation delivered at 2 or 20 Hz during 10 minutes.  (A) Summary graphs 
show mean ± SEM values of LH levels during 2-Hz optogenetic activation of ARN GABA 
neurons in males, diestrus females and diestrus PNA mice. (B) Summary graphs show mean 
± SEM values of LH levels following optogenetic activation of ARN GABA neurons with 
20-Hz stimulation in males, diestrus females and diestrus PNA mice. Triangles in yellow 
indicate statistically different LH levels compared with pre -stimulus baseline values (-7 and 




                                           
To detect and compare changes in LH among the male, diestrus female and PNA mice, the 
magnitude of hormone secretion was calculated by analyzing the average of LH peak values during 
20-Hz optogenetic stimulation (17, 23 and 29 minutes after the start of the stimulus). Although 
PNA mice displayed lower LH peak levels when compared with male and female mice (average 
LH peak levels: males = 4.94 ± 1.32; diestrus females = 5.18 ± 1.02; diestrus PNA = 2.36 ± 0.50 
ng/mL), no significant statistical differences among the groups were detected (P = 0.21). During 
the performance of LH measurement experiments, great differences in baseline values within each 
group were observed, which ultimately might influence the magnitude of LH peak levels (Patel et 
al., 2004). To overcome this problem, fold-changes in LH release were determined for each group. 
Results showed that LH release was significantly higher in males and females when compared with 
PNA mice following 20-Hz optogenetic activation of ARN GABA neurons (P < 0.05), whereas no 
changes were detected when blue light was delivered at 2 Hz (Figure 6.9). These findings showed 




                                           
 
Figure 6.9. High-frequency stimulation of ARN GABA neurons induces LH 
release in mice. Optogenetically-evoked change in LH levels following 2 -Hz and 20-Hz 
optical stimulation in male (N = 6), diestrus female (N = 10)  and diestrus PNA (N = 5) mice. 
*P < 0.05; One-way ANOVA with Tukey’s post hoc test was applied at each frequency.  
6.3.4 Pituitary responsiveness to exogenous GnRH 
The pituitary responsiveness to exogenous GnRH was tested at the end of the optogenetic 
activation protocol, in which mice were given s.c. injection of GnRH (200 ng/kg). The pituitary 
response to s.c. GnRH is also important to evaluate the functioning of the pituitary gland after the 
optogenetic protocol. Although observed as a decreasing trend for pituitary responsiveness in 
VGAT-Cre+/-male (4.3 ± 1.2 ng/mL; N = 6) to female (3.4 ± 0.6 ng/mL; N = 9) to PNA (2.3 ± 0.6 
ng/mL; N = 5) mice, no statististical differences were detected among the groups (F2, 16 = 1.8; P = 
0.19; Figure 6.10 A). On the other hand, GnRH-evoked changes in LH release of control Cre-/- 
diestrus female mice (N = 4) was significantly lower than control Cre-/- male mice (N = 5) (3.1 ± 
Chapter Six 
155 
                                           
0.3 vs. 5.9 ± 0.7 ng/mL; P = 0.02) (Figure 6.10 B).  These data suggest that sex differences in LH 
release may rise from a differential responsiveness from the pituitary gland as observed in control 
mice, although pre-exposure to optogenetically-evoked high LH levels might change the pituitary 
response to exogenous GnRH. 
 
 
Figure 6.10. Exogenous GnRH-evoked change in LH release following optogenetic 
activation protocol.  Graphs show data analysis of s.c. GnRH (200 ng/kg) -evoked increase 
in LH release (mean ± SEM) at the end of optogenetic activation protocol. (A) Histogram 
shows comparison of s.c. GnRH-evoked change in LH secretion among VGAT -Cre+/ -male 
(N = 6), diestrus female (N = 9) and PNA (N = 5) mice. One -way ANOVA with Tukey’s post 
hoc test. (B) Histogram presents pituitary responsiveness dictating change in LH secretion 





                                           
6.4 Discussion  
6.4.1 Summary of findings 
To dissect the functional role of ARN GABA neurons, ChETA expression was selectively targeted 
in these neurons using Cre-Lox recombinase technology. This strategy yielded effective 
transfection with ChETA of ~ 90% and 80% of VGAT neurons in the tARN and cARN, 
respectively. Electrophysiological studies in our laboratory have demonstrated that ChETA display 
high spike fidelity with laser pulses delivered up to 50 Hz and effectively activate ARN GABA 
neurons. Taking advantage of the AAV9 anterograde/retrograde properties, transgene expression 
was widely spread within the ARN and elsewhere in the mouse brain. ChETA expression was 
present in ARN GABA neuronal fibers reaching the rPOA over 1000 µm from the injection site. 
The present study revealed that an in vivo 20-Hz optogenetic stimulation of ARN GABA neurons 
for 10 minutes elicits robust LH release for over an hour in male and diestrus female mice similarly, 
whereas a lower frequency of stimulation (2 Hz) failed to induce changes in LH levels. Despite 
diestrus female and male mice exhibiting similar optogenetically-evoked increase in LH secretion, 
PNA female mice presented significantly lower magnitude of LH release when light pulses were 
delivered at 20 Hz. To determine the nature of these differences, the pituitary responsiveness to 
exogenous GnRH was tested in all groups. Sex differences in GnRH-evoked LH release were found 
in control Cre-/-mice with males exhibiting greater LH release when compared with females. 
Although no significant differences were identified among VGAT-cre+/- male, diestrus female and 
PNA mice, a smaller response in PNA mice was observed during data analysis.  
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6.4.2 Using optogenetics to decipher the functional role of ARN GABA neurons modulates 
GnRH/LH secretion  
To map and probe the functional role of ARN GABA neurons modulating GnRH/LH secretion, a 
ChETA-assisted circuit mapping was performed targeting ARN GABA neuron fibers in the rPOA, 
which contact GnRH neurons. This approach, commonly used to study other circuits in the brain 
(Tye and Deisseroth, 2012), may be an effective tool to interrogate the biological relevance of 
different afferent inputs within the GnRH neuronal network and their role in fertility. Our study 
confirmed that ChETA exhibits high spike fidelity and reports elsewhere have indicated that this 
Ch-2 variant shows fast on/off kinetics, fast post-spiking recovery (Gunaydin et al., 2010) and 
efficient during acute activation in vivo (Jego et al., 2013). Although ChETA has been used to 
activate fast spiking GABA neurons such as parvalbumin interneurons (Urban et al., 2012b; Assaf 
and Schiller, 2016), the present study is novel in the sense of applying this powerful strategy to 
interrogate the role of a specific GABAergic input within the GnRH neuronal network. 
The investigation of GABA actions in GnRH neurons has empirical challenges leading to 
controversial findings across different reports. Early studies demonstrated that injection of GABA 
into the third ventricle (3V) of the brain promotes LH secretion in a dose dependent manner in 
male (Ondo, 1974) and female rats (Vijayan and McCann, 1978). Conversely, the majority of 
pharmacological paradigms reported inhibitory actions of GABA blocking the LH surge by 
infusing GABA in the medial preoptic area (Herbison and Dyer, 1991) or intraperitoneal (i.p.) 
administration of GABAAR agonist muscimol in rats (Adler and Crowley, 1986). These divergent 
findings were likely due to different experimental manipulations, which ultimately obscured the 
functional relevance of specific GABAergic afferents regulating GnRH neuron activity (Herbison 
and Moenter, 2011). This PhD thesis advanced our existing knowledge by applying optogenetics 
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to investigate GABAergic transmission from ARN GABA neurons, which may modulate GnRH 
neuron activity to promote GnRH/LH secretion. Ongoing studies in our laboratory using brain slice 
electrophysiology in VGAT-Cre+/--GnRH-GFP male and diestrus female mice, which were 
injected with AAV9-ChETA into the ARN, will determine the direct effect of the activation of 
ARN GABA neuron on GnRH neuron firing activity. To date, Dr Sabine Hessler has performed 
on-cell recordings from a GnRH-GFP neuron while optogenetically activating ARN GABA neuron 
fibers in rPOA brain slices from VGAT-Cre+/-male mice. Preliminary results show that about 30% 
of GnRH neurons show immediate activation to 10- and 20-Hz blue light stimulation and around 
20% of the cells showed a delayed activation (Figure 6.11). In addition, most GnRH neurons did 
not respond to 2-Hz stimulation (Silva, Hessler, Herbison and Campbell, unpublished data). 
Further experiments are being addressed to uncover whether these responses in GnRH neurons are 




                                           
 
Figure 6.11. Optogenetic activation of arcuate (ARN) GABA neuron fibers 
directly depolarize GnRH-GFP neurons in vitro.  Representative on-cell voltage-
clamped recordings of GnRH-GFP neuron following the activation of ChETA-expressing 
neuronal fibers from ARN GABA neurons in the  rPOA. Coronal brain slices were prepared 
from VGAT-cre+/ -male mice injected with AVV9-ChETA-eYFP into the ARN. Optogenetic 
protocol was performed with 5-ms blue light pulses (indicated by blue traces) delivered at 
10 and 20 Hz over 5 minutes.  
 
 Excitatory and inhibitory actions of GABA on GnRH neurons were also investigated in 
isoflurane-anesthetized GnRH-GFP mice by Constantin and colleagues (Constantin, Iremonger 
and Herbison, 2013). Researchers showed that GnRH neurons located in the anterior hypothalamic 
area (AHA) exhibit excitation or inhibition in response to muscimol administration in on-cell 
recordings. Interestingly, the same group demonstrated early on that the net effect of GABA actions 
is likely to be determined by a differential expression of GABAAR and GABABR along the GnRH 
Chapter Six 
160 
                                           
neuron extent (Constantin et al., 2012). This study showed that GABAAR-mediated net excitation 
was predominantly observed in rPOA brain slices, which preserves the GnRH neuron soma and 
proximal dendrites, whereas an increase in GABABR-mediated net inhibition was seen using 
parahorizontal brain slices that maintain AHA GnRH neurons and distal segments of other GnRH 
neurons (Constantin et al., 2012). In addition, ARN GABA neurons are known to robustly 
innervate the proximal dendrites and cell bodies of GnRH neurons located in the rPOA/OVLT 
region (Moore et al., 2015). Based on these studies, I performed pilot studies at the beginning of 
the PhD project (Appendix IV) and discovered that performing viral transfection with ChR-2 at 
the level of the ARN and optically stimulating ARN GABA fibers in the rPOA led to a robust LH 
release in mice as opposed to aiming the activation of these neurons directly in the ARN. Different 
ARN GABA neurons might project to different parts of the GnRH neuron extent; therefore, using 
this optogenetic strategy might enable us to investigate GABA actions that are known to have a 
more net excitation in GnRH neurons and be involved in the pathophysiology of PCOS.  
6.4.3 Dynamics of LH release following the activation of ARN GABA neurons 
Optogenetic activation of ARN GABA neurons using low frequency stimulation of 2 Hz was not 
effective to induce changes in LH secretion whereas 20-Hz stimulation generated a fourfold LH 
release in male and diestrus female mice and likely to be through the upregulation of GnRH neuron 
activity. The activation of GABA neurons did not promote LH pulse-like release  as seen, for 
instance, following the activation of kisspeptin neurons (Han et al., 2015) or GnRH neurons 
(Campos and Herbison, 2014). Instead, the LH secretion observed after optogenetic activation of 
ARN GABA neurons lasted longer than those observed in previous reports, promoting LH release 
above baseline levels for over 60 minutes in male and diestrus female mice groups.  
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Previous studies showed that low frequencies of stimulation (< 1 Hz) of anteroventral 
periventricular (AVPV) nucleus monosynaptic inputs to GnRH neurons generate predominantly 
GABAAR postsynaptic currents (PSCs), whereas higher frequencies promote delayed activation 
by the neuropeptide kisspeptin in mice (Liu et al., 2011). The present findings, along with the 
literature may indicate two main possibilities. Firstly, different requirements in vitro versus in vivo 
to activate GnRH neurons that are sufficient to promote LH secretion might explain these 
differences. Secondly, the long-lasting LH release at high-frequency stimulation is also suggestive 
of neuropeptidergic transmission along with GABA (Liu et al., 2011). ARN GABA neurons are 
known to express a wide range of neuropeptides and other neuromodulators (Zuure et al., 2013; 
Marshall et al., 2016; Campbell et al., 2017; Chachlaki et al., 2017), which present direct influence 
in GnRH neurons and for the control of fertility. For instance, neuropeptide Y (NPY), which 
represents around one third of the ARN GABA neuronal population (Marshall et al., 2016), is able 
to evoke direct depolarizing and hyperpolarizing responses in GnRH neurons (Roa and Herbison, 
2012). Agouti-related peptide (AgRP), which is also colocalized in NPY neurons, exhibits different 
types of responses in GnRH neurons (Roa and Herbison, 2012). Although ARN kisspeptin neurons 
are known to elicit strong LH release following optogenetic activation (Han et al., 2015), our 
laboratory showed that in fact a small population of VGAT neurons in the ARN express kisspeptin 
(Marshall et al., 2016), which seems unlikely to drive such long-lasting LH secretion as seen in 
our results. A dissection of possible candidates that might drive or be release with GABA from 
ARN GABA neurons is beyond the scope of the present study; however, future studies in our 
laboratory will further investigate this issue. 
Although significant increase in LH levels were observed at 8 minutes following the start 
of optical stimulation, 20-Hz-induced LH peak levels occurred around 23 minutes after the 
beginning of the light stimulation (0 min) in all groups. The present study was limited to determine 
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the mechanism of this delayed rise in LH release. Studies using electrophysiological recordings in 
brain slices from GnRH-GFP male mice and dynamic current clamp showed that excitatory GABA 
induces a delayed temporal shift for excitatory actions of glutamate via AMPA receptors in GnRH 
neurons (Roberts, Hemond and Suter, 2008). Therefore, a pre-exposure to excitatory GABA 
actions might “charge” the membrane capacitance of GnRH neurons in order to increase their 
response to following additional excitatory inputs (Roberts, Hemond and Suter, 2008), which could 
explain the delayed yet long-lasting LH release following optogenetic activation of ARN GABA 
neurons.  
6.4.4 Activation of ARN GABA neuron promotes altered LH secretion in PNA mice 
Enhanced GABAergic transmission in GnRH neuron activity in PNA mice (Sullivan and Moenter, 
2004) may be culprit for the elevated LH pulse frequency secretion in adulthood (Moore et al., 
2015). Based on these evidence, we firstly postulated that the activation of ARN GABA neurons 
would promote a greater LH release in PNA mice than in normal females. Contrary to this initial 
hypothesis, 20-Hz optogenetic activation of ARN GABA neurons induced smaller magnitude and 
changes in LH release of PNA mice when compared with male and diestrus female mice. Of note, 
early studies had shown that small changes in the amplitude of LH secretion are a direct readout 
of a high GnRH pulse frequency. Specifically, high frequency secretion of GnRH generates lower 
LH release amplitude as a reflection of the pituitary LH releasable pool stores in ewes (Clarke and 
Cummins, 1985). Evidence from studies in non-human primates (Wildt et al., 1981) and rodents 
(Lerrant et al., 1995) demonstrated that high-frequency GnRH stimulation decreases LH synthesis 
and secretion. Therefore, we might attribute the small magnitude release of LH in PNA mice due 
to the abnormally elevated GnRH/LH pulsatile secretion in a PCOS-like condition.   
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The pituitary sensitivity following optogenetic protocol was similar among PNA, male and 
diestrus female mice, which indicates that altered LH release might be a primary outcome of altered 
GABAergic wiring but not pituitary responsiveness. Sexually dimorphic differences in the 
pituitary sensitivity could be detected in control Cre-/-mice as previously reported in that males 
display greater GnRH-evoked LH release than female mice (Han et al., 2015). Accordingly, serial 
pulse bleeding studies showed that the LH pulse frequency of male mice is lower than female mice 
(Steyn et al., 2013; Czieselsky et al., 2016), implying that the GnRH/LH frequency determines the 
LH releasable pool in the pituitary gland. However, following robust optogenetically-evoked LH 
secretion in VGAT-cre+/- female and male showed similar exogenous GnRH-evoked LH release. 
This might indicate that a GnRH self-priming effect following optogenetic activation protocol 
might alter the pituitary outcome (Pickering and Fink, 1976, 1979). Future experiments are 
required to determine the pituitary responsiveness in PNA and normal female mice without 
optogenetic activation of ARN GABA neurons. 
6.4.5 Conclusion 
The results in these chapter outline a potential circuit-mediated mechanism by which ARN GABA 
neurons may drive GnRH/LH secretion and be biologically meaningful for the control of fertility. 
Furthermore, I was able to characterize an optogenetic approach, which can be applied to 
specifically target and activate discrete GABAergic populations within the hypothalamus. These 
data show critical support for the hypothesis that ARN GABA neurons are a functional component 
of the GnRH neuronal network and that abnormalities in this circuit generates altered LH release 
such as seen in PCOS. 
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7 Chapter Seven: 
Final Discussion  
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7.1 Physiological and clinical relevance of the study 
PCOS is a major hyperandrogenic endocrine disorder leading to female infertility and affecting 
approximately one in ten women around the world (Dumesic et al., 2015). Women with PCOS 
present distressing effects of circulating androgen excess such as hirsutism, alopecia and acne 
problems (Azziz et al., 2009). PCOS is also strongly associated with metabolic comorbidities, for 
instance obesity and diabetes mellitus type 2 (Ladrón de Guevara et al., 2014), and psychosocial 
disorders such as depression (Milsom et al., 2013). Although PCOS is a prevalent and complex 
disorder, the etiological mechanisms causing the disease remain unclear. Both clinical and basic 
research supports the idea that prenatal androgen excess may change the architecture of the female 
brain and contribute to the development of PCOS during adult life. Specifically, disordered 
GABAergic innervation and activity transmission to GnRH neurons occurs in a PCOS (Sullivan 
and Moenter, 2004; Moore et al., 2015) and women with PCOS display high levels of cerebrospinal 
fluid GABA (Kawwass et al., 2017). Other conditions which leads to high androgen levels, such 
anabolic steroid abuse, impact GABA actions in GnRH neurons (Nieschlag and Vorona, 2015). In 
addition, women under treatment for epilepsy, which ultimately increases the GABAergic tone, 
commonly develop PCOS-like reproductive impairments (Bilo and Meo, 2008). Therefore, this 
triad of androgen excess, enhanced GABAergic innervation to GnRH neurons and reproductive 






                                           
7.2 Background 
The present PhD thesis aimed to investigate the ontogeny, plasticity and functional role of 
GABAergic innervation on GnRH neurons in PCOS. The examination of altered wiring in the 
developing female brain has been highlighted in clinical and pre-clinical studies as one possible 
culprit for the origin of PCOS (Daniels and Berga, 1997; Pastor et al., 1998; Sullivan and Moenter, 
2004). Despite the speculated heritable etiology of PCOS, large genetic studies have failed to detect 
defects in single genes that could explain the complexity and prevalence of this broad disorder. On 
the other hand, prenatal exposure to elevated androgens is strongly associated with the 
developmental origin of the neuroendocrine derangements in PCOS and the postpubertal 
manifestation of the disease (Hague et al., 1990; Sir-Petermann et al., 2002; Padmanabhan and 
Veiga-Lopez, 2013b).  
Prenatal androgen excess is known to induce increased GABAergic transmission (Sullivan 
and Moenter, 2004) and innervation (Moore et al., 2015), which is associated with impairment of 
reproductive function in PNA mice. Elevated GABA actions within the GnRH neuronal network 
may lead to an overexcitation of GnRH neurons that ultimately increase GnRH/LH secretion. In 
addition, clinical evidence identified that altered LH secretion in PCOS can be restored through 
the chronic blockade of androgen-mediated actions (Eagleson et al., 2000) indicating a possible 
rescue of normal brain wiring. Based on these important findings, this PhD project was aimed to 
answer critical questions which remained elusive about the development and functional role of 
altered GABA actions in the brain leading to the manifestation of PCOS.  
The initial studies presented in this thesis aimed to determine the ontogeny of abnormal 
GABA-to-GnRH neuron innervation in relation to the onset of puberty and time of androgen 
Chapter Seven 
167 
                                           
excess. To address this specific object, immuhistochemical studies were performed to identify 
GABA inputs on GnRH neurons in prepubertal PNA mice and circulating testosterone levels were 
assessed (Chapter 3). Further studies aimed to determine the developmental timing of androgen 
excess from puberty to adulthood in PNA mice, and whether the removal of hyperandrogenic 
ovaries in these animals would promote similar LH pulse secretion as detected in normal females 
(Chapter 4).  Exploring the requirement of androgen receptor (AR) signaling in PCOS, this thesis 
investigated the effect of long-term AR blockade on GABAergic contact onto GnRH neurons in 
PNA mice (Chapter 5). Emphasizing the role of altered brain wiring for the manifestation of 
PCOS, this PhD work also interrogated whether rescuing normal GABA-to-GnRH neuron circuit 
would promote improve reproductive cycles and ovarian morphology in PNA mice (Chapter 5). 
Finally, the functional role of ARN GABA neurons in the regulation of LH secretion was 
investigated by applying an optogenetic strategy, which specifically target and activate this 
GABAergic population in normal and PNA mice (Chapter 6). 
 This final discussion will summarize and integrate the main findings of this PhD work and 
highlight the contributions and limitations of these studies. The results of this PhD project will be 
critically outlined and discussed to envision their implications for the understanding of PCOS 
pathophysiology. Lastly, this final discussion will feature some possible avenues for future 






                                           
7.3 Summary of findings 
The initial findings of this PhD work revealed that enhanced GABAergic wiring onto GnRH 
neurons is established early (PND 25), prior to the development of post-pubertal circulating 
androgen excess (Chapter 3). GABAergic innervation was visualized with immunolabeling of 
VGAT contact onto GnRH-GFP neurons. VGAT appositions were significantly greater on GnRH 
neuron soma and both primary and secondary dendrites in PNA females. Very recently, another 
research group has published evidence that GABAergic postsynaptic currents (PSC) are elevated 
in 3-week old PNA mice (Berg, Silveira and Moenter, 2018). This increase GABAergic drive 
might contribute to abnormal GnRH neuron activity in these animals in the same prepubertal stage 
(Dulka and Moenter, 2017). These complimentary findings suggest that prenatal androgen 
exposure drives a biological program that disrupts normal GABA-to-GnRH neuron circuit wiring 
before puberty and may drive the neuroendocrine impairment of PCOS in adulthood. 
 As outlined in the results of Chapter 3, the presence of brain wiring abnormalities might be 
dependent upon early androgen excess in PNA mice and not prepubertal androgen elevation. 
Therefore, the developmental timing of androgen excess in PNA mice was addressed in this study. 
Androgen excess was found to be increased in PNA mice during early adulthood at PND 50 and 
PND 60 (Chapter 4). Interestingly, during pubertal transition at PND 40, control and PNA mice 
exhibited highly variable testosterone levels, which significantly decrease in normal females 
toward adulthood. In contrast, increasing increments of testosterone levels were observed in PNA 
mice leading to elevated circulating androgen levels in adulthood (Chapter 4). All 
hyperandrogenic PNA mice displayed disrupted estrous cyclicity, showing longer metestrous 
stages and lacking the detection of proestrous, which indicate anovulatory cycles (Chapter 4). The 
same cohort of mice were followed to address the question whether hyperandrogenic ovaries were 
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the only culprit in the neuroendocrine impairment of a PCOS-like condition. From this study, 
findings revealed that while post-castration LH pulse frequency and basal LH levels were similar 
between control and PNA mice, PNA mice had a higher LH pulse amplitude and a higher 
magnitude of LH release compared to controls (Chapter 4). These results suggest that even in the 
absence of elevated circulating androgens, the regulation of pituitary gonadotropin secretion is 
different to healthy controls. This suggests that wiring changes in the brain that drive increased LH 
secretion might still be present maintained in a short-term absence of testosterone.   
 Androgen excess might be involved in both the initial developmental programming of the 
PCOS-like phenotype and the progression of the disease during adulthood. Pharmacological 
treatment with flutamide (Flut), over the defined time when androgen excess develops (from PND 
40 to PND 60), tested the hypothesis that blockade of AR signaling would restore reproductive 
cycles by rescuing normal GABA-to-GnRH neuron innervation in PNA mice. I discovered that 
long-term blockade of AR signaling is sufficient to reverse abnormal GABAergic innervation to 
GnRH neurons, improve estrous cyclicity and an increase in the recruitment of preovulatory 
follicles in PNA mice (Chapter 5). Although, I could not detect a significant improvement of 
corpora lutea (CL) in PNA+Flut mice, this group exhibited a ~ 4-fold increase in the number of 
CL when compared to PNA+oil group, suggesting a progressing recovery of the ovulatory rate. In 
addition, AR blockade rescued the normal morphological features of both preovulatory follicle 
granulosa and theca cell layers suggesting an improvement in gonadotropin-mediated actions in 
the ovary (Chapter 5). These compelling findings indicate that improvement of reproductive 
function in PNA mice might result from upstream restoration of normal GABA-to-GnRH neuron 
wiring.  It also indicates that, although prenatal androgen programs altered GABAergic 
innervation, this circuit remains plastic by blocking androgen actions in the adult female brain. 
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 The neuroanatomical evidence of robust innervation from ARN GABA neurons to GnRH 
neurons (Moore et al., 2015) and the current findings implied that this GABA neuronal population 
could have a functional role for the regulation of GnRH/LH secretion. The last chapter of this thesis 
proposed to investigate this idea by applying an optogenetic strategy to activate ARN GABA 
neuronal fibers, which putatively innervate GnRH neurons, located in the rPOA/OVLT. Using viral 
tracing and Cre-LoxP technology, a selective expression of ChETA in ~ 80% of ARN GABA 
neurons was achieved and in vitro studies showed that activation of ChETA-expressing ARN 
GABA neurons could trigger action potentials with high fidelity (Chapter 6). Novel results 
demonstrated that high-frequency optogenetic activation (20 Hz/10 minutes) of ARN GABA 
neurons in vivo can evoke robust LH release in both female and male mice (Chapter 6). These 
findings presented that ARN GABA-to-GnRH neuron circuit is functionally relevant to modulate 
GnRH/LH secretion in both sexes. The activation of ARN GABA neurons also stimulated LH 
release over a similar timeframe and in response to the same frequency in PNA mice; however, 
these animals presented a significantly lower magnitude of LH release. The responsiveness of 
gonadotropes to exogenous GnRH was also decreased in PNA mice, although not statistically 
different from both male and diestrus female mice (Chapter 6). Evidence from an early study 
suggested that high GnRH pulse frequency generates lower LH release amplitude in ewes (Clarke 
and Cummins, 1985). Therefore, this inverted relationship between elevated GnRH pulse 
frequency in a PCOS-like condition and a lower LH releasable pool in the pituitary might drive the 
altered LH pulse amplitude in PNA mice. Future studies may investigate the LH releasable pool in 
non-optogenetically activated PNA and normal female mice to dissect out the nature of the current 




                                           
7.4 Contributions and limitations of the study 
7.4.1 Understanding the ontogeny of altered brain wiring in PCOS 
The results of this thesis have shown that prepubertal GnRH neurons receive pronounced 
GABAergic innervation and that this is significantly increased in PNA mice when compared to 
normal females. This enhanced GABAergic contact on GnRH neurons was present before the 
elevation of circulating androgen levels in PNA mice (PND 25), implying that brain abnormalities 
were programed by androgen excess in utero, not result of the precocious manifestation of 
hyperandrogenism. These data unveil an important aspect of the ontogeny of the PCOS-like 
condition, suggesting that a prenatal biological program promotes altered GABAergic 
synaptogenesis within the GnRH neuronal network.  
 PNA treatment occurs during late pregnancy in mice from gestational day (GD) 16 to 18. 
Before this time, around GD 14 to 15, the vast majority of GnRH neurons have already migrated 
from the olfactory nasal placode into the preoptic area and caudal diencephalon in the mouse brain 
(Wray, Grant and Gainer, 1989). A subset of GnRH neurons can produce GABA during early 
embryonic development and the neurotransmitter synthesis peaks around embryonic day (ED) 15 
and decreases significantly toward a virtual absence in GnRH neurons during perinatal period in 
rodents (Tobet et al., 1996). The restraint of GABA synthesis by embryonic GnRH neurons is 
essential for the normal positioning of these neurons in the forebrain and normal reproductive 
function (Heger et al., 2003). To date, no study has emphasized differences in the number of GnRH 
neurons along the frontal to caudal extent of the hypothalamus in PNA mice, indicating that PNA 
treatment may not impair fertility by changing the organization or migration of hypophysiotropic 
GnRH neurons (Prescott and Campbell, unpublished data). Therefore, it seems unlikely that PNA 
treatment disrupts GnRH neuron migration to the forebrain and changes in GABA-to-GnRH 
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neuron circuit might happen due to altered organization of presynaptic GABAergic innervation 
that projects to GnRH neurons. 
Recently published findings have also shed some light on the temporal resolution of altered 
GABAergic innervation of GnRH neurons during prepubertal development. GnRH neurons are 
reported to receive GABAergic transmission as early as at one week of age in mice (Berg, Silveira 
and Moenter, 2018). Interestingly, in PNA female mice, GABAergic transmission becomes 
robustly elevated at 3-weeks of age, returns to low values similar to controls at 4 weeks and it is 
abnormally high during adulthood (Berg, Silveira and Moenter, 2018). GnRH neurons are 
surprisingly active during prepubertal stages and, specifically, elevated neuronal activity is 
observed around 3-weeks of age in normal female mice (Dulka and Moenter, 2017). In contrast, 
PNA female mice exhibit a decrease of GnRH neuron activity during the same prepubertal stage 
(Dulka and Moenter, 2017). Interestingly, around 4 weeks of age, PNA mice shows GnRH neuron 
firing (Dulka and Moenter, 2017) and GABA PSCs in GnRH neurons (Berg, Silveira and Moenter, 
2018) similar to normal females; however, these are lost over pubertal development and become 
abnormal during adulthood. Together, these findings with the results in this thesis suggest that 
altered GABA inputs and transmission to GnRH neurons manifests around PND 25 but remains 
under some form of homeostatic control that blunts the postsynaptic response to GABA until 
activation of the HPG axis. During pubertal development, this control is lost and an enhanced 
response to GABAergic transmission is initiated and drives inappropriate GnRH/LH secretion. 
This elevated GABAergic innervation actions is likely to convey an altered feedback signal to 
GnRH neurons (Moore et al., 2015), allowing their overexcitation. The establishment of 
hyperandrogenemia may contribute to permit continuous impairment and desensitization of the 
GnRH pulse generator during adulthood (Figure 7.1). 
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Figure 7.1. Development of altered GABAergic innervation to GnRH neurons 
induced by prenatal androgenization. Prenatal androgenized (PNA) mice are generated 
by the induction of androgen excess during late pregnancy in mice from gestational day 
(GD) 16 to GD 18. During prenatal development, overactivation of androgen signaling in 
steroid-sensitive GABAergic afferents program altered brain wiring through unknown 
mechanisms (e.g.: via epigenetic remodeling). On PND 25, altered GABAergic innervation 
to GnRH neurons can be detected in the  hypothalamus, which may promote the increase of 
GABAergic transmission to GnRH neurons detected at this time (Berg, Silveira and Moenter, 
2018) in PNA mice. During pubertal development and maturation o f the reproductive system, 
homeostatic control that maintains reduced GnRH neuron activity through prepubertal 
development (Dulka paper here) might be lost in PNA mice, which allows the manifestation 




                                           
 There is increasing evidence indicating that prenatal androgen excess imprints 
hypothalamic circuits, potentially leading to the development of PCOS features (Moore and 
Campbell, 2017). The mechanisms by which PNA treatment induces altered GABAergic wiring to 
GnRH neurons remains to be determined. To date, it is unclear whether AR signaling acts directly 
on steroid-sensitive GABA neurons. AR is expressed in the developing female brain (Brock, De 
Mees and Bakker, 2015), therefore, AR signaling could directly drive the increased innervation. It 
also remains to be investigated whether increased GABAergic signaling has any excito-cytotoxic 
effect in GnRH neurons, which could affect synaptogenesis as observed in androgen-treated 
prepubertal hippocampal neurons (Nuñez, Alt and McCarthy, 2003; Nuñez et al., 2005).  
This study investigated only one prepubertal developmental time point.  The specific time 
course of neuronal plasticity remains to be determined.  It would be of interest to determine whether 
greater GABAergic innervation is already present before birth and whether is functionally required 
to induce prepubertal alterations within the GnRH neuronal network.  
7.4.2 Understanding the developmental timing of androgen excess and the post-pubertal 
manifestation of PCOS 
Although the origin of PCOS may happen during prenatal life, clinical features commonly manifest 
later during the peripubertal period (D.H. Abbott et al., 1998; Crisosto et al., 2007). There is long 
standing evidence that mild elevation of androgen levels during adolescence might be required for 
the establishment of hyperandrogenemia during adulthood and for the development of PCOS 
(Azziz et al., 2009; McGee et al., 2012). However, it is unknown whether androgen excess occurs 
prior to the neuroendocrine impairment of PCOS or whether it could be the downstream result of 
altered development of the HPG axis. This thesis showed that androgen excess takes places during 
young adulthood and it is associated with the development of anovulatory cycles in PNA mice. 
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The identification of time course of androgen excess in PNA mice contributes with the evidence 
that prepubertal altered brain wiring is not dependent upon precocious elevated testosterone levels. 
It also strengths the idea that abnormal GABAergic wiring on GnRH neurons might be primary to 
the ovarian dysfunction, reassuring the brain a primary site for PCOS pathogenesis.  
Various studies assert the conclusion that unbalanced levels of circulating androgens in 
adult females culminate in derangements of neuroendocrine function and infertility (Lizneva, 
Gavrilova-Jordan, et al., 2016). Clinical evidence indicates that chronic blockade of the classical 
AR with Flut can improve menstrual irregularities (Paradisi et al., 2013) and attenuate circulating 
androgen levels (De Leo et al., 1998). Notably, Flut treatment also rescues the ability of 
progesterone to decrease high LH pulse frequency in PCOS women (Eagleson et al., 2000), 
suggesting that AR blockade may restore normal wiring within the GnRH neuronal network. Initial 
electrophysiological studies revealed that Flut treatment decrease GABAergic transmission to 
GnRH neurons in PNA mice to normal levels (Sullivan and Moenter, 2004). However, it was 
unclear whether Flut treatment was able to change an abnormal brain wiring, which was thought 
to be hardwired before pubertal onset (PND 25) in PNA mice. Despite this evidence supporting 
early organization of wiring defects, long-term AR blockade significantly rescued normal 
GABAergic innervation on GnRH neurons and effectively improved reproductive function in PNA 
mice. The observed changes in the brain were more dramatic when compared to changes in the 
ovarian morphology, which the latest seemed to be gradually recovered. These findings may either 
indicate that the female brain is more sensitive to AR signaling blockade than the ovaries or that 
changes in brain wiring are necessary for the downstream improvement of ovarian function. The 
improvements in granulosa and theca cell layer features suggest that the restoration of normal 
follicle morphology after AR blockade is more likely to be indirect, through the normalization of 
gonadotropin action, which could reflect normalized GnRH/LH secretion. In addition to the current 
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findings, it would be interesting to test in future studies whether Flut treatment improves LH pulse 
frequency and future work is needed to clarify this subject. The present findings advance our 
knowledge of the pathophysiology of PCOS and highlight AR antagonism as a therapeutic target 
(Figure 7.2).  
 
Figure 7.2. Ontogeny and plasticity of GABA-to-GnRH neuron circuit 
abnormalities in a preclinical model of PCOS.  Typically, female androgen levels 
are relatively low throughout pubertal development and into adulthood, with the 
exception of a small peripubertal rise (blue line). Elevated perinatal androgens can 
drive a hyperandrogenic PCOS condition in adulthood (red line). GABA to GnRH 
neuron circuit abnormalities are present before the onset of puberty in prenatally 
androgenized PCOS-like mice, suggesting early programming of this aberrant wiring. 
Adult PCOS-like mice remain with enhanced GABAergic inputs onto GnRH neurons 
associated with an impairment of steroid hormone-mediated negative feedback, 
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disruption of reproductive cycles and ovarian dysfunction. Remarkably, GABAergic 
wiring to GnRH neurons is still plastic through androgen receptor signali ng blockade, 
which also positively impacts reproductive cycles, and improves the recruitment and 
features of preovulatory follicles. (Red dots indicate GABAergic innervation on 
GnRH neurons).  
 
 Flut treatment can both inhibit androgen signaling pathway in androgen-dependent manner 
(Ilagan et al., 2005) and decrease the expression of AR in male and female mice (Kontula et al., 
1985). Studies have mapped the expression of AR throughout the female hypothalamus and 
showed that the number of AR-expressing cells in the AVPV is ~ 30 % greater in PNA mice when 
compared to diestrus controls (Moore et al., 2015). This raises the question of whether chronic Flut 
treatment is able to decrease the AR expression in the AVPV or other regions in the hypothalamus 
involved in the regulation of feedback mechanisms such as the ARN. Ongoing work in our 
laboratory is addressing this specific issue by mapping the expression of AR in the hypothalamus 
of diestrus female and PNA mice after AR signaling blockade. 
 Neuronal circuits are dynamic and the androgen milieu influences synaptogenesis and 
plasticity (Leranth, Hajszan and MacLusky, 2004b; MacLusky et al., 2006). The observed changes 
in GABA-to-GnRH neuron wiring in response to Flut poses the possibility that long-term AR 
blockade might act directly on AR-sensitive neurons to either induce synaptic plasticity or 
desensitize androgen-dependent synaptogenesis (Pettorossi et al., 2013). Considering that AR 
expression exhibits a relatively fast turnover (Kontula et al., 1985), it remains to be investigated 
whether the normal GABA-to-GnRH neuron circuit is maintained following cessation of Flut 
treatment or whether this improvement would be lost. It also remains to be determined whether the 
functionally restored ovarian morphology in PNA mice following Flut treatment would achieve 
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readily fertilizable oocytes. The present study was limited to assess these issues due to a restrain 
of time for the completion of further experiments and future work in our laboratory will address 
these questions.   
The developmental window of AR blockade might also influence the impact on brain 
circuit plasticity. Clinical reports suggest that treatments for PCOS to prevent the progression of 
the disorder may be more effective when applied in adolescence rather than later in life (Ibáñez 
and de Zegher, 2004; Ibáñez et al., 2011; Ornstein, Copperman and Jacobson, 2011). The 
confirmation of this evidence is challenging as long-term investigations are less feasible and 
commonly have ethical burdens. The use of PCOS animal models, such as PNA mice, promotes 
the opportunity to investigate the effectiveness of different interventional paradigms and 
prospective outcomes to be further applied in the clinics (Franks, 2015). The present PhD study 
revealed that Flut treatment during the therapeutic window targeting the early rise of circulating 
testosterone levels (from PND 40 to PND 60) was effective to rescue normal brain wiring and 
estrous cyclicity in PNA mice. However, the effectiveness of other prospective therapeutic 
windows, for instance, before onset of puberty starting at PND 25, or during adulthood after PND 
60 remains to be investigated.  
7.4.3 Understanding the functional role of ARN GABA neurons in the GnRH neuronal 
network 
Previous work suggests that increased GABA innervation to GnRH neurons arises largely from the 
ARN. ARN GABA neurons densely contact GnRH neurons and this innervation is ~ 30 % greater 
in PNA mice compared to diestrus controls (Moore et al., 2015). In addition, ARN GABA neurons 
express progesterone receptor (PR) and this PR expression is dramatically decreased in PNA mice, 
asserting that a loss of progesterone sensitivity in these neurons might underlie the neuroendocrine 
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impairments in PNA mice (Moore et al., 2015). Based on these neuroanatomical observations, the 
present study aimed to address the biological relevance ARN GABA neurons in the modulation of 
GnRH/LH secretion in both normal and PCOS-like condition. The results presented in Chapter 6 
provide compelling evidence that ARN GABA neurons are functionally important within the 
GnRH neuronal network and that activation of ARN GABA neuron fibers around the vicinity of 
GnRH neurons (rPOA/OVLT region) elicits LH release in vivo. 
 As discussed in Chapter 6, different attempts have been made to identify the role of specific 
GABAergic inputs to GnRH neurons mostly using electrophysiological preparations (Glanowska 
and Moenter, 2011; Liu et al., 2011; Constantin et al., 2012). The distance between the ARN and 
the rPOA/OVLT regions (over 1000 µm) poses a technical impediment to study this specific 
pathway as typical coronal brain slice preparations are only 200-300 µm thick.  Of note, reported 
GABA actions in GnRH neurons vary from in vitro studies to in vivo reports (Herbison and 
Moenter, 2011; Constantin, Iremonger and Herbison, 2013), suggesting that brain slice 
preparations may damage GABAergic inputs to GnRH neurons. This PhD study utilised in vivo 
optogenetics to study this neurocircuitry and interrogate the function of ARN GABA neurons in 
HPG axis regulation. Optogenetic experimental designs with channelrhodopsin-2 (ChR-2) are 
widely employed to map and probe circuit function and address specific biological questions in the 
mammalian brain (Yizhar et al., 2011; Tye and Deisseroth, 2012). This PhD study applied ChETA-
assisted circuit mapping to investigate the role of ARN GABA neurons. This approach rendered 
the target of ChETA expression in a substantial proportion of ARN GABA neurons (≥ 80 %) using 
Cre-Lox recombinase technology and revealed that high-frequency optogenetic activation (20 Hz) 
was able to elicit LH release in vivo.  
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 Optogenetically-evoked LH release did not display a pulse-like profile as reported 
following the optogenetic activation of other GnRH neuronal afferents such as ARN kisspeptin 
neurons (Han et al., 2015). It remains unclear whether other optogenetic strategies using alternative 
light stimulation protocols may influence the magnitude of LH release and promote LH pulse-like 
secretion through the activation of ARN GABA neurons. Additional experiments are addressing 
some of these questions and, to date, ongoing examination indicates that 10-Hz optogenetic 
activation of ARN GABA neurons over 10 minutes does not induce significant change in LH 
release (Figure 7.3). To evaluate whether the extent of light pulses could influence LH secretion 
rather than the pace of stimulation (frequency), ongoing experiments have tested optogenetic 
activation using 10-Hz stimulation for 20 minutes. To date, the increment changes in LH secretion 
following this paradigm of optogenetic activation of ARN GABA neurons promoted smaller 
responses than 20-Hz stimulation for 10 minutes (Figure 7.3). Therefore, these preliminary data 
suggest that the pace of neuronal firing rather than the number of delivered spikes might be 
important to evoke sufficient changes in GnRH neuron activity and elicit LH secretion. 
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Figure 7.3. Effect of optogenetic activation of ARN GABA neurons using different 
stimulation patterns.  Example of VGAT-cre+/-female mice injected with AVV9-ChETA-
eYFP into the arcuate nucleus (ARN) and optical fiber implanted into the rostral preoptic 
area (rPOA). The 20-Hz optogenetic activation (10 min) could elicit LH secretion, while 10 -
Hz stimulation (10 min) did not change  the increment in LH release. The same number of 
light pulses of a 20-Hz (10 min) stimulation were delivered over 20 minutes at a frequency 
of 10 Hz. At the end of the protocol, pituitary response was tested with s.c. injection of 
GnRH (200 ng/kg).   
 
Having the evidence ARN GABA neurons express sex steroid hormone receptors (Moore 
et al., 2015) and may contribute to negative feedback mechanisms, we might speculate that the 
activity of ARN GABA neurons is tightly controlled by gonadal hormones to avoid overexcitation 
of GnRH neurons and elevated GnRH/LH release. Decreased PR expression in these cells might 
be linked to a blunted negative feedback and result in unrestrained activity that leads to high 
GnRH/LH secretion (Figure 7.4). The molecular and cellular mechanisms by which ARN GABA 
neurons specifically control GnRH neuron activity in males and females, and throughout the female 
reproductive cycles remain to be investigated. The ARN GABA neuronal population is diverse and 
has been involved in the control of reproduction, metabolism, and underlying some of the 
pathological features of polycystic ovary syndrome (PCOS) (Moore and Campbell, 2016). Using 
transcriptomic technology with Drop-seq generation of single-cell sequencing, researchers 
discovered that around 19 distinct GABA neuron phenotypes reside in the ARN (Campbell et al., 
2017). These ARN GABA neurons co-express important neuromodulators which are also involved 
in the regulation of reproductive function such as somatostatin, NPY, thyrotropin releasing 
hormone (TRH) and dopamine (Campbell et al., 2017). Considering this vast heterogeneity within 
the ARN GABA neuronal population, the optogenetic activation of these neurons is likely to drive 
changes in other physiological systems. Future electrophysiological experiments are needed to 
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address the nature of specific neurotransmitter/neuropeptides that GnRH neurons are responding 
to following the activation of ARN GABA neurons. Therefore, the results introduced in this thesis 
may open the opportunity for further dissection of the biological role of different ARN GABA 
neuronal populations for the modulation of GnRH/LH secretion and fertility. 
 
Figure 7.4. The ARN GABA-to-GnRH neuron circuit in females.  ARN GABA 
neuron project to GnRH neurons and are a functional component within the GnRH neuronal 
network for the regulation of GnRH/LH secretion. Evidence from previous studies suggest 
that ovarian steroid mediated-negative feedback rely upon the proper functioning of steroid -
sensitive ARN GABA neurons (green neurons with light blue nucleus) (Moore et al., 2015). 
ARN GABA also communicate among themselves (dashed green lines) and project to other 
areas in the brain as observed in the present study and in previous reports (Kong et al., 2012; 
Zhang and van den Pol, 2015) . The activation of ARN GABA fibers around the vicinity of 
GnRH neurons can promote LH release in a frequency-depend manner and alterations within 




                                           
 
 As noted in Chapter 6, 20-Hz optogenetic activation of ARN GABA neurons induced 
smaller magnitude and increment change of LH release in PNA mice when compared with male 
and normal female mice. The amplitude of LH secretion is a direct readout of GnRH pulse 
frequency and pituitary responsiveness to pulsatile GnRH actions (Thompson and Kaiser, 2014). 
Specifically,  it has been demonstrated in the ewe that high frequency GnRH secretion results in a 
lower amplitude of LH release reflecting a  smaller LH releasable pool in the pituitary (Clarke and 
Cummins, 1985). The small amplitude LH release in PNA mice points toward an on-going higher 
GnRH pulse frequency that has decreased pituitary stores of LH leading small magnitude release 
(Figure 7.5). These data suggest that long-term exposure to high GnRH pulse frequency may 
remodel the pituitary responsiveness to GnRH in the presence of ovarian hormones. In fact, this 
thesis also showed that castrated PNA mice exhibit an abnormal increase of LH amplitude, 
suggesting that in the absence of negative feedback onto the pituitary gland and in the brain, the 
LH releasable pool stores might be increased in response to high GnRH pulse frequency (Chapter 
4). It is unlikely that postpubertal androgen excess may be directly altering LH synthesis in the 
pituitary as studies showed that conditional AR knockout in the gland mice present normal mRNA 
and content of LH (Wu et al., 2015). It remains to be investigated the pituitary response of control 
versus PNA mice with exogenous GnRH, which future experiments in our laboratory will be 
addressing.   
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Figure 7.5. PNA mice shows decreased amplitude of LH secretion following optogenetic 
activation of ARN GABA neurons. The scheme shows a model of possible 
neuroendocrine mechanism by which PNA mice display smaller increment changes in 
LH release following the optogenetic activation of ARN GABA neurons. Enhanced 
GABAergic innervation may drive a hyperactive state of GnRH neurons, which in 
turn present a high GnRH/LH pulse frequency. Elevated GnRH actions in the pituitary 
gland might induce high LH pulse frequency and smaller LH releasable pool stores. 
Optogenetic activation of ARN GABA neurons promotes a robust LH release, which 
reveals the altered gonadotropin secretion reflecting the high GnRH/LH pulse 
frequency in a PCOS-like condition.  
 
 Although this thesis provides compelling evidence that ARN GABA neurons have a 
meaningful role in the modulation of GnRH/LH secretion, the functional requirement of this circuit 
remains to be defined. During the PhD project, many attempts were made to address the hypothesis 
that ARN GABA neurons are required for normal pulsatile LH secretion and fertility. To test this 
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hypothesis, I aimed to ablate ARN GABA neurons and follow LH pulse release in freely moving 
mice. Firstly, to permanently ablate ARN GABA neurons, stereotaxic injections using rAAV-flex-
taCasp3-TEVp (UNC Vector Core) into the ARN of VGAT-cre+/--TdTomato were performed in 
male and female mice. This approach triggers a Cre-dependent cell-autonomous apoptosis through 
the activation of an exogenous Caspase-3 in neurons as observed in previous reports (Yang et al., 
2013). To date, viral-mediated ablation of ARN GABA neurons could not be achieved using 
smaller volumes of injections (50-100 nL/side). In contrast, a complete ablation of ARN GABA 
neurons was accomplished with a larger volume of injection (1-2 µL) (Figure 7.6). The ablation 
was wide spread in the hypothalamus reaching other GABA neurons which project to the ARN 
such as the dorsomedial hypothalamic (DMH) GABA neurons (Garfield et al., 2016) (Figure 7.6). 
Although neuronal ablation was achieved in the latest experiments, mice presented an abrupt 
weight loss and recurrent seizures after 2 weeks of viral transfection, which were not ethically 
acceptable, and trials were discontinued. Future studies may attempt different titers and volumes 
to achieve a safe range of neuronal ablation and evaluate the impact of arcuate-specific GABA 




                                           
 
Figure 7.6. Permanent ablation of ARN GABA neurons with Cre -dependent 
expression of Caspase-3 in mice. (A) VGAT-cre+/ --TdTomato were injected with saline 
vehicle showing the expression of TdTomato (red) in GABAergic neurons in the arcuate 
nucleus (ARN) and dorsomedial hypothalamus (DMH). (B) Higher magnification showing 
VGAT-TdTomato-expressing neurons in the ARN. (C) VGAT-cre+ /--TdTomato were injected 
with rAAV-flex-taCasp3-TEVp, which drives the expression of exogenous caspase -3 in 
neurons. TdTomato (red) signal was absent from ARN and other regions such as DMH. (D)  
Higher magnification showing the absence of VGAT -TdTomato-expressing neurons in the 





                                           
7.5 Future directions 
7.5.1 Investigating prepubertal markers and mechanisms of altered brain wiring in PCOS 
Various studies have attempted to find genetic (polymorphisms) and epigenetic markers for PCOS, 
which are associated with the manifestation of the disorder. The majority of these studies have 
include women of reproductive age (Cui et al., 2013; Mutharasan et al., 2013; Day et al., 2015) as 
the identification of prepubertal girls who will later develop PCOS remains unclear. Animal 
models represent an important tool to investigate developmental changes in PCOS and to identify 
possible markers before the pubertal manifestation of the disease. One example that future 
investigations could take advantage of is the recent discovery showing the relationship between 
epidermal growth factor receptor (EGFR) family members such as ERBB4 and ERBB3 and the 
pathogenesis of PCOS (Day et al., 2015). EGFRs are known to participate in the regulation of 
ovarian LH-mediated steroidogenesis (Park et al., 2004) and have a strong influence on brain 
circuit development (Namba et al., 2017). Polymorphisms of EGFR family members could be 
identified through skin samples as they are expressed in the human and in the mouse epidermis 
(Hoesl et al., 2018) and serve as a potential marker for the development of PCOS. Therefore, it 
could be possible that PNA treatment may promote epigenetic changes that affect EGFR signaling 
in GABAergic inputs within the GnRH neuronal network. These changes could be detected early 
in life and contribute to the development of PCOS-like features in PNA mice.   
Early detection and treatment of PCOS could be ideal as the disorder does not only affect 
reproductive function but is strongly associated with diabetes mellitus, obesity and an increased 
risk of cardiovascular disease (Apter, 1998). Bearing the evidence that neuroanatomical alterations 
occur within the GnRH neuronal network, it would be reasonable to address the question whether 
prenatal androgen excess can program altered GABAergic innervation in brain circuits involved 
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in the regulation of metabolism and cardiovascular function. For instance, hypothalamic circuits 
involved in the control of reproduction and metabolism as the ARN agouti related peptide 
(AgRP)/NPY/GABA neurons (Padilla et al., 2016) and TH/GABA neurons (Brown et al., 2016) 
could also be affected in prepubertal PNA mice. Interestingly, AgRP/NPY/GABA neurons can 
modulate arterial pressure and heart rate and influence obesity-related cardiovascular dysfunction 
(Shi, Madden and Brooks, 2017). Future work may define whether prenatal androgen excess may 
also affect these different brain circuits and contribute for the complex and heterogeneous 
manifestation of PCOS. 
It is known whether AR signaling is required in GABA neurons to drive the development 
of PCOS-like features in PNA mice. To address this specific question a Cre-loxP approach might 
be effective to genetically knockout AR expression from GABA neurons in the brain. Future 
experiments in our laboratory will address this issue by crossing AR-floxed transgenic mice  (De 
Gendt and Verhoeven, 2012) with VGAT-cre+/+ mice to investigate whether PNA treatment is able 
or not to recapitulate brain abnormalities and neuroendocrine dysfunction in the absence of AR 
signaling in GABA neurons.  
Future studies may also define whether prenatal androgen exposure alters GABAergic 
wiring specifically through the AR. Androgens such as DHT can be converted into 5-androstane-
3-17-diol (3-diol), which have high affinity for estrogen receptor  (ER) (Lund, Hinds and 
Handa, 2006). GnRH neurons express ER (Abrahám et al., 2003) and could be indirectly affect 
by PNA treatment with DHT. Future studies could address this subject by generating PNA mice 
which are also transgenic knockout animals for ER in order to evaluate whether PNA treatment 
remains able to induce the PCOS-like phenotype. 
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7.5.2 Investigating the mechanisms of AR signaling blockade which contribute for the 
reversal of brain abnormalities in PNA mice 
The present study demonstrated that long-term blockade of AR signaling from PND 40 to PND 60 
can reverse altered GABAergic wiring on GnRH neurons, restore estrous cyclicity and improve 
the recruitment of preovulatory follicles in PNA mice. It is possible that different windows of 
treatment can be more efficient or that a loss in efficiency when testing AR blockade in different 
developmental stages may give new insights about the pathophysiology of PCOS. Future studies 
could determine the impact of Flut treatment either at the time of prenatal androgen exposure or 
postnatally before altered GABAergic wiring can be identified. 
Flut is a non-steroidal anti-androgen, which may present some adverse effects as early 
clinical report indicated the possibility of liver failure due to hepatotoxicity during treatment for 
hirsutism (Andrade et al., 1999). Despite this initial finding, the risk of Flut side-effects was 
assessed in clinical (Ibáñez et al., 2005; Dikensoy et al., 2009) and meta-analysis studies (Domecq 
et al., 2013) and the majority of the findings suggest a minimal or total absence of hepatotoxicity 
of Flut doses, which are used for the treatment of PCOS symptoms. Future studies may address the 
impact of other AR blockers on rescuing normal sensitization of the GnRH pulse generator and 
restoring fertility in PCOS. For instance, bicalutamide, branded as Casodex, has been recently 
found to improve hirsutism in PCOS patients (Moretti et al., 2017) and remains to be investigated 
whether this anti-androgen could also improve normal neuroendocrine regulation of LH secretion. 
In addition, a third-generation of AR blocker currently applied for the treatment of prostate cancer 
named tetraaryl cyclobutane, or CB (Pollock et al., 2016). The CB compounds may be more 
efficient than other AR antagonists (e.g.: flutamide and enzalutamide) as it acts by impeding the 
translocation of AR into the nucleus of the cell and may present less side-effects (Pollock et al., 
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2016). Therefore, future pre-clinical and clinical work could investigate the potential therapeutic 
application of this drug for the treatment of PCOS. 
7.5.3 Investigating the biological function and requirement of ARN GABA neurons in the 
control of GnRH/LH secretion and female fertility 
This thesis provided evidence that ARN GABA neurons might be involved in the control of 
GnRH/LH secretion as optogenetic activation of these neurons evoked robust LH release in female 
and male mice. Interestingly, optogenetic activation of ARN GABA neurons in PNA mice also 
evoked LH secretion but with a significant smaller amplitude of LH release. As discussed 
previously (Chapter 6), this altered magnitude of LH secretion might be the result of an elevated 
GnRH/LH pulse frequency in PNA mice. If abnormal pituitary responsiveness is driven by altered 
GnRH pulse frequency, future studies may combine Flut treatment and optogenetic activation of 
ARN GABA neurons in order to test whether rescuing the abnormal GABAergic wiring from this 
specific GnRH neuronal afferent may promote robust LH release similar to normal female mice.  
 Increased GnRH/LH secretion following optogenetic activation of ARN GABA neurons 
may rise from other neurotransmitters/neuropeptides which are also expressed in ARN GABA 
neurons and have an impact in reproduction (Marshall et al., 2016; Campbell et al., 2017). Future 
electrophysiological studies may determine the nature of signals which are being released from 
ARN GABA neuron terminals during optogenetic stimulation. Transgenic and Cre-LoxP 
technologies have provided important tools to investigate the physiological function of distinctive 
neuronal phenotypes involved in the control of reproduction using in vivo optogenetics (Qiu et al., 
2016; Clarkson et al., 2017). Different Cre-driver transgenic lines of interest are available to 
examine the role of specific ARN GABAergic inputs to GnRH neurons such as TH-cre mice 
(Runegaard et al., 2017), dopamine transporter (DAT)-cre mice (Yip et al., 2017), AgRP-cre mice 
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(Aponte, Atasoy and Sternson, 2011), among others. Future work may also attempt to decipher 
whether PNA treatment affects ARN GABA neurons in general or whether prenatal androgen 
insult is phenotype-specific. 
 As mentioned above, during this PhD project, experiments aiming to test the requirement 
of ARN GABA neurons for GnRH/LH pulsatility and fertility were firstly performed driving the 
expression of exogenous caspase-3 in VGAT-expressing neurons. The detection of wide spread 
cell ablation generated real concerns about the severity of side-effects. As an alternative for this 
objective, future studies will address the same question using a technique that leads to neuronal 
silencing of ARN GABA neurons. In this approach, VGAT-cre+/+mice will receive bilateral 
injection of Cre-dependent AAV-DJ-TeNT (AAV-TetTox) virus into the ARN. AAV-TetTox 
drives the expression of tetanus toxin light chain in neurons, which inhibit neurotransmitter release 
and altered postsynaptic sites by decreasing the density of dendritic spines in the receptor cell 
(Heimer-McGinn et al., 2013). This approach has been successfully used by others when 
investigating the requirement of AgRP/NPY neurons in adaptive behaviors such as food seeking 




                                           
7.6 Concluding remarks 
The work presented in this PhD thesis supports the hypothesis that prenatal androgen excess is an 
important factor for the development of PCOS and that brain circuit abnormalities, which may 
underlie the pathogenesis of the disorder, are present well before the onset of puberty. Additionally, 
this altered GABAergic innervation on GnRH neurons in the prepubertal brain may not be 
dependent upon early rise of circulating androgen levels in PNA mice; however, the molecular and 
cellular mechanisms triggering these brain abnormalities remain elusive. Major changes in 
circulating testosterone levels occur after pubertal development during early adulthood in PNA 
mice, which may be the result of an abnormal maturation of the HPG axis in a PCOS-like condition. 
Targeting this rise of circulating androgen levels in PNA with long-term AR blockade, resulted in 
the rescue of normal GABAergic wiring to GnRH neurons followed by an improvement of 
reproductive function. ARN GABA neurons are considered to cause the increased GABAergic 
innervation on GnRH neurons in PNA mice and were suggest to regulate LH secretion. Functional 
studies addressed this subject and showed that in vivo optogenetic activation of ARN GABA 
neurons result in robust and sustained LH secretion. Conversely, activation of ARN GABA 
neurons in PNA mice led to small LH release amplitude, which may reflect an altered regulation 
of the LH releasable pool in the pituitary by a high GnRH pulse secretion in these animals. The 
results presented in this PhD thesis advance our existing knowledge in the fields of PCOS and 
androgen excess in the female brain, providing new insights about the pathophysiology of PCOS 
and prospective therapeutic interventions for future use in the clinics.  
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9.1 Appendix I: List of chemical reagents  
Solution Reagents pH 
0.1 M Phosphate-buffered saline 
(PBS) 
0.1 M sodium phosphate monobasic 
0.1 M sodium phosphate dibasic 
7.4 
4% Paraformaldehyde 4% (w/v) paraformaldehyde 
0.1 M phosphate buffer 
7.6 
1X Tris-buffered saline (TBS) 0.5 M Tris-hydrochloride  
0.5 M Tris-base 
0.15 M sodium chloride 
7.6 
30% Sucrose (cryoprotectant 
sucrose) 
30g of sucrose in  
100 mL of 1X TBS 
7.4 
Cryoprotectant  
(to store of brain sections at -20ºC) 
1.0 M phosphate buffer 
0.9% (w/v) NaCl 
30% (w/v) sucrose 
1% (w/v) polyvinylpyrrolidone (PVP-40) 
30% (w/v) ethylene glycol 
7.6 
Citrate buffer 1.03% (w/v) citric acid [5.15g] 
1.816% (w/v) sodium phosphate [9.08g] 
[values for 500 mL of solution] 
5.0 
PBS-Tween 20 0.1 M PBS 
0.05% Tween-20 
7.4 
Incubation solution 1X TBS 
0.25% (w/v) Triton-X-100 
0.3% (w/v) bovine serum albumin (BSA) 
2% (w/v) normal goat serum  
7.6 
Flutamide 
(Sigma-Aldrich, St Louis, MO,USA) 
 
  Dose: 25 mg/kg/day 
▪ 0.10 g of Flutamide + 1 mL of absolute ethanol 
to make up a 10X stock solution 
▪ Flutamide ethanol solution is diluted in nine 




Table 9.1. List of chemical reagents for solutions used in all experiments.  
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9.2 Appendix II: Characterization of primary antibodies for 
immunohistochemistry 
List of primary antibodies: 
 
Table 9.2. Validity of primary antibodies. 
 
  










# GFP - 1020 
 
Specificity was verified by western 
blot (Aves Labs, data sheet) and by 
the absence of immunoreactivity in 
wild-type mice that lacked 
endogenous GFP expression  













# 131 003 
 
Specificity verified in knockout 
studies (Synaptic systems, data 
sheet) and by western blot 











Gift by Dr Greg Anderson 
(University of Otago, 
New Zealand) 
 
Specificity verified by peptide pre-
absorption 
(Rizwan et al., 2012) 
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9.3 Appendix III: Verification of anti-androgenic effects of Flutamide dose 
Background and objectives: 
Pharmacological therapies aiming to ameliorate the impact of hyperandrogenemia (HA) in PCOS 
use antiandrogens such as Flutamide (Flut). Flut is a nonsteroidal anti-androgen acting as a 
selective antagonist of the androgen receptor (AR), competing with other androgens such as 
testosterone and dihydrotestosterone (Schulz et al., 1988).  Previous studies reported that a 
10mg/kg/day dose of  Flut s.c. was able to improve reproductive cycles in PNA mice and restore 
normal GABAergic transmission to GnRH neurons (Sullivan and Moenter, 2004). Early pilot 
studies in our laboratory tested this dose and could not find any impact or improvement of estrous 
cyclicity in PNA mice. Initially, a pilot study aimed to confirm anti-androgenic effect of a higher 
dose of s.c. Flut 25 mg/kg/day as used in other previous reports (Shouqi Luo et al., 1997; Kim et 
al., 2002).  
Methods: 
Male (N = 4) and female (N = 4) C57BL6 mice were injected daily with 100μL of Flut at a dose 
of 25mg/kg/day for 15 days. Control vehicle animals received 100μL of sesame oil during the 
same period. Male mice were used as biological control to assess the effectiveness of Flut treatment 
according to studies elsewhere (Poyet and Labrie, 1985; Shouqi Luo et al., 1997). Animals were 
euthanized using cervical dislocation at the end of treatment and tissues were collected. Seminal 
vesicles and adrenal gland weights were measured from treated intact male mice, and ovaries and 
adrenal gland weights were measured from treated female mice. Statistical analysis was performed 
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with PRISM software 7.0 (GraphPad Software, La Jolla, CA, USA). Control and Flut-treated mice 
were compared using Mann-Whitney U test. 
Results and conclusion: 
In males, s.c. Flut 25 mg/kg/day for 15 days significantly decreased seminal vesicle weight (P < 
0.05) and adrenal gland weight (P < 0.05) compared to oil-treated controls, confirming the anti-
androgenic effect of this dose (Figure 9.1). In healthy females, the same treatment protocol had 
no effect on ovarian or adrenal gland weight. The results demonstrated that s.c. Flut 25 mg/kg/day 
has pronounced antiandrogenic effects in androgen-responsive tissues of male mice, and 
benchmarked this dose to be used in further experiments of Chapter 5. The absence of changes in 
either adrenal or ovarian weight were expected and confirm that antiandrogenic treatment effects 
are better visualized in male mice. 
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Figure 9.1. Effects of flutamide (Flut: 25mg/kg/day) administration in male and female mice. 
Flut was administered by subcutaneous (s.c.) injections daily for 15 days. 
Antiandrogenic effects at the dose of 25mg/kg/day were determined by measuring the 
weight of (A) seminal vesicles and adrenal glands from male mice (N = 4), our 
positive biological control, and the weight of (B) ovaries and adrenal glands from 





                                           
9.4 Appendix IV: Trials for optogenetic activation of ARN GABA neurons 
Background and objectives: 
Optogenetics haven opened opportunities to investigate the physiological role of discrete neuronal 
circuits in different systems (Tye and Deisseroth, 2012). During the initial stage of this PhD 
project, a series of pilot studies aimed to determine the best optogenetic strategy to activate ARN 
GABA neurons, which could promote LH secretion in mice. Following the establishment of the 
technique in our laboratory, pilot studies which firstly aimed the activation of either ARN GABA 
neuron cell bodies or neuronal processes in the rPOA. Trials undertook different protocols, which 
mainly varied the time and frequency of light stimulation. This appendix resumes the results found 
during the performance of the optogenetic pilot studies.   
Methods: 
Animals: Male and female mice from either GnRH-Cre+/- mice or VGAT-Cre+/-transgenic lines 
were housed at the Hercus Resource Unit (University of Otago - Dunedin) under 12h: 12h light-
dark cycles (lights on at 0700h) with ad libitum access to water and food.  
AAVs:  
• AAV9-ChR2-mCherry = AAV2/9-EF1-dflox-hChR2-(H134R)-mCherry-WPRE-hGH; 
4.35x1013GC/mL (PennVector Core). 
• AAV9-ChR2-eYFP = EF1a-DIO-hChR2-(H134R)-eYFP-WPRE-hGH; 6.12x1013GC/mL 
(PennVector Core). 




                                           
 
General protocol for optogenetic stimulation: Three weeks after AAV injection, mice were 
given 2% isoflurane anesthesia and same surgical procedures as reported in Chapter 6. Cannula 
with a 100-μm diameter optical fiber (Thorlabs, Inc.) was implanted either into the rPOA or into 
the ARN. The light stimulation consisted of 5-ms blue light (473 nm) pulses using a Grass S88X 
stimulator controlled by diode-pumped solid-state (DPSS) laser (IkeCool©). The power light at 
the tip of the optical fiber was set at 5mW. Serial blood samples and LH measurements were 
performed as described above (Chapters 2 and 6).  
Results and conclusion: 
Table 9.1 presents an overview of the results from all optogenetic pilot studies, which predated the 
findings showed in Chapter 6. Initial pilot study (Pilot 1) was performed in order to establish 
optogenetics in our laboratory based on previous reports (Campos and Herbison, 2014). As 
expected, optogenetic activation of GnRH neuron cell bodies in the rPOA at 5, 10 and 20 Hz 
promoted robust LH secretion (Figure 9.2 A). Pilot study 2 aimed to target the expression of ChR-
2 in the ARN and stimulate ARN GABA neurons cell bodies using the same light stimulation 
protocol as used in Pilot 1. In contrast, results showed that this optogenetic activation protocol did 
not promote changes in LH release (Figure 9.2 B). A similar outcome with no changes in LH 
levels was observed during the execution of pilot study 3, which tested 2 Hz (10 and 20 min) and 
10 Hz (10min) light stimulation (Figure 9.2 C). Taking advantage of the retrograde properties of 
AAV9-ChR2-mCherry, Pilot 4 attempted to backfill ARN GABA neurons which project to the 
rPOA. Viral transfection was not efficiently present in the ARN and optogenetic activation of ARN 
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GABA neurons did not elicit LH secretion (Figure 9.2 D). In pilot 5, viral transfection with AAV9-
ChR-2 was aimed at the level of ARN GABA neuron cell bodies and optical fiber was positioned 
in the rPOA, around the vicinity of GnRH neurons. Results showed that 2 mice (1 male/1 female) 
out of 7 showed sufficient transfection and LH secretion following 20-Hz stimulation for 10 
minutes (Figure 9.2 E). Pilot 6 applied the same transfection and light stimulation strategy, but 
with AAV9-ChETA and all mice with sufficient transfection exhibited robust LH secretion 
following 20-Hz stimulation for 10 minutes (Figure 9.2 F). Therefore, the same optogenetic 
strategy from pilot study 6, named ChETA-assisted circuit mapping, was applied to investigate the 
functional role of ARN GABA neurons in mice.  
Appendices 
231 
                                           
 
 Table 9.3. Results from optogenetic pilot studies. 
Pilot Mice Sex AAV








1 GnRH-Cre+/- Female (N = 7) AV9-ChR2-mCherry ME rPOA
2, 5, 10 and 20 Hz 
(5 min each)
LH release was 









Female (N = 8); 
Male (N = 5)
AV9-ChR2-mCherry ARN ARN
2, 5, 10 and 20 Hz 
(5 min each)






Female (N = 5) AV9-ChR2-mCherry ARN ARN
2 Hz (10 / 20 min);                   
10 Hz (10 min)






Female (N = 6) AV9-ChR2-mCherry rPOA ARN
2 and 20 Hz            
(10 min each)






Female (N = 5); 
Male (N = 2)
AV9-ChR2-eYFP ARN rPOA
2 and 20 Hz            
(10 min each)
LH release with 20 Hz 







Female (N = 3); 
Male (N = 5)
AV9-ChETA-eYFP ARN rPOA
2 and 20 Hz            
(10 min each)
LH release with 20 Hz 




                                           
 
Figure 9.1. Optogenetic pilot studies.  Graphical examples from pilot studies 1 (A), 2 
(B), 3 (C), 4 (D), 5 (E) and 6 (F) to investigate the functional role of ARN GABA neurons 
in the modulation of LH secretion.  
 
